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The incidence of infertility is rising and estimated to affect one in six couples, yet 
a significant number of couples have an undefined cause for their infertility. The search 
for causes of male infertility has been the focus of many recent investigations, however, 
many questions remain. We hypothesized that genetic and epigenetic states of the mature 
sperm are important for establishing proper germ cell identity, function, and 
developmental capacity. We reason that perturbations to the genome or epigenome may 
underlie a subset of idiopathic cases of infertility. This dissertation addresses some 
potential genetic causes of male infertility; focusing on the genetic causes of an abnomal 
protamine ratio. Our gene re-sequencing studies examined whether single nucleotide 
polymorphisms (SNPs) in the untranslated regions of the protamine genes (Chapter 3) or 
in a transcriptional regulator of the protamine genes known as YBX2 (Appendix A) may 
account for the altered P1/P2 ratio in infertile men. We concluded that gene mutations in 
these two regulatory elements were a rare cause of male infertility. As an alternative we 
turned to examine whether epigenetic changes in the germline may underlie some cases 
of male infertility. Initially we focused on characterizing the sperm chromatin of fertile 
men. A comprehensive analysis of the sperm epigenome revealed novel biological 
features that revised our understanding of the potential role of sperm chromatin in the 
creation of a totipotent gamete (Chapter 5). We then assessed whether changes in the 
chromatin landscape associate with infertility or poor reproductive outcome. Interesting, 
we show significant changes in DNA methylation at a number of imprinted loci (Chapter 
6 and 7) and subtle changes in the overall chromatin landscape (H3K4me and H3K27me) 
genome-wide that may have a detrimental effect on fecundity (Chapter 7). Taken 
together, these studies reinforce the dogma that infertility is a complex disease and that 
changes in the genetic and the epigenetic states of the mature sperm may account for 
some, but not all, cases of idiopathic infertility. Furthermore, these data suggest that germ 
cell chromatin may have a significant role in germ cell function and possibly contribute 
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Infertility is a major health problem worldwide, affecting at least one in every 
eight couples. Many infertility problems are currently attributed to endocrinopathies, 
ejaculatory failure, gametogenesis dysfunction, tubal disease, uterine abnormalities, 
ovarian dysfunction and environmental exposure; however, a significant number of 
couples also have unexplained infertility. The high prevalence of unexplained infertility 
cases can be attributed, in part, to the poor understanding of the basic genetic and 
epigenetic mechanisms regulating fertility. We hypothesized that genetic and epigenetic 
states of the mature sperm are important for establishing proper germ cell identity, 
function, and developmental capacity. We reasoned that perturbations to the genome or 
epigenome may underlie a subset of idiopathic cases of male infertility and/or poor 
reproductive outcome. This dissertation aims to understand the contribution of sperm 
chromatin to the creation of a totipotent gamete, fertility, and development.  
 
Human Sperm Chromatin Packaging: Protamines and Their Role in Fertility 
During postmeiotic maturation of male haploid germ cells, chromatin undergoes 
dramatic reorganization including the exchange of canonical histones with intermediate 
highly basic transition nuclear proteins, which are subsequently replaced with protamines 
(discussed in Chapter 2 Review).1 Protamines are arginine rich sperm specific nuclear 
proteins that are evolutionarily related to H1 linker histone.2,3 The protamine family is 
comprised of protamines 1, 2, 3, and 4. Most mammals only express protamine 1 (P1), 
whereas mice and humans express P1 and P2, and at much lower abundance, P3 and P4. 
In mice, protamine haploinsufficiency or premature expression of the P1 results in male 
infertility,4,5 suggesting that not only are protamine genes important for fertility, but the 
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temporal control of protamine gene transcription and translation are important to ensure 
proper sperm packaging and function.  
In humans P1 and P2 are expressed in relatively equal quantities.6 The P1/P2 ratio 
in human sperm donors of known normal fertility lies close to 1,7 with a normal range 
from 0.8 to 1.2.8,9 Patients with either low or high P1/P2 ratio have significantly reduced 
semen parameters (lower sperm concentration, motility, and morphology), increased 
sperm DNA damage, and reduced fertilization ability, as compared to patients with 
normal P1/P2 ratio (discussed in Chapter 2).8,10-12 The reduced fertilization resulting from 
sperm abnormalities can be partially overcome by the use of intracytoplasmic sperm 
injection (ICSI); however, implantation and pregnancy rates remain significantly 
reduced.8,12-15   
Interestingly, while a direct relationship between abnormal protamine expression 
and semen parameters (sperm count, motility, and morphology) or fertilization ability is 
apparent, the molecular mechanism for this association remains unclear. The reduction in 
P1 or P2 in infertile patients may be attributed to reduced protamine transcription, altered 
translation of the transcript or failed posttranslational modifications, but none of these 
scenarios would directly help explain the associated decline in sperm counts and function 
unless the regulation of protamines is linked to a broader control of spermatogenesis 
(discussed in Chapter 2).16  
 
Protamine Gene Polymorphsims Are a Rare Cause of Infertility 
To better understand the aetiology underlying a deregulated protamine ratio 
coupled with abnormal semen parameters, several mechanisms were proposed including 
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mutations in the protamine genes, untranslated regions (UTRs-Chapter 3), or in the 
transcriptional regulators (Contrin- YBX2 – Appendix; discussed in Chapter 2).17-19 
Candidate gene re-sequencing studies were performed to identify genetic variants 
that might alter protein structure or function and possibly explain the abnormality in 
protamine ratio and alteration in semen parameters in infertile men. The human 
protamine gene re-sequencing studies revealed many known and novel synonymous 
single nucleotide polymorphisms (SNP), however, these mutations were not significantly 
different between infertile patients with or without protamine alterations and fertile 
controls.17,18,20,21 These data suggest that the presence of pathogenic mutations in the 
protamine genes are a rare cause of infertility.17,19-24 
Since little genetic variability in the protamine genes was observed in a large 
population of infertile patients and controls, we and others subsequently extended the 
analysis to the untranslated regions (UTRs) of the protamine genes. UTRs (e.g., 
promoters and 3’ UTRs) are predicted to be highly enriched in functional regulatory 
elements, which may be important in modulating gene expression or possibly accounting 
for changes in the transcriptional /translational regulation of the protamine genes.25 Our 
study examined a total of 315 patients and we identified 14 single nucleotide 
polymorphisms (SNPs), of which 13 were novel SNPs in the UTRs of P1 and P2, and 
verified the existence of a variable length repeat (VLR), GAn, in the P2 5' region 
(discussed in Chapter 3).26 However, SNP frequencies and VLR allelic frequencies were 
not significantly different between patients and fertile control populations.26 In contrast, 
Gazquez et al. in a much smaller patient population (30 patients and 7 controls) identified 
a PRM1 –190 CA polymorphism that is significantly associated with abnormal sperm 
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head morphology and abnormal P1/P2 ratio in infertile patients.24 The discrepancy 
between the two datasets may be attributed to differences in patient population or 
ethnicities. In conclusion, the literature general consensus is that alterations in the 
protamine genes or the untranslated regions are probably not singularly responsible for 
the protamine deficiency or abnormal spermatogenesis, but rather abnormal protamine 
ratio is a read-out of a general spermatogenic defect which affects a wide-range of 
spermatogenesis specific genes, including protamines. However, it remains possible that 
a combination of SNPs  (haplotypes) together may predispose patients to abnormal 
protamine ratio and/or alteration in sperm parameters.  
The application of candidate gene sequencing methods to elucidate genetic causes 
of male infertility have been inefficient and have yielded poor associations (with the 
exception of two gene mutations described in aryl hydrocarbon receptor repressor 
(AHRR) and methylenetetrahydrofolate reductase (MTHFR)).27-31 Given the growing 
number of candidate ‘fertility genes’ important for proper sperm formation and function32 
and the complexity of the disease, genome-wide SNP studies acquired  popularity due to 
the unprecedented amount of genetic information obtained from a single sample.33-35 
These preliminary genome wide studies are making significant contributions to the 
understanding of the complexity of the genetic element of male factor infertility. 
Furthermore, genomewide studies support the notion that infertility is a multifactorial 
disease, and like other complex diseases, numerous etiologies likely contribute to male 
infertility, with genetics or epigenetics being potential contributors. 
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Epigenetics and Its Cellular Function 
Epigenetic modifications on the DNA sequence (DNA methylation) or on 
chromatin-associated proteins (i.e., histones) comprise the “cellular epigenome”; together 
these modifications play an important role in the regulation of gene expression.36,37 
Unlike the genome, the cellular epigenome is highly variable between cells and is 
dynamic and plastic in response to cellular stress and environmental cues.38,39 The role of 
the cellular epigenome has been increasingly highlighted and has been implicated in 
many cellular and developmental processes such as embryonic reprogramming, cellular 
differentiation, imprinting, X chromosome inactivation, genomic stability, and complex 
diseases such as cancer.  
DNA methylation in mammals is a post-replication modification that is 
predominantly found on cytosines of the dinucleotides sequence CpG. DNA methylation 
is a major regulator of gene expression and a primary chromatin attribute associated with 
the main mode of repression at transposons and retroviral elements.40-44 DNA 
methylation is established by DNA methyltransferases (also known as DNMTs)45,46 and 
recognized by methyl-binding proteins which then recruit chromatin silencing machinery 
to reinforce a repressive chromatin state.47-49 
DNA methylation is just one component of a wider epigenetic program along with 
the histone code. Histone proteins are subject to over 100 known posttranslational 
modifications, including acetylation, methylation, ADP-ribosylation, ubiquitination, and 
phosphorylation.50,51 These modifications occur on the histone tails and functionally 
impact transcription, replication, recombination, and repair. Many of the modifications 
and the chromatin regulators (example: MLL and EZH2) have been implicated in a range 
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of early embryonic developmental processes and physiologic pathways.52-55 
 
Epigenetics and Its Role in Development 
A central question in early development is how is totipotency and pluripotency 
established in early embryos?  Studies in embryonic stem (ES) cells have produced many 
interesting concepts for pluripotency, such as the use of special chromatin attributes 
(histone modifications) and a transcriptional network to prevent cellular differentiation.56-
59 In 2006, Bernstien et al. first described a novel chromatin structure at the promoters of 
important developmental transcription factors in embryonic stem cells.  This novel 
chromatin structure, termed bivalent domains, consists of two contrasting chromatin 
marks, a large region of Lys27 methylation (a repressive histone modification) 
overlapping with a smaller region of Lys4 methylation (an activating histone 
modification). It was subsequently shown that these bivalent promoters were also DNA 
hypomethylated and co-occupied by a network of transcription factors (Oct4, Sox2, 
Nanog, FOXD3, PRC2 etc). The combination of bivalent domains, DNA 
hypomethylation and co-occupancy of key transcription factors together maintains 
pluripotency and promotes self-renewal.56-59 These findings in ES cells have led to the 
question of how and when pluripotency/totipotency is established. Specifically, can germ 
cell chromatin contribute to this poised state in ES cells or is this chromatin state 
established in the ES cell? To address these questions, we have focused on understanding 
the chromatin of human sperm.  
 
  8 
The Emerging Role for Epigenetics in the Male Germline 
 
During spermatogenesis male germ cells undergo unique and extensive chromatin 
and epigenetic remodeling soon after their specification (determination to become a 
spermatocyte) and during differentiation.60 During mitosis and meiosis, male germ cell 
DNA is packaged in nucleosomes, comprised of histone 2A (H2A), histone 2B (H2B), 
histone 3 (H3) and histone 4 (H4), all of which are susceptible to covalent modifications, 
such as methylation, acetylation, ubiquitination and phosphorylation. Each of these 
chemical modifications to histones works alone or in concert to influence gene repression 
and/or activation and promote subsequent events in chromatin remodeling (discussed in 
Chapter 4).  
Although sperm undergoes dramatic chromatin changes, the exchange process is 
incomplete; approximately 5-15% of the genome remains packaged in nucleosomes.61,62 
This chromatin composition led to the predominant notion that paternal contribution of 
epigenetic information to the embryo may be limited to the few paternally imprinted 
genes since the vast majority of the sperm genome is packaged by protamines and 
protamines are not known to propagate information via modifications. This low level of 
histone retention raised an intriguing question of whether the presence of nucleosomes 
may simply be due to inefficient protamine replacement, leading to a low random 
genomewide distribution with no function in the embryo, or the retained nucleosomes 
along with their attendant epigenetic modifications are of potential significance to the 
developing embryo. Before genomewide array and sequencing technologies were readily 
available, two groups examined the sperm chromatin composition at few loci required in 
embryogenesis, and both reported significant histone enrichment at these tested loci.61,63 
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These early studies suggested that histone retention might be enriched at developmental 
loci; however, a limited number of regions were evaluated.     
To characterize the complete sperm epigenome, we applied genomewide 
approaches to examine the localization of retained histones. We found that nucleosomes 
were significantly enriched at developmental transcription factors, imprinted genes, 
miRNAs, and spermatogenesis gene promoters.64 This work was subsequently validated 
by several other groups.65,66 Furthermore, we found that spermatogenesis and cell cycle 
gene promoters retained H3K4me, a mark of gene activation, whereas developmental 
gene promoters retained H3K4me and H3K27me similar to embryonic stem cells.64-66 
This work suggests that the unique chromatin structure in ES cells may begin in the 
germ-line and is recapitulated in the embryo.  
This differential poising at spermatogenesis and cell cycle vs. developmental 
transcription factors is not limited to human male germ cells, but was found to be 
conserved in both mouse and zebrafish sperm.66,67 This conservation in histone marking 
raises the question of whether the retained nucleosomal regions are important for early 
embryonic development or are simply residual marks from the spermatogonial stem cell.  
 
Epigenetics and Infertility 
 Retaining histones at developmental promoters and imprinted loci in fertile men 
expands the role of the paternal sperm epigenome and provides the paternal genome the 
opportunity to convey instructive epigenetic information to the offspring. Therefore, one 
may envision that infertile men with an altered P1/P2 ratio or histone retention may posit 
a risk for transmission of aberrant epigenetic marks to offspring. If an epigenetic role is 
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ascribed to the retained nucleosomes for humans, then there are obvious and profound 
implications for sperm with abnormal histone retention and protamine levels, and for the 
use of such sperm, or any immature sperm, to achieve a pregnancy with the use of 
assisted reproductive technologies (ART; Chapter 7).  
Precedence for epigenetic abnormalities and infertility first stemmed from early 
work of in-vitro fertilization (IVF) in animal models. Offspring conceived by assisted 
reproductive technologies in animals had an increased incidence of large offspring 
syndrome.68 In humans, a meta-analysis showed that children born from assisted 
reproductive technology (ART) have a four fold increased incidence of Beckwith-
Weidemann syndrome compared with children conceived naturally.69-72  This rise in 
imprinting errors was attributed to embryo or gamete manipulation, in-vitro culture 
conditions, hormonal stimulation, or ovulation induction.70,72-75 However, an alternative 
hypothesis is that the increased incidence of imprinting disorders might be due to 
facilitation of conception using gametes of infertile couples that may have elevated risk 
of epigenomic errors. This view aligns with the limited number of reports, including our 
own data, which showed abnormal methylation patterns at a number of imprinted loci 
(SNRPN, MEST, LIT1) in the gametes of infertile men (Chapter 6).76-82 These findings 
are concerning and require a better understanding of the effects of existent or acquired 
epimutations on embryo quality, IVF success rate, or the potential risk for 
transgenerational inheritance of epimutations.  
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Dissertation Overview 
 
This dissertation describes the sperm genetic and epigenetic contributions to early 
development and infertility. We hypothesize that genetic and epigenetic states of the 
mature sperm are important for establishing proper germ cell identity, function, and 
developmental capacity. We reason that perturbations to the genome or epigenome may 
underlie a subset of idiopathic cases of male infertility and/or poor reproductive outcome. 
Initially, we investigated potential genetic causes of male infertility by evaluating 
protamine 1 and 2 UTRs in fertile and infertile men. Following the genetic analysis, the 
epigenetic status of fertile and infertile men was evaluated to determine whether 
epigenetic alteration in sperm chromatin contribute to the spectrum of abnormalities in 
spermatogenesis or poor reproductive outcome. Sperm DNA methylation and histone 
localization and characterization was performed using state of the art genome-wide 
technologies. The analysis of sperm chromatin in fertile men demonstrated that modified 
nucleosomes enriched specifically at imprinted loci, developmental and miRNA gene 
promoters, which raised the possibility that sperm chromatin packaging may be 
instructive to the zygote. Furthermore, when comparing the epigenetic profile of fertile 
and infertile men we find many subtle differences throughout the genome that may have 
cumulative detrimental effect on fertility. Together this body of work provides a better 
understanding of the sperm genetic and epigenetic states and their potential role in 
spermatogenesis, fertility, and early embryo development.  
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During the elongating spermatid stage of spermiogenesis, human sperm chromatin undergoes a complex transition in
which histones are extensively replaced by protamines in a carefully regulated transition including histone modifi-
cations and intermediate and temporary replacement of the histones by sperm-specific transition proteins. The replace-
ment of most histones by protamines 1 and 2 facilitates a high order of chromatin packaging necessary for normal
sperm function andmay also be necessary for DNA silencing and imprinting changes within the sperm cell. Protamines
1 and 2 are usually expressed in nearly equal quantities, but elevated or diminished protamine 1/protamine 2 ratios are
observed in some infertile men and is often associated with severe spermatogenesis defects. Human and animal studies
demonstrate that expression of the protamine proteins is uniquely regulated by transcription/translation factors,
including storage of the mRNA in ribonucleoprotein (RNP) particles composed of the mRNA, transcription factors
and a kinesin molecule necessary for transport of the RNP to the cytoplasm and removal of transcriptional activators
from the nucleus. Recent studies indicate that most patients with abnormal protamine protein levels have elevated
levels of protamine transcript in the mature sperm cell, indicating a possible defect in transcription or translation.
The regulation of protamine expression is unique and includes several possible mechanisms which may be responsible
for dysregulation of protamine expression and concurrent broad spectrum defects in spermatogenesis. We suggest two
hypotheses: (i) that abnormal protamine expression is indicative of a generalized defect in mRNA storage and/or trans-
lation which affects other mRNA transcripts or (ii) that protamines may act as a checkpoint of spermatogenesis.
Key words: chromatin/gene expression/protamine/spermatogenesis/transition protein
Introduction
Sperm chromatin is a highly organized, compact structure consist-
ing of DNA and heterogeneous nucleoproteins. The most abundant
nucleoproteins in mature sperm are the protamines, positively
charged molecules that replace histones during spermiogenesis.
Protamines confer a higher order of DNA packaging in sperm
than that found in somatic cells, and the condensed and insoluble
nature of the highly condensed sperm chromatin protects the
genetic integrity of the paternal genome during its transport
through the male and female reproductive tracts (Gatewood
et al., 1987; Balhorn et al., 1999; Brewer et al., 2002). Protamine
replacement may also be necessary for silencing of the paternal
genome and reprogramming of the imprinting pattern of the
gamete (Aoki and Carrell, 2003).
Humans express two protamines, protamine 1 (P1) and prota-
mine 2 (P2), both of which are expressed in roughly equal quan-
tities (Balhorn et al., 1999; Corzett et al., 2002). Protamines are
highly basic sperm-specific nuclear proteins that are characterized
by an arginine-rich core and cysteine residues (Dixon et al., 1986;
Krawetz and Dixon, 1988). The high level of arginine causes a net
positive charge that facilitates strong DNA binding (Balhorn et al.,
2000). The cysteine residues facilitate the formation of multiple
inter and intra-protamine disulphide bonds that are essential for
the high order of chromatin packaging necessary for normal
sperm function (Courtens and Loir, 1981; Loir and Lanneau,
1984; Singh and Rao, 1988; Le Lannic et al., 1993; Szczygiel
and Ward, 2002).
During spermiogenesis, protamines progressively replace
somatic histones in a stepwise manner (Dixon et al., 1986).
First, somatic histones are replaced by testis-specific histone var-
iants, which are then replaced by transition proteins (TP1 and TP2)
in a process that involves extensive DNA rearrangement and
remodeling (Ward et al., 1989). During the elongating spermatid
stage, the transition proteins are replaced in the condensing chro-
matin by protamines. In humans, ! 85% of the histones are
replaced by protamines. (Hecht, 1989, 1990; Oliva and Dixon,
1990; Dadoune, 1995; Steger, 1999). This sequential process
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facilitates molecular remodelling of the male genome within the
differentiating spermatid nucleus (Figure 1) (Sassone-Corsi, 2002).
Previous studies have shown that the mean P1/P2 ratio in
human sperm is approximately 1.0 (Balhorn et al., 1999; Carrell
and Liu, 2001; Oliva, 2006). Sperm from some infertile men
have been shown to have altered P1/P2 ratios and/or non-
detectable P2 in mature sperm, whereas the occurrence of prota-
mine abnormalities in sperm from fertile men is extremely rare
(no known cases have been reported) (Balhorn et al., 1988;
Chevaillier et al., 1987; Belokopytova et al., 1993; de Yebra
et al., 1998; Aoki et al., 2005a; Oliva, 2006). Additionally, trans-
genic mice with protamine haploinsufficiency have severely
altered spermatogenesis and male infertility (Cho et al., 2001).
The link between abnormal protamine levels and infertility is intri-
guing because abnormal protamine expression has been associated
with low sperm counts, decreased sperm motility and morphology,
diminished fertilization ability and increased sperm chromatin
damage, some of which are not intuitively linked to abnormal
chromatin structure (Carrell and Liu, 2001; Mengual et al.,
2003; Aoki et al., 2005a).
A direct relationship between abnormal protamine expression
and sperm count, motility, morphology or fertilization ability is
not readily apparent. The reduction in P1 or P2 in these patients
may be explained by reduced protamine transcription, altered
translation of the transcript or failed post-translational modifi-
cations, but none of these scenarios would directly explain the
associated decline in sperm counts and function unless the regu-
lation of protamine exchange is linked to a broader control of
spermatogenesis.
This review will briefly summarize the current understanding of
protamine replacement of histones, the link between altered prota-
mine replacement and male infertility, the regulation of protamine
Figure 1. Diagram highlighting the key events in the transition of somatic histones to replacement by protamines. Somatic histones undergo site-specific methyl-
ation, phosphorylation and ubiquitination which facilitates their replacement by testis-specific histones (t) during meiosis. Hyperacetylation of H4-t is a key factor in
relaxation of the DNA coil to facilitate replacement of the testis-specific histones by the transition proteins, whereas topoisomerase 1 relieves torsional stress by
causing double-strand breaks which are subsequently re-ligated. Protamines 1 and 2, processed from a pool of RNP particles, undergo maturation before
and during binding to the DNA and replacemnt of the transition proteins. HR6B, ubiquitin-conjugating enzyme E2B (UBE2B) (RAD6 homolog); HAT, histone
acetyltransferase; Suv39, H3 Lys 9 histone methyltransferase.
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expression during spermatogenesis and possible causes of altered
protamine expression. Two possible models will be discussed
regarding the link between abnormal protamine expression and
aberrant spermatogenesis. The first hypothesis is that abnormal
protamine expression is indicative of a general abnormality of
spermatogenesis, possibly due to abnormal function of a transcrip-
tional or translational regulator. Candidate regulatory factors will
be discussed. The second hypothesis to be discussed is that the pro-
tamines may act as a checkpoint regulator of spermatogenesis and
that abnormal protamine expression leads to induction of
an apoptotic process that ends in severely diminished semen quality.
Clinical significance of abnormal protamine expression
Abnormal protamine expression is clearly associated with inferti-
lity, as recently thoroughly reviewed by Oliva (Oliva, 2006).
Briefly, studies have identified males with undetectable P2,
which has consistently been linked to severe male infertility (de
Yebra et al., 1993; Carrell and Liu, 2001). In mice, haploinsuffi-
ciency of the protamines has been shown to cause altered sperma-
togenesis, including lowered sperm counts and DNA damage
(C. Cho et al., 2001; Cho et al., 2003). Numerous studies have
demonstrated that an altered ratio of P1/P2, either increased or
decreased, is associated with reduced fertility (de Yebra et al.,
1998; Carrell and Liu, 2001; Aoki et al., 2006d; Oliva, 2006).
Interestingly, no reports have been made of P1/P2 expression
abnormalities in males of known fertility.
Initial studies suggested that the most common protamine
abnormality in infertile men was an elevated P1/P2 ratio (Oliva,
2006). The elevated P1/P2 ratio is often the result of decreased
P2 protein levels, concomitant with an increased level of P2 pre-
cursors (Carrell and Liu, 2001; de Yebra et al., 1998; Aoki
et al., 2006d). Under expression of P2 accounts for the majority
of the cases with high P1/P2 ratio, but subsequent studies have
demonstrated that P1 dysregulation also accounts for some
abnormalities (Aoki et al., 2005a). However, P2 dysregulation is
more common and this may be explained by the fact that the
P2 gene is derived more recently than the P1 gene, which may
suggest that the regulatory mechanisms governing P2 gene
expression are not as stringent and more susceptible to variation
than the P1 gene (Lewis et al., 2003).
Human sperm protamine dysregulation is associated with
diminished semen quality parameters, sperm functional ability
and sperm DNA integrity (de Yebra et al., 1993, 1998; Balhorn
et al., 1999; Carrell and Liu, 2001; Aoki et al., 2005a). Aoki
et al. (2005b) have shown that sperm concentration, motility and
morphology are significantly reduced in patients with either a
low or a high P1/P2 ratio when compared with patients with a
normal P1/P2 ratio. In addition, an altered P1/P2 ratio is associ-
ated with decreased fertilization ability, although fertilization and
pregnancy rates are not different when patients undergo intracyto-
plasmic sperm injection (ICSI) as opposed to standard in vitro
fertilization (IVF) (Carrell and Liu, 2001; Nasr-Esfahani et al.,
2004; Aoki et al., 2005b).
Protamines and DNA damage
One potential consequence of abnormal protamine expression is a
susceptibility to DNA damage. Our laboratory has measured DNA
integrity using an assay similar to the sperm chromatin structure
assay and compared the DNA fragmentation index with protamine
levels in human sperm. Patients with low P1/P2 ratio had signifi-
cantly elevated DNA fragmentation when compared with patients
with normal and high P1/P2 ratios (Aoki et al., 2005b). Moreover,
patients who under-expressed P1, P2 or both P1 and P2 had signifi-
cantly elevated levels of DNA fragmentation compared with
patients normally expressing P1and P2. Additionally, Torregrosa
et al. (2006) have recently shown a positive correlation between
TUNEL-positive sperm and the presence of P2 precursors.
These studies emphasized the important role protamines play
in protecting the genetic content of the mature sperm from
nucleases.
A recent study evaluated the role of protamine abnormalities at
an individual cell level by using fluorescence immunohistochem-
istry techniques to simultaneously evaluate protamine levels, cell
viability and DNA damage as measured by the TUNEL assay
(Aoki et al., 2006c). Concurrently, global protamine levels were
evaluated with a fraction of the semen sample that underwent stan-
dard nuclear protein extraction and electrophoresis. The data not
only confirmed a close correlation between the mean protamine
levels determined by fluorescence microscopy and the standard
electrophoresis technique, but also showed that within a semen
sample there is heterogeneity in protamine expression and a
clear correlation between under-expression of protamines, DNA
damage and lack of viability (Aoki et al., 2006c). The
intra-ejaculate protamine heterogeneity observed in this study is
consistent with other reports using CMA3 and Aniline Blue stain-
ing to assess protamine quantity indirectly (Manicardi et al., 1995;
Hammadeh et al., 2001), but novel in the direct link between pro-
tamine abnormalities in a given cell and DNA damage within
the cell.
Possible mechanisms of DNA damage
DNA nicks may be induced through apoptotic processes (Cisternas
and Moreno, 2006). Apoptosis regulates germ cell over prolifer-
ation and eliminates defective germ cells from the genetic pool
(Hikim et al., 1995; Rodriguez et al., 1997; Pentikainen et al.,
1999). Apoptosis is characterized by DNA double-stranded
breaks which occur as a result of activated endogenous DNA
nucleases (Gorczyca et al., 1993). In somatic cells, the apoptotic
cascade involves the formation of apoptotic body; however, in
highly differentiated spermatozoa, the sequence of events may
differ as a result of the highly condensed sperm nucleus (Hikim
et al., 1995). Spermatozoa that are marked for apoptotic degra-
dation may have normal mitochondrial activity, high or low moti-
lity (Barroso et al., 2000) as well as normal morphology (Host
et al., 2000a,b). Oosterhuis et al. (2000) reported that 20% of eja-
culated spermatozoa showed DNA strand breaks and the apoptotic
marker annexin V, whereas, Sakkas et al. (1999) reported that
DNA strand breaks and apoptotic markers did not co-exist together
in the same mature spermatozoa. Ejaculated spermatozoa with
apoptotic markers appeared to have escaped programmed cell
death in a process called abortive apoptosis (Sakkas et al.,
1999). Therefore, it will be important to distinguish between
cells that show high levels of DNA strand breaks and cells that
are positive for apoptotic markers. It is inappropriate to assume
that strand breaks are synonymous with apoptotic degeneration.
Altered protamine expression and diminished spermatogenesis
315






DNA damage may also be increased if the DNA nicking and
ligating activities of topoisomerase II are defective. The presence
of higher than usual levels of topoisomerase II found during the
elongating spermatid stage is associated with high levels of
DNA nicks (Roca and Mezquita, 1989; McPherson and Longo,
1993), possibly needed to relieve torsional stress caused by the
negative supercoiling associated with histone to protamine
transition (Balhorn, 1982; Risley et al., 1986; McPherson and
Longo, 1993). These nicks are not usually harmful, since they
are usually re-ligated prior to completion of spermiogenesis and
ejaculation (McPherson and Longo, 1993). However, if the
activity of topoisomerase is blocked or disrupted, then DNA
nicks remain in mature sperm or are not repaired properly (Morse-
Gaudio and Risley, 1994).
Shaman et al. have recently demonstrated that topoisomerase II
likely acts in two ways. First, it relieves torsional stress by causing
double strand breaks which are re-ligated (termed sperm chroma-
tin fragmentation). Second, it acts in conjunction with an extra-
cellular nuclease to cause regulated double-strand breaks in
protamine-bound DNA at ! 50 kb intervals, the DNA span of
one loop bound to protamine (termed sperm DNA degradation)
(Sotolongo et al., 2005; Shaman et al., 2006). In the absence of
protamines, extensive degradation occurs. This topoisomerase/
nuclease-induced DNA degradation may be a specialized apopto-
tic pathway in sperm, different from the normal function of topoi-
somerase in relieving torsional stress, followed by re-ligation of
the DNA break (Shaman et al., 2006).
Caron et al. (2001) suggested that the transient DNA nicks can
be repaired by transition protein 1. Transition proteins have
been found to have an undefined enzymatic activity that is respon-
sible for repairing single-stranded breaks and UV-induced DNA
lesions in vivo; therefore, the role of transition proteins extends
beyond initiating DNA compaction to restoring transient DNA
nicks. Evidence from the literature indicates that the dis-
appearance of single-strand breaks during spermiogenesis is
coincident with the presence of the transition proteins in elonga-
ting spermatid (Sakkas et al., 1995; Kistler et al., 1996; Smith
and Haaf, 1998).
Reactive oxygen species and chromatin damage
In recent years, concern has been expressed about the generation
of reactive oxygen species (ROS) in the male reproductive tract.
High levels of ROS are toxic to sperm quality and function
(Saleh and Agarwal, 2002). Elevated levels of ROS have been
reported in 25–40% of the infertile patients (Padron et al.,
1997). Two factors that protect the DNA from oxidative stress
are tight DNA packaging and antioxidants present in seminal
plasma (Twigg et al., 1998). Oxidative stress happens as a result
of the imbalance between ROS generation and antioxidants
scavenging activities (Sikka, 2001). Strong evidence suggests
that the presence of single and double-stranded breaks observed
in infertile patients is a result of ROS (Fraga et al., 1996;
Kodama et al., 1997; Sun et al., 1997; Aitken and Baker, 2004).
The presence of 8-hydroxy-2-deoxyguanosine in seminal plasma
has been used as a marker for oxidative DNA damage (Ames
et al., 1993). A significant positive correlation was established
between DNA fragmentation and ROS (Barroso et al., 2000). Fur-
thermore, exposure of sperm to artificially produced ROS resulted
in a significant increase in DNA damage in the form of deletions,
frame shifts, DNA cross-links and chromosomal rearrangements
(Twigg et al., 1998a,b; Kemal Duru et al., 2000). However,
direct studies on ROS-induced damage in protamine deficient
sperm have not been performed.
Protamine abnormalities and assisted
reproduction techniques
The intrasample heterogeneity of protamine content is clinically
significant for patients undergoing assisted reproductive techno-
logy (ART) (Aoki et al., 2006c). Protamine-deficient patients
undergoing human IVF/ICSI have been shown to have normal
embryo quality, implantation and pregnancy rates (Carrell and
Liu, 2001; Nasr-Esfahani et al., 2004; Aoki et al., 2005b). This
heterogeneity in protamine concentration in sperm of a given
semen sample may explain how ICSI appears to overcome poor
semen quality and DNA damage (Aoki et al., 2006e). It is possible
that selection of the most morphologically normal motile sperm
for ICSI injection inherently selects for sperm with normal prota-
mine expression, although studies evaluating sperm morphology
and protamines in individual sperm have not been performed.
Interestingly, the above findings are inconsistent with the data pre-
sented from the mouse protamine-deficient haploinsufficiency
model, in which haploinsufficient mice were found to have a
higher rate of embryo death when ICSI was performed (Cho
et al., 2001, 2003). This difference in embryo lethality, reflecting
a more severe effect of abnormal protamine expression in this
model, may be the result of a homogeneous pathology throughout
the seminiferous tubule rather than the variable expression seen in
infertile men with protamine expression defects or may be the
result of a lack of effect on sperm morphology in mice.
The long-term consequences of ICSI with DNA-damaged
sperm is still not clear (Silber, 1995; Ludwig, 2005; Verpoest
and Tournaye, 2006). Animal studies have suggested a sperm
DNA damage threshold below which a normal embryo can
develop (Ahmadi and Ng, 1999). Others have demonstrated that
the oocyte may have the DNA repair system that aids in ‘repairing’
altered chromatin (Ashwood-Smith and Edwards, 1996; Perry
et al., 1999). Another concern regarding the use of sperm with
abnormal chromatin is the potential for improper gene imprinting,
since protamines have been suggested to be a possible regulator of
normal genomic imprinting (Aoki and Carrell, 2003; Oliva, 2006)
and since imprinting errors have been suggested to be elevated in
patients undergoing ART (Allen and Reardon, 2005; Chang et al.,
2005; Ludwig et al., 2005). Hartman et al. (2006) have recently
noted no increase in imprinting errors in men with severe sperma-
togenesis defects. Our laboratory has recently reported that defects
in global methylation are not observed in men with known prota-
mine abnormalities (Aoki et al., 2006b). Clearly, there is a need
for further studies to evaluate specific gene imprinting in those
patients and other potential defects in sperm with abnormal
protamine replacement and/or DNA damage.
Protamine replacement of histones
Although protamine replacement is often termed ‘a two-step
process’ (histones replaced by transition proteins which are
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replaced by protamines), more steps are involved, including the
expression and incorporation of testis-specific histone variants,
histone hyperacetylation, replacement of histones with transition
proteins and protamine incorporation and phosphorylation (Aoki
and Carrell, 2003; Churikov et al., 2004b). Each of these steps
is critical to proper progression of chromatin maturation and
spermiogenesis.
Histone modifications
In somatic cells, nucleosomes are composed of two molecules of
histones 2A, 2B, 3 and 4 (H2A, H2B, H3 and H4). Histone 1
(H1 or linker histone) links inter-nucleosomal DNA. In addition
to the somatic-type histone variants, spermatogenic cells express
testis-specific histones that replace somatic histones (Dadoune,
2003). Although termed ‘testis-specific’ histones, at least one
testis variant, an H3 variant, has been shown to be expressed in
somatic cells (Govin et al., 2005).
The characterization of testis-specific histone variants is in the
early stages, but several testicular variants have been identified
in the human for both the nucleosome and linker histones
(Churikov et al., 2004b; Govin et al., 2005). The differences
observed between testis-specific histones and somatic histones
include structural differences in the N-terminal region, the core
region and the C-terminal region. Interestingly, some testis-
specific histone variants do not undergo 30 polyadenylation and
are translated early during spermatogenesis (Zalensky et al.,
2002; Churikov et al., 2004a). Among those variants is an H2B
variant which has been shown to localize in telomeres and may
be important in meiosis (Gineitis et al., 2000). Another key differ-
ence in the testis variant of H2B is the replacement of four prolines
found in the N-terminal region of the somatic H2B with phosphor-
ylatable amino acids, likely indicating that their function is regu-
lated by phosphorylation (Churikov et al., 2004a).
Recently, Zhang et al. (2006) have shown that increased levels
of histone 2B in sperm is associated with lower levels of prota-
mines. Although previous studies have demonstrated high levels
of histones in the sperm of some infertility patients and an indirect
link between histone retention and altered sperm protamine
expression, this study is the first direct evidence of abnormal
histone retention linked to altered protamine replacement. Future
studies will likely focus on the further characterization of
histone variants and whether abnormal expression of a testis-
specific histone variant may be directly responsible for altered pro-
tamine replacement. In that regard, Tanaka et al. have recently
evaluated the gene sequence of HANP1 in infertile and fertile
men. HANP1 is the human orthologue of the mouse Hanp1/Hit2
gene that encodes a testes variant of H1; homozygous disruptions
of this gene in mice has previously been shown to cause male
infertilty (Tanaka et al., 2005, 2006). Although five single nucleo-
tide polymorphisms (SNPs) were identified for HANP1 in their
study population, the SNPs did not appear to be linked to male
infertility (Tanaka et al., 2006). Further studies are warranted to
evaluate both the protein and the gene in males with known prota-
mine abnormalities.
Hyperacetylation of the histones is critical for normal pro-
gression of spermatogenesis and is regulated by an interplay of
histone acetyl transferases and histone deacetylases (Candido
and Dixon, 1972; Grimes and Henderson, 1984; Meistrich et al.,
1992; Hazzouri et al., 2000; Marcon and Boissonneault, 2004).
Histone hyperacetylation reduces the binding between nucleo-
somes and DNA, leading to chromatin relaxation (Hong et al.,
1993), and is also associated with the activation of topoisomerases
in inducing strand breaks. Species that retain histones throughout
spermiogenesis have relatively low levels of acetylated histones
(Kennedy and Davies, 1980, 1981). It has been suggested that
hyperacetylation of core histones may facilitate their displacement
by protamines (Oliva and Mezquita, 1982, 1986; Oliva et al.,
1987), and a double bromodomain containing testis-specific
factor (BRDT) has been identified in mice as a possible key
factor in the transition process. BRDT has been shown to be
capable of condensing acetylated chromatin (Pivot-Pajot et al.,
2003) by recruiting a highly expressed chaperone protein,
CIA-II, to mediate histone removal (Umehara and Horikoshi,
2003) .
Sonnack et al. (2002) have demonstrated a relationship between
decreased acetylation and abnormal spermatogenesis. They also
observed increased acetylation in spermatocytes of testes exhibit-
ing maturation arrest, indicating a possible relationship between
premature hyperacetylation and maturation arrest. This same
laboratory has also demonstrated that the administration of
histone deacetylases results in severe infertility (Fenic et al.,
2004). Future studies will likely evaluate the degree of acetylation
in protamine-deficient patients and experimental models with
abnormal protamine expression.
Replacement of histones with transition proteins
DNA relaxation, as a result of hyperacetylation and topoisomerase
activity, facilitates the exchange of histones with transition
proteins which are proteins of intermediate basicity (Wilkins,
1956; Courtens and Loir, 1981; Luerssen et al., 1989; Oliva and
Dixon, 1991; Ward and Coffey, 1991; Kierszenbaum, 2001;
Meistrich et al., 2003). TP1 and TP2 mRNA are first seen in the
post-meiotic, round spermatid stage in mice and are degraded
around stages, 13–14. The proteins are observed in stages 12 and
13 and are removed by stage 14 when they are replaced with prota-
mines (Figure 2) (Kistler et al., 1996). There is significant overlap in
Figure 2. Immunofluorescence microscopy of the localization of DNA, tran-
sition protein 1 and protamine 1 in a round spermatid and elongating spermatid.
(A) In the round spermatid, transition protein 1 is seen within the nucleus (green
fluorescence) and protamine 1 is located in the cytoplasm (red fluorescence).
(B) An elongating spermatid shows no staining for transition protein 1 within
the nucleus, although mature protamine is observed throughout the nucleus
(red fluorescence) (for methods, see Aoki et al., 2006).
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the expression of histones, transition proteins and protamines
(Meistrich et al., 2003). Expression of the proteins has been
shown to have some overlap in human-elongating spermatids
(Aoki et al., 2006c).
TP1 is a 60 kDa protein with numerous basic amino acids dis-
tributed randomly throughout the molecule (Kistler et al., 1975).
TP1 has important DNA-destabilizing properties due to the
presence of two tyrosine residues flanked by basic amino acids
(Singh and Rao, 1988). TP2 is a 13 kDa protein that contains
proline, serine, arginine and lysine residues (Grimes et al.,
1975). Two potential zinc finger domains exist in mouse and rat
TP2 and may play an important role in the initiation of chromatin
condensation and cessation of transcriptional activity during mam-
malian spermiogenesis (Baskaran and Rao, 1991). In transgenic
mice, animals devoid of transition protein 2 had reduced
amounts of processed P2 proteins and failed to complete chroma-
tin compaction (Cho et al., 2003; Meistrich et al., 2003). In
addition to incomplete chromatin condensation, sperm from TP2
null mice show an increase in DNA denaturation when compared
with sperm from control mice (Zhao et al., 2001). The increased
denaturability of the DNA is believed to result from DNA strand
breaks (Sailer et al., 1995; Aravindan et al., 1997).
Studies using double knock out mice for both TP1 and TP2 have
shown that the absence of one transition protein does not affect the
level of transcription or translation of the other transition protein
or the protamines, but does affect the retention of the other tran-
sition protein through post-translational modifications (Shirley
et al., 2004; Zhao et al., 2004). Although the redundancy is not
complete, there is compensation for one transition protein by the
other, as demonstrated by the fact that double heterozygous
mice exhibit more severe sperm defects than do mice homozygous
for a single mutation. Interestingly, sperm from transition protein-
deficient mice are able to fertilize oocytes using ICSI if the sperm
were isolated from the testis or caput epididymus, but are not
capable of fertilization if isolated from the cauda epididymus
(Suganuma et al., 2005).
Replacement of transition proteins with protamines
Protamine 1 is translated as a mature protein of 50 amino acids,
whereas protamine 2 is initially 103 amino acids and undergoes
N-terminus cleavage to a mature protein of 57 amino acids
(Figure 3) (Aoki and Carrell, 2003). Following translation, pro-
tamine 1 is immediately phosphorylated, primarily under the
control of serine/arginine protein-specific kinase 1 (SRPK1)
(Green et al., 1994; Papoutsopoulou et al., 1999). A protamine 2
intermediate protein is phosphorylated, largely under the control
of Ca2þ/calmodulin-dependent protein kinase 4 (CAMK4). The
phosphorylation of the P2 intermediate is requisite for binding
of the protein to chromatin, which is required for final cleavage
of the protein to its mature form of 57 amino acids.
Protamine phosphorylation is not only necessary for final
processing of P2, but also for proper binding of the proteins to
DNA. However, once bound to DNA, the protamines are
de-phosphorylated. The de-phosphorylation appears to be essen-
tial for proper condensation of the chromatin, although some
controversy exists (Gusse et al., 1986; Aoki and Carrell, 2003).
A recent study evaluating the effects of organophosphorous pesti-
cides on sperm protamine phosphorylation showed that the
resulting sperm had abnormal chromatin condensation with sub-
sequent DNA damage (Pina-Guzman et al., 2005). Abnormal
phosphorylation may be relevant to human exposure to organo-
phosphorous pesticides (Sanchez-Pena et al., 2004; Pina-Guzman
et al., 2005, 2006).
The replacement of transition proteins with protamines induces
a conformational change in the packaging of the chromatin. The
chromatin forms loop domains, which are less than half the size
of somatic cell histone loops, then forms toroidal structures,
which have a 6–20-fold increase in packaging compaction
(Ward and Coffey, 1991; Balhorn et al., 2000). The mechanism
by which protamines induce the conformational changes is not
well understood (D’Auria et al., 1993; Bianchi et al., 1994;
Fuentes-Mascorro et al., 2000; Aoki and Carrell, 2003). P1 and
P2 may bind to the major and minor groove of DNA or to the
DNA surface by interacting electrostatically with phosphate
residues (D’Auria et al., 1993; Bianchi et al., 1994; Balhorn
et al., 1999; Fuentes-Mascorro et al., 2000).
Protamines are currently thought to be necessary for (i) conden-
sing the male genome to generate a more compact and hydrodyn-
amic nucleus, (ii) protecting the genetic message from nucleases,
mutagens or damage from ROS or other factors, (iii) epigenetic
modification during spermiogenesis and (iv) removing transcrip-
tion factors and proteins to help reset the imprinting code in the
oocyte (Oliva, 2006). Altering the sperm protamine content can
disrupt any of the functions listed above.
Regulation of protamine expression and potential
causes of abnormalities
The human sperm haploid genome encodes a single copy of
human P1 and P2 genes which maps to chromosome 16p13.3
(Domenjoud et al., 1991). This locus also contains the TP2
gene. The P1–P2–TP2 locus spans a 28.5 kb region in which
the three genes are arranged in a linear array, presumably facilitat-
ing concurrent or co-ordinated gene expression (Schluter et al.,
1992; Choudhary et al., 1995). The P1 gene is present in all mam-
malian species, whereas P2 is present in mouse, hamster, rat, stal-
lion and man (Calvin, 1976; McKay et al., 1985, 1986; Poccia,
1986; Bower et al., 1987; de Yebra et al., 1993). However, in
some species, the protamine 2 gene is present but the protein is
absent (Maier et al., 1990) . These findings suggest that P1 is
inherited from a common ancestor, since it is present in all
species and that the P2 gene may have been derived from the
P1 gene through divergent evolution. Alternatively, the P1 and
P2 genes may have been inherited from a single common ancestor,
but successive species have lost the ability to express protamine 2
(Calvin, 1976; Oliva and Dixon, 1990).
Several factors have been postulated and studied as possible
causes of P1/P2 deregulation. These factors are summarized in
Table I and discussed in the following sections.
Gene polymorphisms
The protamine or transition protein genes could harbour mutations
or polymorphisms that could induce conformational changes in the
proteins, which could alter their incorporation into sperm chroma-
tin. De Yebra et al. (1993) performed a preliminary mutational
analysis of the protamine gene analysis in four patients with
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markedly altered P1/P2 ratios with no mutations observed. Sub-
sequently, Schlicker et al. (1994) screened 36 infertile patients
with chromatin anomalies, but he failed to identify any mutations
in the genes encoding P1, P2 or TP1. Tanaka et al. (2003) reported
four synonymous polymorphisms in P1 and one SNP in P2 that
generated a premature stop codon. The SNP in the P2 gene that
induces translation termination may result in male infertility due
to haploinsufficiency of P2.
Iguchi et al. (2006) sequenced the protamine genes in men exhi-
biting semen quality defects consistent with protamine abnormal-
ities (i.e. sperm DNA damage). In their study, a heterozygous SNP
which altered a highly conserved arginine residue was found in
10% (3/30) of the patients studied, but not seen in controls.
This SNP converts one of the highly conserved arginines to a
serine residue, therefore creating an RS sequence which can
serve as a potential phosphorylation site for the enzyme SRPK1.
Improper phosphorylation can substantially alter both DNA
binding and protamine-to-protamine interaction in the sperm
nucleus.
Recently, a larger patient population with known abnormal pro-
tamine ratios was screened to identify SNPs in the protamine and
transition protein genes potentially responsible for the patients’
altered protamine expression (Aoki et al., 2006a). Fifteen SNPs
were identified in this study (three SNPs in P1, seven in P2, two
Figure 3. A schematic drawing of key regulators of expression of protamines 1 and 2 at the levels of genomic transcription, translation and post-translational modi-
fications to yield the mature protamine products. The key regulating protein complexes are shown for each stage of protein maturation. CREM, cAMP response
element modulator; ACT, activator of CREM in the testis; TFIIA, transcription factor II alpha; CRE, CREM response element; TBP, TATA box binding
protein; PABP, poly-a binding protein; CPE, cytoplasmic polyadenylation element; CPEB, cytoplasmic polyadenylation element binding protein; PCM, polyaden-
lyation consensus motif; SRPK1, serine/arginine protein-specific kinase-1; CAMK4, calcium/calmodulin-dependent protein kinase IV.
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in TP1 and three in TP2); however, the frequencies of these SNPs
were similar in protamine-deficient patients, severely infertile
patients without protamine defects and fertile controls. The
SNPs identified in this study included differences from the SNPs
reported by Tanaka et al. (2003). It is important to note that the
differences may reflect differences in the populations studied
(European ancestry versus Japanese ancestry). Also, it is important
to note that the P1 SNP reported by Iguchi et al. was not elevated
in the study by Aoki et al. (2006a) (Iguchi et al., 2006). In
summary, these studies indicate that gene SNPs in the protamine
and transition protein genes are not likely to be a common cause
of protamine abnormalities.
In addition to evaluating the coding gene sequences, it is
important to consider possible mutations in the upstream and
downstream non-coding regions of the gene. De Jonckheere
et al. (1994) examined potential mutations in the untranslated
regions (UTRs) of the protamine genes and identified a candidate
mutation in the GA repeat upstream of the transcriptional start site
of P2. Recently, our laboratory identified 14 SNPs in the UTRs of
P1 and P2 (Emery et al., 2006, submitted for publication). Of
greatest significance was a GC change 62 bp into the 30-UTR of
P2, which occurred in five infertility patients and in six of the
Utah CEPH database patients. Interestingly, none of the men
with confirmed normal protamine ratios, or the fertile sperm
donors, carried this change. This G/C SNP was found in the
sperm cDNAs and in the genomic sequence. We also noted the
previously identified GA repeat in the genomic P2 50-UTR.
The variable length GA repeat length occurs with equal frequency
in UGRP controls and in men with abnormal protamine expression.
The most prevalent GA repeat lengths were 12, 15 and 18 bp.
Regulation of transcription
Protamines are expressed in the round spermatid stage, but prota-
mine transcription and translation are temporarily uncoupled in the
developing spermatid due to transcriptional and translational regu-
latory mechanisms (Calvin, 1976; Sassone-Corsi, 2002). Tran-
scriptional regulation depends on potentiation of the genes via
association with nuclear matrix attachment regions (MARs), and
binding of trans-acting factors to the promoter region (Martins
et al., 2004; McCarrey et al., 2005).
The 50 and 30 regions surrounding P1/P2/TP2 genes contain
MARs which are cis-regulatory units involved in attachment of
the DNA to the protein scaffolding of the nuclear matrix in an
organized manner of loop domains which potentiates the genes
for transcription dependent on other trans-regulatory factors
(Martins et al., 2004). The MARs are located at the linker sites
of protamine toroids and contain repetitive elements which may,
contrary to the usual paradigm, be highly methylated in the
round spermatid stage in which the genes undergo transcription
(Choi et al., 1997; Shaman et al., 2006). Kramer et al. (1997)
scanned the P1–P2–TP2 locus in several oligozoospermic, infer-
tile individuals and identified mutations in the sperm nuclear
matrix of two of the five affected individuals. This laboratory
later used transgenic analysis to evaluate the relationship
between the nuclear matrix associations and the expression of pro-
tamine genes (Martins et al., 2004). This study demonstrated that
in the absence of the 50-MAR and with the presence of only the
30-MAR, protamine transcription was reduced but not ablated.
This suggests that the 30-MAR provides a protective role against
silencing of the protamine genes and that synergy between the
upstream and downstream MARS is required for the proper
regulation of the protamine genes (Martins et al., 2004).
Trans-regulatory factors of transcription act via the promoter
region and include the TATA-box protein (TBP), cAMP response
element modulator (CREM) and Y-box proteins (Steger et al.,
2000; Maclean and Wilkinson, 2005; Tanaka and Baba, 2005;
DeJong, 2006). TBPs bind to the TATA sequence in conjunction
with other factors to facilitate RNA polymerase 2 interaction
with the gene sequence. TBP is not essential for gene expres-
sion, but is important in initiating transcription (Schmidt and
Schibler, 1997; Kimmins et al., 2004a). TBP over-expression
occurs between 18 and 28 days in mice, which corresponds with
the transcription of genes in haploid cells (Schmidt and Schibler,
1995). TBP-like factor (TLF) has a sequence similar to TBP and
a similarly unique expression profile in the testis, but is unique
in that it binds to TATA-less promoters such as pes-10
(Kaltenbach et al., 2000). TLF is seen in the cytoplasm during
Table I. Studies that have identified potential causes for P1/P2
dysregulation
Gene studies
Protamines Maier et al. (1990)
Cho et al. (2003)
Cho et al. (2001)
Tanaka et al. (2003)
Aoki et al. (2006)
Iguchi et al. (2006)
Queralt et al. (2003)
Schnulle et al. (2004)
Transition proteins Yu et al. (2000)
Adham et al. (2001)
Meistrich et al. (2003)
Shirley et al. (2004)
Suganuma et al. (2005)
Zhao et al. (2004)
Protamine UTR Our laboratory’s unpublished results
De Jonckheere et al. (1994)
Ancillary genes
CAMK4/SRPK1 Wu et al. (2000)
AF5q31 Urano et al. (2005)
MARs Wykes et al. (2003)
Martins et al. (2004)
Transcription
CREM Steger (1999)
Behr et al. (2000)
Bleny et al. (1996)
Weinbaur et al. (1998)
ACT /KIF17B Macho et al. (2002)
Kotaja et al. (2004)
MSY2 Yang et al. (2005b)
Storage
Protamine 30 UTR Lee et al. (1995)
Fajardo et al. (1994, 1997)
Kwon and Hecht (1993)
Translation
PRBP/TRBP Zhong et al. (1999)
Braun et al. (2000)
ACT /KIF17B Macho et al. (2002)
Kotaja et al. (2004)
A summary of studies investigating potential abnormalities that may underlie
aberrant P1 and P2 expression. These include mutations in the protamine
genes or in ancillary genes, defects in transcriptional regulatory mechanisms,
alterations in RNA binding proteins or RNA binding protein sites and
aberrant translational regulatory factors.
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the early pachytene stage, then enters the nucleus and remains
there throughout the round spermatid stage until it moves to the
cytoplasm again in the elongating spermatid stage when
transcription is terminated (Martianov et al., 2002). TLF may
act as both an activator and a repressor of transcription (Moore
et al., 1999). TLF null mice have abnormal heterochromatin
organization, which may affect protamine replacement and
chromatin condensation and induce apoptosis (Martianov et al.,
2001, 2002).
The transcription factor CREM is highly expressed in male germ
cells (Delmas et al., 1993) and is known to regulate the expression
of several post-meiotic genes, such as the transition proteins
and protamines, and is likely the key regulator of gene expression
during spermatogenesis (Krausz and Sassone-Corsi, 2005;
Hogeveen and Sassone-Corsi, 2006). Targeted disruption of the
CREM gene blocks the differentiation program in the first step
of spermiogenesis (Blendy et al., 1996; Nantel et al., 1996).
These findings indicate a crucial role of CREM in post-meiotic
germ cell differentiation, linking the action of hormonal stimuli
to direct regulation of spermatogenesis genes (Sassone-Corsi,
1998).
The cAMP response element (CRE) is found in the promoter
region of the protamine genes and it serves as a binding site for
the transcriptional activator CREM tau in the testes. CREM tau
is associated with the activator of CREM (ACT) and the testis-
specific kinesin protein KIF 17B. In addition to serving as a mol-
ecular motor for mRNA transport, KIF 17B also acts as a co-factor
to ACT, and hence as an activator for CREM-mediated transcrip-
tion. Interestingly, all mRNAs isolated by co-immunoprecipitation
with KIF 17B and testis–brain RNA-binding protein (TB RBP)
are transcripts which are regulated through CREM activity
(Chennathukuzhi et al., 2003a). By transport of the ribonucleopro-
tein (RNP) to the cytoplasm, KIF 17 B/ACT is not available in the
nucleus, and hence CREM-regulated transcription is repressed
(Kimmins et al., 2004b; Krausz and Sassone-Corsi, 2005). The
linkage of KIF 17B to regulation of both CREM-mediated tran-
scription and temporal regulation of translation indicates the
major role this protein plays in the regulation of the expression
of protamines and other key spermiogenesis proteins (Nagamori
et al., 2006; Sassone-Corsi, 2005).
Male mice lacking a functional CREM gene are sterile due to
maturation arrest at the round spermatid stage (Blendy et al.,
1996; Nantel et al., 1996). Mice with selective ACT deletion
display a drastic decrease in the number of mature sperm and
exhibit major defects in sperm head morphology (chromatin com-
paction and acrosome defects) and tail morphology (Kotaja et al.,
2004). Our laboratory recently identified potentially significant
polymorphisms of the ACT gene in men with severe infertility
(Christensen et al., 2006), but studies in patients with known pro-
tamine expression abnormalities have not yet been completed.
The role of Y-box proteins in the regulation
of protamine expression
Y-box proteins are important regulators of protein expression
during spermatogenesis. They bind both DNA and RNA and,
generally, up-regulate transcription and down-regulate translation.
Several Y-box proteins have been identified in the germ cells of
mice and humans (Braun, 1990; Tafuri et al., 1993; Yiu and
Hecht, 1997; Tekur et al., 1999; Iuchi et al., 2001) Among the
Y-box proteins active during spermatogenesis is Contrin and its
mouse orthologue MSY2, which are found in very high concen-
trations in male germ cells (Gu et al., 1998; Tekur et al., 1999).
Two functions have been proposed for Contrin/MSY2 RNA-
binding protein in regard to protamine expression (Yang et al.,
2005b). First, it serves as a co-activator for protamine transcription
by binding to the Y box element sequence found in the gene
promoter region. Second, it stabilizes the maternal and paternal
transcripts in the cytoplasm to effect the temporal regulation of
translation as described above. Yang et al. generated an MSY2
knockout model to define the function of MSY2 in mammalian
development (Yang et al., 2006). MSY2-null male mice were
sterile, with severely amorphous and multinucleated spermatids.
The sperm were observed in the seminiferous tubules, but not in
the epididymus (Yang et al., 2006).
Translin is another DNA/RNA-binding protein involved in
translational regulation during spermatogenesis. There is a high
degree of similarity between Translin and its mouse orthologue,
TB RBP. Like Contrin, Translin binds to specific mRNAs in the
testis, forming an RNP complex which is transported to the cyto-
plasm and adjacent cells through intercytoplasmic bridges
(Morales et al., 2002). TB RBP interacts with a protein termed
Translin-associated factor X that has a nuclear localization
signal, although TB RBP has a cytoplasmic localization signal.
The ratio of the two proteins determines the actual localization
of the complex (Cho et al., 2004). KIF 17B is essential for
proper movement of the Contrin and Translin-containing RNP
particles to the cytoplasm and through adjacent cytoplasmic
bridges (Chennathukuzhi et al., 2003a). Mice lacking the TB
RBP gene are able to sire offspring, but have reduced sperm
production (Chennathukuzhi et al., 2003b). The direct effect of
TB RBP gene knock-out on protamine expression is not known
(Kimmins et al., 2004a; Sassone-Corsi, 2005).
Regulation of translation
Protamines 1 and 2 undergo translational control during spermio-
genesis (Steger, 2001). Protamines are transcribed in the round
spermatid stage, but the mRNAs are stored in translationally
repressed RNPs in early haploid cells and activated in elongated
spermatids (Kleene, 1989) . This stage-specific pattern of gene
expression is essential for correct sequential nucleoprotein
exchange and complete differentiation of round spermatids into
mature spermatozoa. Delaying mRNA translation prevents new
mRNA synthesis in elongated spermatids, precocious chromatin
condensation and infertility (Lee et al., 1995).
The mechanism by which translational regulation is operating is
not entirely understood; nevertheless, a few regulatory sites in the
30-UTR have been identified to have profound effects on trans-
lation. The Y-box proteins Contrin and Translin and the kinesin
KIF 17B are essential for transport of the RNP to the cytoplasm
and for delayed translation (Kwon and Hecht, 1991, 1993;
Murray et al., 1992; Fajardo et al., 1994; Aoki et al., 1995;
Fajardo et al., 1997; Iuchi et al., 2001). Poly-A-binding protein
also has two important roles in regulating translation. First, it pro-
tects the mRNA transcript from degradation, thereby preserving
the transcript until translational repression is removed. Second,
it serves as a repressor protein (Bernstein et al., 1989). Protamine
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translation is initiated by covalent modification of the RNP, which
leads to the release of the mRNA from the RNP and the shortening
of the poly-A-tail (Kleene, 2003).
One interesting protein which may be involved in translational
regulation of the protamines is protamine 1 RNA-binding protein
(PRBP) and its human orthologue TAR RNA-binding protein
(TRBP) (Lee et al., 1996; Siffroi et al., 2001). PRBP is highly
expressed in the differentiating male germ cell and contains two
copies of a double-stranded, RNA-binding domain which binds
to the 30-UTR of protamine 1 (Lee et al., 1996). Male mice with
PRBP deletion are infertile and severely oligozoospermic due to
failure of protamine transcripts to undergo translation, which
results in delayed replacement of the transition proteins and sub-
sequent failure of spermatogenesis (Zhong et al., 1999). TRBP
is a 43 kDa protein found in the cytoplasm of elongating sperma-
tids. No studies have evaluated this protein in men with known
protamine defects (Siffroi et al., 2001).
Post-translation modifications
P1 is translated as a mature protein, whereas P2 is synthesized as a
103 aa precursor that undergoes proteolytic cleavage at the
N-terminus to generate the mature form (Meistrich et al., 1992;
Oliva and Mezquita, 1982; Balhorn et al., 1999). P1 is rapidly
phosphorylated by SRPK1 after translation, whereas CAMK4
phosphorylates P2 protein subsequent to its proteolytic modifi-
cations and its binding to the DNA (Green et al., 1994; Papoutso-
poulou et al., 1999). Phosphorylation of these proteins ensures their
proper binding to DNA (Figure 3). Mutations or polymorphisms of
SRPK1 or CAMK4may be potential causes of abnormal protamine
expression, but have yet to be evaluated. Targeted mutations in the
CAMK4 gene in male mice resulted in infertility, a specific loss of
P2 and retention of TP2, which suggests that the mature, phos-
phorylated P2 protein must interact with chromatin to displace
TP2 (Wu et al., 2000). Yoshii et al. (2005) have recently performed
2D electrophoresis and identified five bands for variants of prota-
mine 1 and six bands for protamine 2 variants. This technique
may be valuable in identifying post-translational defects of prota-
mines in patients with known defects of protamine expression.
The relationship between abnormal protamine expression
and spermatogenesis
Two caveats are relevant in considering the relationship between
abnormal protamine expression and spermatogenesis. First, abnor-
mal protamine expression is relatively common in male infertility
patients, but rare in men with known fertility (Carrell and Liu,
2001). Second, many patients with abnormal protamine expression
exhibit severe defects of semen quality, including oligozoosper-
mia (Carrell and Liu, 2001; Aoki and Carrell, 2003; Aoki et al.,
2005a). The link between abnormal protamine expression and
severely altered spermatogenesis is not intuitively obvious, but
animal studies have also shown that spermatogenesis is severely
altered when protamine expression is experimentally reduced
(Zhong et al., 1999).
One possible explanation for the possible link between altered
protamine expression and severely reduced spermatogenesis is
the hypothesis that protamine expression may act as a ‘checkpoint’
during spermiogenesis and that abnormal protamine expression
leads to an increased level of apoptosis. This hypothesis is sup-
ported by the fact that protamine haploinsufficiency causes
severe disturbances of spermatogenesis in the mouse and the
fact that protamine alterations are associated with DNA damage
which may result in the initiation of an apoptosis pathway
(Cho et al., 2001, 2003). Differences in microenvironments
within the seminiferous tubules or incomplete (abortive) apoptosis
may allow some sperm survival.
An alternative hypothesis may be that abnormal protamine
expression is usually the result of an abnormal functioning of a
regulator of transcription, translation or post-translational modifi-
cations that affects not only the protamines, but also a broad range
of genes involved in spermatogenesis. Candidate regulators may
include ACT, CREM, Translin, Contrin and KIF17B. Particularly
attractive targets in this regard may be the Y-box proteins Translin
and Contrin, and the associated kinesin, KIF 17B, because they are
involved not only in transcriptional regulation, but also in trans-
port to the cytoplasm and translational regulation, since the data
indicate that patients with abnormal protamine expression often
have higher than normal levels of transcript in mature sperm
(Aoki et al., 2006d). Other key regulators, such as phosphorylation
mechanisms, could be responsible for a broad defect affecting
spermatogenesis.
Conclusions
From studies performed to date, it is clear that the presence of an
altered P1/P2 ratio is clinically relevant and portends a reduced
fertility. Semen samples with altered P1/P2 ratios generally
have other abnormalities, such as increased DNA damage, low
sperm counts and reduced fertilizing capacity (Aoki et al.,
2006e; Oliva, 2006). Two over-riding questions should be
addressed in future studies. First, what is the clinical relevance,
beyond low sperm quality, of abnormal sperm protamine
expression? and, second, what is the cause of abnormal protamine
expression?
When undergoing IVF with ICSI, men with abnormal protamine
expression have fertilization, implantation and pregnancy rates
equal to patients undergoing IVF for other diagnoses, including
obstructive azoospermia (Aoki et al., 2006e). However, given
the role of protamines in silencing and resetting the paternal
genome, and given the controversial, but possible relationship
between increased imprinting errors in offspring and ICSI,
future studies are needed to evaluate the potential risks of under-
going ART with sperm of known protamine abnormalities
(Allen and Reardon, 2005; Chang et al., 2005; Ludwig, 2005).
Those studies will likely include an evaluation of offspring
derived from animal models and also include further human
sperm studies, such as the imprinting status of specific genes.
Additionally, preliminary studies indicate that the P1/P2 ratio
may be a more sensitive and accurate predictor of sperm functional
ability than other available sperm function assays (Aoki et al.,
2006e). This concept should be further analysed.
Second, abnormal protamine expression is an intriguing
pathology due to its relationship with altered spermatogenesis.
Future studies will include analysis of regulators of transcription
and translation and post-translational modifications, areas that
will likely yield an increased understanding of the cause of
abnormal protamine expression, and may also provide important
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information regarding spermatogenesis in general. Protamines
may be an important marker in better understanding the key
regulatory pathways of spermatogenesis, especially if abnormal
protamine expression reflects a aberrant function of a key
transcription of translation regulator or acts as a crucial part of a
checkpoint pathway.
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Deregulation of sperm nuclear protamine ratio (P1=P2) has been shown to
correlate with male factor infertility in humans, but the cause of this abnor-
mal protein expression has yet to be identified. Recent studies have shown
that there is little genetic variability in the coding regions of either of the
protamine gene sequences. However, these studies did not investigate
the 50 or 30 non-coding regions of these genes for mutations that might
account for changes in the transcriptional or translational regulation of the
protamines.
In an effort to determine if genetic variation in these non-coding regions may
account for aberrant protamine expression, we have sequenced the 50 and 30
untranslated regions (UTRs) of both protamine 1 (P1) and protamine 2 (P2)
genes in a population of infertile men with protamine deregulation, men pre-
senting for infertility work-up with normal protamine ratios, and a population
of unrelated, fertile men from the Utah Genetic Reference Project (UGRP). This
analysis has identified 14 single nucleotide polymorphisms (SNPs), of which 13
were novel SNPs in the UTRs of P1 and P2, and verified the existence of a vari-
able length repeat (VLR), GAn, in the P2 5
0 region. The SNP frequencies and VLR
allelic frequencies did not achieve statistical significance between the popula-
tions, however, one of the SNPs identified in the 30 UTR of protamine 2 was
found at a low frequency in the abnormal protamine patients, but was
completely absent in men with verified normal protamine ratio and donors of
known fertility.
In conclusion, a number of SNPs have been reported in the protamine
genes and the untranslated regions, however, these gene variants do not
appear to be responsible for protamine deficiency. Hence, the underlying
cause for aberrant protamine expression may possibly be due to abnormali-
ties in candidate spermatogenic transcriptional=translational regulators,
post-translational modifiers, or as-of-yet unidentified factors affecting the
testicular environment.
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During spermiogenesis, the sperm nucleus undergoes genome-wide reor-
ganization, which involves the removal of histones and their replacement by
various nuclear proteins, including highly positively charged protamines
[Wouters-Tyrou et al. 1998; Sassone-Corsi 2002]. Humans express two types
of protamines, protamine 1 (P1) and protamine 2 (P2), expressed in the
post-meiotic haploid spermatid and stored in messenger ribonuclear protein
(mRNP) particles [Steger et al. 1998; Steger 1999], and translated in the elon-
gating spermatid [Steger 2001; Steger et al. 2002]. The temporal uncoupling
of transcription and translation prevents precocious chromatin condensation
and spermatogenic arrest [Lee et al. 1995].
Biochemical analysis of human sperm from proven fertile donors and
infertile males suggests that the relative proportion of protamines
(P1=P2) bound to DNA is associated with male infertility. The mean
P1=P2 ratio in human sperm nuclei is approximately 1.0 [Balhorn et al.
1999; Carrell and Liu 2001; Oliva 2006]. A number of studies have
described infertile male populations with an elevated P1=P2 [Balhorn et
al. 1988; Belokopytova et al. 1993; Aoki et al. 2005a], non-detectable levels
of P2 [Chevaillier et al. 1987; Balhorn et al. 1988; Belokopytova et al. 1993;
de Yebra et al. 1998; Carrell and Liu 2001; Aoki et al. 2005a; Oliva 2006], or
a diminished P1=P2 [Aoki et al. 2005a]. Taken together these studies indi-
cate abnormal protamine stoichiometry derives from aberrant expression
of either P1 or P2.
Several groups evaluated the coding sequences of protamine 1, 2 and
transition protein 1, 2 to identify specifically relevant alterations that may
possibly explain the cause of protamine deregulation [de Yebra and Oliva
1993; Schlicker et al. 1994; Tanaka et al. 2003; Miyagawa et al. 2005; Aoki
et al. 2006a; Iguchi et al. 2006]. Generally, there was no correlation between
the absence of protamines and mutations within the coding regions of the
protamine genes or transition protein genes. These findings suggest that
genetic sequence aberrations are an unlikely cause for protamine
deficiency. Subsequent studies reported that patients with an elevated
P1=P2 ratio under-expressed P2 protein and retained higher levels of prota-
mine 2 transcript when compared to patients with normal or high P2 protein
[Aoki et al. 2006c; Torregrosa et al. 2006]. However, patients with a dimin-
ished P1=P2 ratio under-expressed P1 protein and over-expressed P1
transcript [Aoki et al. 2006c; Torregrosa et al. 2006]. Previous studies have
indicated that patients with an elevated protamine 2 transcript had higher
levels of DNA damage [Torregrosa et al. 2006], whereas patients with
increased protamine 1 transcript retention had low sperm motility [Lambard
et al. 2004; Aoki et al. 2006c]. This variation in transcript retention may
be explained by reduced protamine transcription, altered translation of the
transcript or simply altered retention of unprocessed transcripts, but this is
inconclusive as to the cause of altered transcript retention. Nevertheless, there
may be defective regulatory element in the protamine genes, which cause a
change in protein expression. It is possible that this regulatory element is
related to the binding sites in the 50 or 30 untranslated regions (UTR) of the
protamine genes.
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Several studies have emphasized the importance of
the UTRs of the protamine genes and their role in
transcriptional and translational regulation [Braun
1990; Tamura et al. 1992; Schmidt et al. 1997; Schmid
et al. 2001]. These studies identify several trans-acting
factors that bind to certain motifs within these regions
in order to modulate gene expression. However, the
genomic sequence of the untranslated region of the
protamine genes has not been evaluated. Single
nucleotide polymorphisms in the conserved 50 and
30 UTRs may alter the binding dynamics of trans-act-
ing factors. Consequently, this may interrupt prota-
mine transcription, promote premature translation,
or delay translational activation. The objective of this
study was to screen a population composed of
severely infertile men with identified aberrations in
the P1=P2 ratio, individuals with a normal protamine
ratio, fertile donors, and men from the Utah Genetic
Reference Program (UGRP) for mutations in the
untranslated regions of P1 and P2.
RESULTS
Four primer sets were used to analyze the 50 and 30
untranslated regions of protamine 1 and 2 in 315
study participants. Direct sequencing of the PCR
amplified DNA identified 14 SNPs in the untranslated
regions of both protamine genes, 1 of which was
previously reported (rs 2301365) (Table 1), and one
variable length repeat (VLR) in 50 UTR of protamine
2 (Figure 1). The SNP frequencies were compared
among the different groups using chi square test to
determine if there was a significant difference in
the occurrence of SNPs. The frequencies of SNPs
reported were not significantly different between
infertile men with an abnormal P1=P2 ratio, men
with normal P1=P2 ratio, and men from the Utah
Genetic Reference Program (UGRP). Of greatest
interest was a G=C change 62 bp into the 30 UTR of
P2, which occurred in five infertile heterozygous
men with an abnormal P1=P2 and 6 heterozygotes
from the UGRP. Interestingly, none of the men
with confirmed normal protamine ratios carried this
change. This G=C SNP was confirmed in cDNA sam-
ples of men with abnormal P1=P2 ratios, but absent
in all fertile donors tested.
The P2 50 GA repeat lengths were found at relatively
equal frequency among the abnormal P1=P2 ratio,
normal P1=P2 ratio, and UGRP patients (Figure 1).
The most common GA repeat length was 29 base
pairs long. Chi square analysis was used to deter-
mine whether the observed allelic heterozygosity
may vary among the different groups, however, sig-
nificant difference was not achieved. The observed
percentages for allelic hetrozygosity were: 63% in
UGRP, 73% in normal P1=P2 ratio patients, and
80% in abnormal P1=P2 ratio. These percentages fell
within the normal distribution of Hardy-Weinberg
TABLE 1 Identified Single Nucleotide Polymorphisms in the Untranslated Regions of the Protamine Genes
Allele frequency in the study populations
Single nucleotide polymorphism (SNP) UGRP Donors (cDNA) Normal P1=P2 Abnormal P1=P2
1 P1 30 (þ86bp) tgccaC=Tcatcca 0.000 0.000 0.021 0.000
2 P1 30 (þ98bp) tccaA=Gtaaaa 0.036 0.000 0.000 0.000
3 P1 50 ("274bp) tcttG=Ttat 0.000 N=A 0.011 0.000
4 P1 50 ("247bp) ggcagC=Accc 0.000 N=A 0.005 0.013
5 P1 50 ("236bp) actcG=Agggg 0.000 N=A 0.011 0.031
6 P1 50 ("189bp) caggC=Acacc 0.263 N=A 0.255 0.208
7 P1 50 ("112bp) caggC=Tcgca 0.000 N=A 0.011 0.000
8 P1 50 ("105bp) agaG=Cctggc 0.000 N=A 0.005 0.009
9 P1 50 ("91bp) ctggC=Tccct 0.000 N=A 0.005 0.000
10 P2 30 (þ 62bp) aagtG=Caggc 0.027 0.000 0.000 0.020
11 P2 50 ("392bp) atgtG=Acgta 0.043 N=A 0.053 0.044
12 P2 50 ("389bp) gcgT=Caccc 0.112 N=A 0.147 0.149
13 P2 50 ("371bp) gggaC=Gatga 0.048 N=A 0.059 0.022
14 P2 50 ("226bp) agttG=Atgac 0.016 N=A 0.035 0.026
The SNP locations are numbered according to their positions in the genomic sequence: upstream of the first start codon (negative value) and
downstream of the termination codon (positive value).















































equilibrium as evaluated using the genetic popu-
lation software package GenALEx 6.0 (Peakall and
Smouse 2006).
The majority of reported SNPs in this study are
novel SNPs (Table 1), however, a few additional
SNPs were not observed in our patient population.
Two SNPs, a C=T change and a C=G change
(rs11544791 and rs1126926), were noted in the
untranslated regions of protamine 1 50 and 30 and were
both identified in cDNA samples [Lee et al. 1987].
In addition, four SNPs were reported in protamine
2, two were found in genomic sequence (T=C and
G=C) (rs 424908 and rs 452495) and the other two
were in cDNA samples (A=T and C=T) (rs 1042801
and rs11545258) (Domenjoud et al. 1988; Kramer
and Krawetz 1996). Bioinformatic analysis failed to
localize any of the newly identified SNPs to tran-
scriptional or translational factor binding sites.
DISCUSSION
The study objective was to determine whether
mutations in the untranslated regions of the prota-
mine genes account for aberrant transcription and
translation regulation of these genes. This study
identified 14 SNPs by direct sequencing in both the
forward and reverse directions. Of greatest sig-
nificance was a G=C change in 30 UTR of P2 of abnor-
mal protamine patients which did not localize to a
known regulatory binding region, but it may be asso-
ciated with an unknown mRNA regulator-binding
site given that it did not appear in known fertile
donors or patients with a verified normal protamine
ratio, even in a heterozygous manner. All identified
SNPs were present in similar frequencies in normal
P1=P2, fertile donors, UGRP, and protamine deficient
patients. These SNPs may possibly achieve signifi-
cance if a greater sample size was evaluated.
The variable GA repeat upstream of the transcrip-
tional initiation start site was reported from Ceph
families in earlier studies [De Jonckheere et al.
1994; Schnulle et al. 1994]. Both studies, as well
as ours, consistently reported several GA repeat
lengths, the most common length reported in all
populations tested is 29bp, which suggests that the
variability in the untranslated region is unlikely to
account for the diminished expression of P2 in infer-
tile patients. From these data we can conclude that
the screened populations have a significant number
of repeat lengths present, but the repeat variability
does not reflect a direct association with protamine
deregulation.
Understanding the cause of protamine deregula-
tion has been of great interest. Indeed, many investi-
gators have attempted to identify any significant
mutations in the protamine coding regions [de Yebra
and Oliva 1993; Schlicker et al. 1994; Aoki et al.
2006a]. However, Tanaka, et al. in 2003 identified
one azoospermic patient with a premature stop
codon in P2 [Tanaka et al. 2003]. The SNP occurred
at very low frequency (1=153 patients), however, it
was absent from the fertile patient population
screened. This SNP in the P2 gene should induce
translation termination, which may result in male
infertility due to haploinsufficiency of P2.
Later, Iguchi et al. sequenced the protamine genes
in men exhibiting semen quality defects consistent
with protamine abnormalities (i.e. sperm DNA dam-
age, abnormal morphology, and normal sperm con-
centration) [Iguchi et al. 2006]. In their study, a
heterozygous SNP which altered a highly conserved
arginine residue in P1 was found in 10% (3=30) of
the patients studied, but not seen in controls or
reported in the literature. This SNP converts a highly
conserved arginine to a serine residue, therefore cre-
ating a RS sequence which can serve as a potential
phosphorylation site for the enzyme serine arginine
protein kinase 1 (SRPK1). The P1=P2 ratio in the
patient carrying this SNP is unknown. These findings
can be a potential explanation for the occurrence of
a small proportion of the abnormalities seen in
protamine deregulation. However, the observations
in both these studies were infrequent and limited
to Asian populations.
FIGURE 1 (GA)n Variable Length Repeat (VLR) and Allelic
frequency percentage in three test groups.















































The data from this current study is consistent with
previously published data, which indicates that the
genetic variability of the protamine gene locus is evi-
dent, even within the 50 and 30 non-coding regions
(i.e. the low frequency þ 62 bp G=C P2 30 SNP).
Nevertheless, these changes do not account for a
large percent of protamine deregulation cases. Given
this conclusion, the over-riding question would be:
what is the cause of protamine deregulation.
Two factors are worth considering when address-
ing protamine deregulation. First, abnormal prota-
mine expression is strikingly common in infertility
patients. Second, patients with abnormal protamine
expression generally have a low sperm count,
decreased sperm motility and morphology, increased
sperm DNA damage [Mengual et al. 2003; Aoki et al.
2006d]. These clinical findings may suggest a defect
in a more general spermatogenic-regulatory mech-
anism affecting a wide range of spermatogenic-
specific genes, including the protamines. The
indirect association between abnormal protamine
expression and severely altered spermatogenesis
may not be intuitively obvious, but animal studies
have also shown that spermatogenesis is severely
altered when protamine expression is experimentally
reduced [Zhong et al. 1999; Aoki et al. 2005]. In con-
trast to human data, haploinsufficient mice show a
homogenous population of severely affected sperm,
while infertile male patients with protamine deregu-
lation exhibit a truly heterogenous population of
sperm [Cho et al. 2001; Aoki et al. 2005; Aoki et al.
2006b; Zhang et al. 2006]. This may be due to focal
disruptions in the tubular structure of the testis or
disruption of upstream regulators with an incom-
plete phenotypic penetrance.
A possible explanation for the link between
altered protamine expression and severely reduced
spermatogenesis is that abnormal protamine exp-
ression is the result of an abnormal functioning of
a regulator of transcription, translation, or post-trans-
lational modifications that would affect not only the
protamines, but a broad range of genes involved in
spermatogenesis [Carrell et al. 2007]. Candidate regu-
lators are trans regulatory factors of transcription that
act via the promoter region such as cAMP response
modulator (CREM) and Contrin. The testis-specific
isoform of CREM, highly expressed in male germ
cells [Delmas et al. 1993], is known to regulate the
expression of several post-meiotic genes, such as
the transition proteins and protamines [Krausz and
Sassone-Corsi 2005; Hogeveen and Sassone-Corsi
2006].
The CREM dependent pathway is associated with
other factors such as ACT, KIF17B, and Translin,
whereas the Contrin pathway is not yet fully eluci-
dated [Herbert and Hecht 1999; Yu et al. 2002;
Hogeveen and Sassone-Corsi 2006]. Two functions
have been proposed for Contrin, the human MSY2
RNA binding protein, in regards to protamine
expression [Yang et al. 2005a; Yang et al. 2007]. First,
it serves as a co-activator for protamine transcription
by binding to the Y box element sequence found in
the gene promoter region. Second, it stabilizes
paternal transcripts in the cytoplasm to effect the
temporal regulation of translation as described
above.
Mice lacking any of the listed proteins are usually
infertile and express a wide range of sperm abnor-
malities. Therefore, these proteins appear parti-
cularly attractive targets for abnormal protamine
expression [Blendy et al. 1996; Nantel et al. 1996;
Kotaja et al. 2004; Yang et al. 2005b; Yang et al.
2006]. Other key regulators, such as phosphorylation
mechanisms, could also be responsible for a broad
defect in spermatogenesis.
In conclusion, future studies will include analysis
of regulators of transcription, translation, and post-
translational modifications. These areas will possibly
provide a better understanding of the underlying
causes of abnormal protamine expression, and help
clarify important information regarding spermato-
genesis in general. Protamines may be an important
marker in better understanding key regulatory path-
ways of spermatogenesis, especially if abnormal pro-
tamine expression reflects an aberrant function of a
key transcriptional or translational regulator.
MATERIAL AND METHODS
Study Population
University of Utah Institutional Review Board
approval was obtained for all aspects of this study.
A total of 315 patients were recruited for the 50 and
30 UTR screening. These patients were classified into
four groups: group one contained 123 infertile men
with an abnormal P1=P2 ratio, group 2 contained
96 patients with a normal P1=P2 ratio, group 3
includes 30 fertile donors, used to confirm the GA















































polymorphism in P2 5 UTR, and group 4 contains 96
DNA samples from the UGRP. The later group was
selected based on unrelatedness and known
paternity. The cut-off values for abnormal (low
<0.8 or high >1.2) or normal (0.8–1.2) P1=P2 ratio
was determined in a previous study in our lab [Aoki
et al. 2005a]. The abnormal protamine group con-
tains men with severely abnormal semen parameters
and are all teratoozospermic.
Evaluation of Sperm P1/P2 Ratio
Study participants with an abnormal protamine
ratio were identified using nuclear protein extrac-
tion, gel electrophoresis, and densitometry analysis.
Sperm nuclear proteins were extracted from cryopre-
served semen aliquots as previously described
[Carrell and Liu 2001]. Gel electrophoresis reagents
were obtained from BioRad Laboratories (Herculles,
CA, USA). All other reagents were obtained from
Sigma Chemical Company (St Louis, MO, USA).
Briefly, neat cryopreserved semen samples were
centrifuged (500# g, 5 minutes) and washed in
1mM phenylmethylsulfonylfluoride (PMSF). The pellet
is resuspended in Tris buffer (100mM) contain-
ing EDTA (20mM) and PMSF (1mM, pH 8), 6M
Guanidine and 575mM dithiothreitol, and 522mM
sodium iodoacetate. The suspension was kept at
room temperature in the dark for 30 minutes and
mixed with 100% ethanol. The ethanol wash was
repeated and then resuspended in 0.5M HCL, incu-
bated for 15 minutes at 37$C. The nuclear proteins
were precipitated by the addition of 100% trichloro-
acetic acid (at a final concentration of 20%) to the
supernatant. The solution was incubated (4$C for
5minutes), centrifuged (12,000# g, 10 minutes), and
washed twice in 1% 2-mercaptoethanol in acetone.
The final pellet was dried and stored at "20$C for
electrophoresis. Acetic acid urea gel electrophoresis
was used to evaluate the intensity of the protamine
bands, as previously described. Band intensity was
measured using the NIH Image J software.
Screening the Untranslated Regions
of the Protamine Genes
Venous blood was obtained using standard phleb-
otomy techniques and genomic DNA extraction was
done using Puregene DNA extraction kit (Minneapolis,
MN). The cDNA samples were prepared from
previously extracted RNA samples using Trizol1
Reagents (Invitrogen, CA, USA) and reverse tran-
scribed using MMLV RT enzyme (Promega, WI,
USA). Primer sets were designed and optimized to
amplify cDNA and genomic DNA untranslated
regions of the protamine genes with standard poly-
merase chain reaction (PCR) techniques. Primer pairs
are as described (Table 2). Primary PCR products
were cleaned using Exosap-it, and sequenced in the
forward and reverse direction.
Samples were sequenced using ABI 3700 capillary
sequencer. Sequence traces were assembled using
the Phrap software and analyzed for significant
changes using Phred and Consed. Phred assigns a
quantitative value to quality of each sequenced base.
This base quality provides a probabilistic estimate of
the correctness of the base call. The sequences were
assembled using Phrap program.
Potential mutations were identified using Consed,
which has the ability to search for high quality base
discrepancies in the assembled sequence. Visual
analysis was also used to confirm identified poly-
morphisms and potential mutations. The nucleotide
base changes are reported alongside the location of
TABLE 2 Primer Sequences
Region Primer sequence Temperature
P1 50F TGGTGCATGTCTGTAGTCCAACTACTG 61
P1 50R ACTTACTCATGGCTCTCCTCCGT
P1 30F GCAGATATTACCGCCAGAGACA 64
P1 30R TCAAGAACAAGGAGAGAAGAGTGG
P2 50F GGTAGAGGCTGCTATGATCCATGATTGC 64
P2 50R ATGCAACTGCTGCCTGTACA
P2 30F CCACCTGACAAAAGCTCCAG 64
P2 30R AGCCAGGTTTGTGTGATTCG















































the SNPs. The frequencies of novel SNPs were com-
pared by chi-square analysis.
GA Repeat
The lengths of the GA repeat located 50 of the P2
gene was identified in men from three groups, men
with abnormal P1=P2 ratios (n ¼ 41), normal P1=P2
ratios (n ¼ 45), and men from the UGRP (n ¼ 45).
The genotyping followed standard amplified frag-
ment length polymorphism (AFLP) genomic analysis
protocols. Briefly, PCR was performed using a FAM-
labeled reverse primer and forward primer with a
GTTTCT genotyping enhancement element flanking
the P2 50 GAn. The PCR product was diluted into
96-well Applied Biosystems trays, processed, and
analyzed on an Applied Biosystems 3130# l Genetic
Analyzer at a university core facility. The fragment
length was determined using Applied Biosystems
GeneMapper v3.7 and then converted to the repeat
length by comparison to direct sequencing of a
known homozygous individual.
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abstract: Along with many of the genome-wide transitions in chromatin composition throughout spermatogenesis, epigenetic modi-
fications on histone tails and DNA are continuously modified to ensure stage specific gene expression in the maturing spermatid. Recent
findings have suggested that the repertoire of epigenetic modifications in the mature sperm may have a potential role in the developing
embryo and alterations in the epigenetic profile have been associated with infertility. These changes include DNA demethylation and the
retention of modified histones at important developmental, signaling and micro-RNA genes, which resemble the epigenetic state of an
embryonic stem cell. This review assesses the significance of epigenetic changes during spermatogenesis, and provides insight on recent
associations made between altered epigenetic profiles in the mature sperm and its relationship to infertility.
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Introduction
In vitro fertilization (IVF) and other assisted reproductive technologies
(ART) have accounted for !3 million births since the world’s first IVF
baby was born in 1978 (Cohen, 1978). Reports examining the long-
term health consequences of these babies are limited; however,
follow-up studies have reported increased intrauterine growth restric-
tion and lower birth weights in singletons conceived by IVF compared
with natural conceptions (Steel and Sutcliffe, 2009). More recently,
increased perinatal mortality, congenital anomalies and epigenetic
abnormalities have been reported to be associated with IVF (Seif
et al., 2006; Allen et al., 2008; Kalra and Molinaro, 2008; Reefhuis
et al., 2009; Steel and Sutcliffe, 2009).
The underlying causes of increased anomalies in IVF offspring are
unknown, but alterations in the normal epigenetic state of gametes
of severely infertile patients undergoing IVF has been proposed as
one potential contributor (Cutfield et al., 2007; Lim et al., 2009; Man-
ipalviratn et al., 2009). Epigenetic modifications are covalent modifi-
cations present on either the DNA itself or to the proteins that are
closely associated with DNA (histones in somatic cells and histones
and protamines in sperm), both of which are important in modifying
gene expression without changing the genetic code itself. These modi-
fications comprise what is commonly referred to as the epigenome,
which in somatic cells regulates cellular fate and function (Bernstein
et al., 2002, 2005, 2006; Li, 2002; Jones and Baylin, 2007). It is now
well understood that the epigenome can become disrupted or
altered, which may contribute significantly to the onset of epigenetic
changes observed in many diseases and may be causative of some
diseases (Feinberg, 2007; Jones and Baylin, 2007).
Recent studies have demonstrated that sperm have unique and
potentially important epigenetic modifications. This brief review
describes chromatin and epigenetic changes throughout spermatogen-
esis, their potential role in normal embryonic development, and their
implications in male infertility.
Histone Modifications During
Spermatogenesis
Male germ cells undergo unique and extensive chromatin and epige-
netic remodeling soon after their specification (determination to
become a spermatocyte) and during the differentiation process to
become a mature spermatozoon (Seki et al., 2005). Although the
mechanisms regulating and orchestrating specification and spermio-
genesis remain poorly understood, some progress has been made in
elucidating the changes associated with the complex cellular
changes. During mitosis and meiosis, male germ cell DNA is packaged
in nucleosomes, comprised of histone 2A (H2A), histone 2B (H2B),
histone 3 (H3) and histone 4 (H4), all of which are susceptible to
covalent modifications, such as methylation, acetylation, ubiquitination
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and phosphorylation. Each of these chemical modifications to histones
works alone or in concert to influence gene repression and/or acti-
vation (Fig. 1).
Histone methylation on lysine (K) residues of H3 or H4 can
promote gene activation and/or repression (Lachner and Jenuwein,
2002; Suganuma and Workman, 2008). Monomethylation, dimethyla-
tion and trimethylation modifications of H3K4, H3K9 or H3K27
display tightly controlled temporal expression and ensure proper pro-
gression through spermatogenesis (Khalil et al., 2004; Godmann et al.,
2007; Payne and Braun, 2006). The level of H3K4 methylation peaks in
the spermatogonial stem cell stage (Fig. 2), and a targeted loss of
H3K4 methylation, caused by reduction of Mll2 activity (an H3K4
methyl transferase), results in a dramatic reduction in the number of
spermatocytes (Table I), suggesting that H3K4 methylation is essential
Figure 2 Hypothetical expression profiles of histone modifications and DNA methyltransferases during spermatogenesis. In the top panel, solid lines
indicate investigated histone level. In the bottom panel dashed lines indicate low expression. Ac ¼ acetylation, me ¼ methylation, TPs ¼ transition
proteins, Ax ¼ phosphorylation, MSC1 ¼ meiotic sex chromosome inactivation, DNMT ¼ DNA methyl transferase, RS ¼ round spermatid, ES ¼
elongated spermatid, M ¼ mature spermatid.
Figure 1 Chromatin modifications determine gene state. Histone modifications promote either gene activation or repression; however, in
embryonic stem cells and sperm a subset of genes are commonly associated with both active and inactive marks. ac ¼ acetylation, me ¼ methylation,
ub ¼ ubiquitination.
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for the exit from the stem cell stage and commitment to become a
spermatocyte (Glaser et al., 2009). In contrast, H3K9 methylation
and H3K27methylation are low in the stem cell and increase during
meiosis (Fig. 2), persisting long after meiosis is complete, presumably
to ensure gene-silencing (Payne and Braun, 2006). The role ascribed
to each of these modifications has been primarily characterized by
immunofluorescence data with no gene specific localization. Methyl-
ation on lysine 9 of histone H3 (H3K9me) is associated with the sex
chromosomes, euchromatin and heterochromatin in the late pachy-
tene stage, however, the levels of H3K9 methylation drop upon com-
pletion of meiosis. This reduction in H3K9me is concurrently
associated with an increase in H3K4me levels (Fig. 2) (Glaser et al.,
2009).
The timing of establishment and removal of methylation marks is
critical to normal spermatogenesis, as demonstrated by numerous
transgenic animal models. Loss of LSD1/KDM1 (H3K4me demethy-
lase) during mid to late meiosis in Caenorhabditis elegans results in
germ cell apoptosis and progressive sterility that is maintained
through many generations (Shi et al., 2004; Lee et al., 2005; Katz
et al., 2009) (Table I). Similarly, removal of H3K9me at the end of
meiosis is essential for the completion of spermatogenesis (Okada
et al., 2007). Targeted disruption of the H3K9 demethylase
JHDM2A (JmjC domain containing histone demethylase 2A, also
known as JMJD1A) (Table I) results in complete loss of protamine 1
(PRM1) and transition protein 1 (TNP1) expression, defective chro-
matin condensation, and infertility (Okada et al., 2007). These
studies show that methylation acts through various mechanisms to
guide spermatogenesis (Table I).
Histone acetylation of lysine residues is dynamically regulated by
histone acetyltransferases (HATs) and histone deacetylases
(HDACs), both of which are shown to be essential for spermatogen-
esis (Christensen et al., 1984; Grimes and Henderson, 1984; Hazzouri
et al., 2000; Lahn et al., 2002; Sonnack et al., 2002; Fenic et al., 2004,
2008; An, 2007, Kurtz et al., 2007). Histone acetylation relaxes chro-
matin and promotes polymerase II (Pol II) gene transcription, whereas
deacetylation is associated with gene silencing (Jenuwein and Allis,
2001). Acetylation levels on both H3 and H4 are high in the stem
cell phase and are completely removed during meiosis (Fig. 2).
Re-acetylation of H4 happens in the elongating spermatid and is
known to be a prerequisite for the histone-to-protamine exchange
process (Fig. 2) (Hazzouri et al., 2000). However, recent studies
show that both H3 and H4 acetylation occur simultaneously in the
elongating stage, possibly extending to H2A and H2B acetylation as
well (Nair et al., 2008). These data raise the question whether all his-
tones may need to be acetylated to ensure proper histone to prota-
mine exchange in maturing sperm. Enzymes involved in H4
hyperacetylation in the round spermatid are unknown, however,
two candidates have emerged, testis specific chromodomain protein
(CDY) and HAT (monocytic leukemia) 4 (MYST4). Both of these acet-
yltransferases are expressed during the maturing spermatid stage,
localize to the nucleus, and have been shown to have potent H4 acet-
ylase activity (Lahn et al., 2002; McGraw et al., 2007). H3 acetylation in
the elongating spermatid was shown to be Pygopus 2 (Pygo 2) depen-
dent. Pygo 2 has an evolutionarily conserved plant homeodomain
(PHD) finger domain that binds trimethylated H3K4 and facilitates
H3 acetylation (Nair et al., 2008). Evidence for H2B acetylation has
been recently described by mass spectrometery studies, however,
very little is known about its function during spermatogenesis or the
enzymes required for its acetylation (Lu et al., 2009).
Although acetylation is broad, studies using HDAC inhibitors have
demonstrated that the acetylation process is also necessarily specific.
The effect of HDAC inhibitors on spermatogenesis is poorly defined,
but a few studies have shown that although treating mice with HDAC
inhibitors did not result in hyperacetylation, it did cause severe infer-
tility (Fenic et al., 2004). Trichostatin A (TSA) treated animals had no
evidence of H4 hypercetylation in the round spermatid, but the
number of spermatids was significantly reduced (Fenic et al., 2004,
2008). The inability to detect the hyperacetylation following TSA
treatment maybe due to an increase in apoptosis in cells with abnor-
mal acetylation levels, or due to a compensatory mechanism involving
alternative HDACs that are insensitive to TSA (Pivot-Pajot et al.,
2003).
Histone phosphorylation occurs at serine residues of all core his-
tones and is generally associated with gene activation (Berger,
2002). However, H2Ax phosphorylation (also known as gH2Ax) in
germ cells confers the formation of X/Y sex body during spermato-
genesis and is a marker for telomere clustering and double stranded
breaks (Fernandez-Capetillo et al., 2003a, b). H2Ax phosphorylation
is dependent on the ataxia telangiectasia DNA repair and Rad3
related protein ATR, and on the tumor suppressor BRCA1. Together
gH2Ax, ATR and BRCA1 initiate meiotic sex chromosome inacti-
vation (MSCI), but to maintain MSCI throughout the pachytene
stage there are many other epigenetic modifications including ubiqui-
nated H2A that are localized to the XY body, however, the exact
function each performs are unknown (Hoyer-Fender, 2003).
The effect of ubiquination varies depending on the core histone
modified: ubiquination of H2A associates with transcriptional repres-
sion, whereas, mono-ubiquination of H2B is linked to transcriptional
activation in sperm (Baarends et al., 2005; Zhu et al., 2005). In male
germ cells, recruitment of ubiquinated H2A to the sex body and tel-
omeres occurs long after gH2Ax incorporation (Fig. 2), which indi-
cates that H2A-ubiquination may be involved in maintaining silencing
in the inactive chromatin, but not establishing MSCI.
These brief descriptions of histone modifications during sperm-
atogenesis (data summarized in Fig. 2) demonstrate the varied
........................................................................................





DNMT1 Maintenance DNA methyltransferase
DNMT3a de-novo DNA methyltransferase
DNMT3b de-novo DNA methyltransferase
DNMT3L de-novo DNA methyltransferase (no catalytic
activity)
Mll H3K4 methyl transferase
JHDM2A H3K9 demethylase
HAT Histone acetyl transferase
HDACs Histone deacetylase
LSD1/KDM H3K4 demethylase
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ways in which epigenetic modification regulate spermatogenesis.
Although most histones are replaced with protamines during the
elongating spermatid stage, some of the modified nucleosomes
escape the histone to protamine transition and as a result are retained
in mature sperm, suggesting that these retained nucleosomes may also
play a role in the paternal contribution to the embryo.
The Role of Paternal Histones
in the Epigenetic Control
of Embryogenesis
A hallmark of spermiogenesis is the widespread changes in chromatin
structure during spermiogenesis, including the exchange of most cano-
nical histones for protamines (Ward and Coffey, 1991). Protamines
are small basic proteins that bind DNA to form toroids; tightly
packed structures which compact the genome beyond what is attain-
able by nucleosomes. The high-level of compaction is an essential
attribute for genome transport in the mature sperm head (Balhorn
et al., 2000). The histone to protamine exchange process is incom-
plete, with a small percentage (5–15%) of the genome bound to
nucleosomes (Tanphaichitr et al., 1978; Wykes and Krawetz, 2003).
The replacement of somatic histones by protamines is important for
nuclear chromatin compaction, sperm maturation and fertility
(Gatewood et al., 1987, 1990; Balhorn et al., 1988; de Yebra et al.,
1998; Corzett et al., 2002; Aoki et al., 2004, 2005, 2006a, b, c;
Hammoud et al., 2009a, b). In humans the relative proportion of
protamine-1 (P1) to protamine-2 (P2) is strictly regulated at approxi-
mately a 1:1 ratio and alterations in the P1/P2 ratio are very rare in
fertile men and relatively common in infertile men (Chevaillier et al.,
1987; Balhorn et al., 1988, 1999; Belokopytova et al., 1993; de
Yebra et al., 1998; Carrell and Liu, 2001; Corzett et al., 2002; Aoki
et al., 2005, Oliva, 2006; Carrell et al., 2007). Reports from many
labs have shown that changes in the P1/P2 ratio are not only associ-
ated with altered sperm quality, but also associated with decreased
embryo quality and IVF outcome compared with infertile patients
with a normal P1/P2 ratio (Aoki et al., 2006a, b, c; Depa-Martynow
et al., 2007). These preliminary associations suggest that protamines
and histones may have a greater role during the preimplantation
embryo development than previously expected.
The retained nucleosomes are comprised of canonical histones
(H2A, H2B, H3, H4) as well as a testes-specific histone variant
(tH2B) (Gatewood et al., 1990; Kimmins and Sassone-Corsi,
2005). Until recently, the role for the retained nucleosomes was
unknown, but it was speculated that the retained nucleosomes
were either remnants of incomplete histone to protamine replace-
ment, or that they may have a biologically significant role during
early embryogenesis. In recent work from our laboratory, we have
shown that nucleosomes retained in sperm are not simply randomly
distributed remnants of inefficient protamine replacement, but are
instead significantly enriched at many loci important for embryo
development, including genes of key embryonic transcription
factors and signaling pathway proteins. Histones were also signifi-
cantly enriched at the promoters of miRNAs and imprinted genes
(addressed in more detail below) (Hammoud et al., 2009a, b).
These findings challenge the widely assumed notion that the paternal
genome provides little in epigenetic contributions beyond a small set
of paternally imprinted genes and a modest repertoire of packaged
RNA, due to the repackaging of the vast majority of the genome
by protamine.
The identification of retained nucleosomes at key developmental
genes was striking, but to have any potential paternal contribution
to the developing embryo secondary modifications on the retained
nucleosomes (such as the modification discussed above) may be key
to differentiate the paternally poised genes from all other genes that
have acquired acetylated histones following protamine displacement
soon after fertilization. To better understand the chromatin landscape
at histone-associated developmental, signaling and miRNA genes three
chromatin attributes were tested: histone variants, histone modifi-
cations and DNA methylation. We hypothesized that consistent,
orderly and biologically relevant patterns in histone modifications, var-
iants and/or DNA methylation could imply a programmatic marking,
such as ‘poising’ genes for activation during early embryogenesis, as
opposed to a random and non-biologically relevant inefficiency in pro-
tamine replacement and epigenetic marking.
The first logical candidate tested for paternal genome poising was
the testis specific H2B variant (tH2B) which is incorporated late in
spermatogenesis and comprises a large percentage of retained his-
tones (Hammoud et al., 2009a, b). Analysis of tH2B distribution
throughout the sperm genome revealed a very significant enrichment
of this histone variant at genes for ion channels and genes involved in
spermiogenesis, but not at promoters for developmental genes. A
second variant in spermatogenesis that has been recently implicated
in gene poising in other cell types, such as embryonic stem (ES)
cells, is the histone variant H2Az. H2Az in ES cells were shown to
be a key regulator of chromatin function and associated with targets
of the Polycomb complex at genes essential for ES cell differentiation
(Creyghton et al., 2008). In contrast to its role in ES cells, H2Az in
sperm was enriched at pericentric heterochromatin, which is consist-
ent with prior immunostaining studies (Rangasamy et al., 2003). Data
from these two variants suggested that canonical histones might be an
alternative at developmental genes.
Chromatin immunoprecipitation (ChIP) followed by either microar-
ray or deep sequencing analysis clearly shows that modified canonical
nucleosomes reveal attributes of a remnant spermatogenesis program
(primarily enriched with H3K4me3), as well as a future developmental
program (enriched with H3K27me3, H3K4me2 and H3K4me3)
(Hammoud et al., 2009a, b). GO term analyses for H3K4me3
yielded genes important for changing nuclear architecture, RNA
metabolism, spermatogenesis and a selected number of transcription
factors important for embryonic development. However, the majority
of the developmental and signaling transcription factors were signifi-
cantly enriched with H3K27me3 and H3K4me2. Interestingly, many
of the developmental promoters harboring an activation mark such
as H3K4me3 also retained a silencing mark H3K27me3 (Bernstein
et al., 2002, 2006), resembling the bivalently marked (H3K4me3 and
H3K27me3) promoters commonly seen in ES cells that are typically
silenced prior to ES cell differentiation, but necessary for embryonic
differentiation (Fig. 1). Furthermore, modified canonical nucleosomes
extended beyond known gene promoters to promoters of non-coding
RNAs, miRNAs and imprinted loci. No clear pattern was seen at
many of the miRNA and non-coding RNA promoters, but this is pri-
marily due to the limited knowledge on the functional role of these
miRNAs in development. Taken together, these data reveal extensive
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histone modification patterns, and significant similarities to patterns
observed in ES cells that may indicate a significant role for sperm epi-
genetic marking in the establishment of embryonic totipotency.
Significance of DNA methylation in the
paternal germline
Packaging and transcriptional control of DNA in eukaryotes is by in
large governed by the highly conserved role of histones, however, in
higher organisms DNA methylation has been shown to have an essen-
tial role in normal embryonic development, regulating gene
expression, X chromosome inactivation, genomic imprinting and silen-
cing of endogenous retroviruses (Jaenisch and Jahner, 1984; Surani,
1998; Ng and Bird, 1999). DNA methylation occurs primarily at cyto-
sine residues in a CpG context and is catalyzed by two important
classes of DNA methyltransferases (DNMTs): maintenance DNA
methyltaransferase (Dnmt1) and de novo DNA methyltransferases
(Dnmt3a, Dnmt3b, Dnmt3l) (Fig. 2, Table I) (Eden and Cedar, 1994).
Dnmt1 is the major methyltransferase in somatic cells. It has a pre-
ference for hemimethylated DNA and is critical for the maintenance of
DNA methylation patterns in replicating cells (Bestor, 1992; Lei et al.,
1996) (Table I). Mice homozygous for a targeted partial deletion of
Dnmt1 or complete loss of function of Dnmt1 have retarded growth
and die by mid-gestation (Li et al., 1992, 1996). Dnmt1 deficient
embryos have less than 5% of the normal levels of cytosine methyl-
ation, regain biallelic expression at imprinted loci and have ectopic
expression of Xist and retrotransposons (Li et al., 1993; Panning and
Jaenisch, 1996; Walsh et al., 1998; Goll and Bestor, 2005).
The second class of DNMTs are de novo methyltransferases
(Dnmt3a, 3b, 3l) and are essential for establishing new DNA methyl-
ation patterns during development (Table I). Embryos lacking Dnmt3a
or 3b lost all de novo methylation capabilities in ES cells and early
embryos (resulted in embryonic lethality), but had no effect on the
maintenance of imprinted loci (Hsieh, 1999; Lyko et al., 1999;
Okano et al., 1999). Dnmt3a and b were required for methylating cen-
tromeric loci and imprinted genes. Dnmt3l is closely related in
sequence to DNMT3A and B, but lacks the catalytic domain. Dnmt3l
mediates de novo methylation by stimulating the catalytic activity of
DNMT3A2, an isoform variant of DNMT3A (Hata et al., 2002;
Suetake et al., 2004). Dnmt3A2 along with its cofactor Dnmt3l estab-
lishes locus-specific DNA methylation of paternal imprints prior to
meiosis in spermatogenesis (Bourc’his et al., 2001; Kaneda et al.,
2004). Males’ haploinsufficient for Dnmt3l are phenotypically normal
and fertile, but have subtle changes in methylation and chromatin
state of the genome in pre-meiotic spermatogonia (Bourc’his and
Bestor, 2004; Webster et al., 2005). The phenotype for DNMT3L
null male germ cells is significantly different in male versus female
germ cells. Male germ cells fail to methylate LINE-1 (long interspersed
elements) and IAP (intracisternal A particles) classes of retrotranspo-
sons, have severe asynapsis at meiotic prophase, and undergo apopto-
sis of all germ cells before pachytene (Bourc’his and Bestor, 2004).
Whereas, methylation patterns at the small number of paternally
methylated DMRs are almost normal, suggesting some functional
redundancy between DNMTs (Bourc’his and Bestor, 2004; Webster
et al., 2005). Strikingly, in the oocyte DNMT3L deficient germ cells
carried out normal meiosis and methylation at repeat sequences,
but the obvious methylation defect was limited to maternally
imprinted loci. The differences observed between male and female
knockouts are intriguing and raise many questions regarding targeting
mechanism and differential regulation between sexes.
In addition to the DNMT gene knockout or happloinsufficiency
studies used to assess the functional significance of DNA methylation
in the germ line and early embryo, animals treated with DNMT inhibi-
tors such as 5-aza-2’-deoxyCytidine showed altered gene expression
patterns and loss of methylation in the germline. The severity of the
phenotype observed in the treatment group was heavily dependent
on the duration of treatment: short-term exposure in mice and rats
decreased fertility (Seifertova et al., 1976; Raman and Narayan,
1995),whereas, prolonged treatment of 5-azacytidine (11weeks) in
male rats resulted in a dose-dependent reductions in testis, epididymal
weights and sperm counts, increase in germ cell apoptosis, and a sig-
nificant increase in preimplantation loss (Doerksen and Trasler, 1996;
Doerksen et al., 2000). These findings suggest that sperm DNA
methylation plays a critical role in the differentiation of spermatogonia
and early embryo viability, however, this appears counterintuitive since
DNA methylation patterns are erased and reestablished immediately
after fertilization and once again when primordial germ cells (PGCs)
reach the genital ridge (Reik et al., 2001; Hajkova et al., 2002, Seki
et al., 2005, 2007).
In humans, the relationship between bulk methylation levels with
respect to IVF outcome was recently examined in one study. No sig-
nificant correlation was made between bulk DNA methylation levels
and the fertilization rate or embryo quality, but a lower 5-methyl cyto-
sine signal (,555 AU) intensity correlated with a lower pregnancy
(8.3 versus 33.3%) rates (Benchaib et al., 2005). These preliminary
associations in humans are interesting, but interpretation and impli-
cations of measuring bulk methylation levels are limited and provide
very little understanding of causality or the programs perturbed (acti-
vation of retrotransposons, changes at imprinted genes, etc.), and
more genome-wide approaches are needed.
Sperm DNA Methylation Profiles
and its Role in the Paternal
Germline
Germ cells undergo extensive epigenetic reprogramming during pro-
liferation and migration to the genital ridge (Seki et al., 2005, 2007).
DNA methylation is erased and re-established in a sex and sequence
specific manner during gametogenesis (Reik et al., 2001; Hajkova et al.,
2002). The timing for methylation reestablishment differs between
sexes and is continual for certain gene classes (Trasler, 2006). In
males, de novo genomic methylation begins prenatally (prospermato-
gonia) at imprinted loci and repetitive elements with a general consen-
sus being, that methylation patterns are completed by the end of
pachytene stage of meiosis (Oakes et al., 2007a, b). However, excep-
tions have been reported at a few gene promoters that are expressed
early in spermatogenesis (Pgk-2, ApoA1 and Oct-3/4) but are
silenced in the maturing spermatid by gradually acquiring methylation
in postmeiotic spermatocytes (Ariel et al., 1991, 1994).
Recent genome-wide methylation studies have indicated that the
sperm epigenome differs markedly from that of somatic cells, but is
very similar to ES cells and embryonic germ cells (EG) (Eckhardt
et al., 2006, Oakes et al., 2007a, b; Weber et al., 2007; Farthing
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et al., 2008). Examining sperm DNA methylation of chromosomes 6,
20 and 22 using restriction landmark genomic studies showed that
many loci were differentially methylated between sperm and
somatic cells. Extending methylation analysis genome-wide to all pro-
moters of the human genome showed that the promoters that were
differentially methylated in sperm and somatic tissue (or acquire
methylation upon differentiation) were promoters with ‘weak’ CpG
islands. More recently, we have shown in our gene ontology analysis
that the hypomethylated promoters in the mature sperm are the pro-
moters of developmental transcription and signaling factors. Interest-
ingly, the DNA hypomethylated promoters in mature sperm greatly
overlapped with the developmental promoters bound by the self
renewal network transcription factors in human ES cells (e.g. OCT4,
SOX2, NANOG, KLF4 and FOXD3 proteins) (Boyer et al., 2005).
In ES cells, these pluripotency proteins promote self renewal and
also work with repressive polycomb complexes (PRC2) to help
repress a large set of developmental regulators (including HOX
genes) to prevent differentiation (Cao et al., 2002; Bernstein et al.,
2006; Lee et al., 2006; Muller and Kassis, 2006; Schwartz et al.,
2006; Takahashi et al., 2007; Tanay et al., 2007; Wernig et al.,
2007; Kopp et al., 2008). This overlap suggested that pluripotency
or polycomb complex factors might be involved in the establishment
and maintenance of sperm DNA methylation poising in sperm. Unfor-
tunately, pluripotency and polycomb factors were not detected in the
mature sperm, in fact many of the pluripotency promoters including
several key members of the self-renewal network (OCT4, NANOG,
FOXD3) themselves acquire methylation throughout spermatogenesis,
whereas their developmental target genes remain hypomethylated,
consistent with recent studies in mice (Down et al., 2008; Farthing
et al., 2008; Illingworth et al., 2008; Mohn et al., 2008). These findings
show that genes encoding early developmental transcription factors as
well as signaling proteins are DNA hypomethylated and histone
bound. Furthermore, developmental promoters are selectively
methylated during development, which may help commit cells to
differentiation decisions. Histone retention and DNA demethylation
contribute to a poised state that ensures transcriptional competence
and activation of developmental regulators in the early embryo.
Epigenetic alterations and male infertility
The incidence of infertility has been rising, currently affecting one in
every seven couples in the western population. Male infertility is
responsible for roughly half of the cases of infertility. The underlying
cause of male infertility is unexplained in !50% infertile men, and
genetic causes have been proposed to be likely (Carrell, 2008a, b;
Matzuk and Lamb, 2008). Several studies have explored possible
genetic causes using mouse models (O’Bryan and de Kretser, 2006),
candidate gene sequencing (Miyamoto et al., 2003; Aoki et al.,
2006a, b, c; Hammoud et al., 2007, 2009a, b), and recently the first
genome-wide association study in oligozoospermic and azoospermic
men has been completed (Aston and Carrell, 2009). However,
these studies have revealed that single gene polymorphisms are not
likely to be the cause of most cases of male infertility, but male infer-
tility is likely to be a multifactorial disease. Similar to other complex
diseases, such as cancer, epigenetic alterations may be a component
contributing to infertility.
As described above, recent studies have shown that epigenetic
modifications in sperm (both histone modifications and DNA methyl-
ation) appear to poise the paternal genome to participate in early
embryogenesis. Additionally, several studies indicate that DNA
methylation is altered, in at least imprinted genes, oligozoospermic
men and men with improper histone to protamine replacement
(Marques et al., 2004, 2008; Bowdin et al., 2007; Doornbos et al.,
2007; Hammoud, in press; Kobayashi et al., 2007, 2009). These obser-
vations beg the question of whether methylation defects, of both
imprinted and non-imprinted genes, as well as other epigenetic
defects (such as histone localization or modifications in the mature
sperm), may play an important role in the development and growth
of ART offspring (Manipalviratn et al., 2009). If epigenetic profiles of
the mature sperm are critical, then alterations in epigenetic patterns
in infertile males can provide a logic for the increased risk for
preterm birth, low birthweight, congenital anomalies, perinatal mor-
tality, and several other pregnancy-related complications seen at a
higher frequency in babies conceived by IVF (Hansen et al., 2002;
Kalra and Molinaro, 2008). This growing field of epigenetics in early
gametes and embryos may be of benefit in understanding such obser-
vations (Carrell, 2008a, b). Current studies in our laboratory are
focusing on genome-wide changes in histone localization as well as
DNA methylation (discussed below) in male partners of recurrent
pregnancy loss patients, repeated failed IVF patients and infertile
males with an altered histone to protamine ratio.
Current findings showing that epigenetics patterns in germline are
extensive and of potential significance, only strengthens further the
previous associations that showed abnormal methylation of imprinted
genes (genes expressed in a parent-of-origin manner), in the gametes
of some infertile men or babies conceived by IVF (DeBaun et al., 2003;
Gosden et al., 2003; Maher, 2005). A gain or loss of expression of
imprinted genes has been implicated in many diseases (Jaenisch and
Bird, 2003; Seitz et al., 2004; Morgan et al., 2005; Royo et al., 2006)
including Beckwith–Weidemann syndrome (BWS) and Angelman’s
Syndrome (AS), both of which have been significantly correlated
with IVF babies (DeBaun et al., 2003; Gosden et al., 2003; Maher,
2005).
Whether the increased incidence of imprinting abnormalities in IVF
babies arises from in vitro manipulations of embryos or gametes, are
due to ovulation induction medications, or are inherited from the
gametes of infertile patients is unclear (Cummins and Jequier, 1994;
de Kretser, 1995; Edwards and Ludwig, 2003; Marques et al., 2004,
2008; Bowdin et al., 2007, Doornbos et al., 2007, Kobayashi et al.,
2007, 2009; Laprise, 2009). Support for all former hypotheses
have been provided but this review will focus on one aspect,
preexistent methylation alterations in the gametes of infertility
patients (Cummins and Jequier, 1994; de Kretser, 1995; Edwards
and Ludwig, 2003; Marques et al., 2004, 2008; Bowdin et al., 2007,
Doornbos et al., 2007, Kobayashi et al., 2007, 2009; Laprise, 2009).
This finding first surfaced a few years ago and showed that DNA
methylation patterns at paternally imprinted loci are altered in the
sperm of severely oligozoospermic patients (Marques et al., 2004,
2008). Subsequently in 2007, Houshdaran et al. reported that a
broader alteration in DNA methylation in sperm is seen at a handful
of imprinted loci, CpG islands upstream of gene promoters, and a
few repetitive elements in infertile patients with poor semen par-
ameters (Houshdaran et al., 2007). Furthermore, our lab has shown
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that methylation alterations extend beyond severely oligozoospermic
patients to patients with relatively normal sperm counts but with
abnormal chromatin packaging, defined by an altered P1/P2 ratio
(Hammoud, in press). Interestingly, in the small number of patients
tested with either oligozoospermia or abnormal protamine expression
we observed that methylation alterations varied between the two
different etiologies of infertility. For instance oligozoospermic patients
were hypermethylated at MEST, an imprinted gene associated with
Silver Russell Syndrome (SRS), whereas abnormal protamine patients
had significant changes at LIT1 and small nuclear ribonucleoprotein
polypeptide N (SNRPN), genes that may be associated with cases of
transient neonatal diabetes milletus (TNDM) and alternative splicing
(AS). These findings suggest that the risk of transmitting epigenetic
alterations may vary with the classification of infertility; however, it
is important to note that not all patients or alleles were affected to
a similar extent. The differences in the degree of methylation within
some genes or alleles compared with others raises an important ques-
tions for future studies: whether there is a variable risk to the different
CpGs and whether abnormal methylation has a threshold level for
conferring disease risk in the embryo or is a gradual continuum.
Pre-existent methylation alterations in the gametes of infertile
patients pose a risk for transgenerational epigenetic inheritance. Evi-
dence for transgenerational epigenetic inheritance remains controver-
sial in humans (Oswald et al., 2000; Reik et al., 2003; Morgan et al.,
2005), however, considerable evidence for transgenerational epige-
netic inheritance in mice has become apparent at intracisternal A par-
ticles (IAPs) and imprinted genes(Bultman et al., 1992; Morgan et al.,
1999; Rakyan et al., 2003). In humans, evidence for germline epige-
netic inheritance has come almost exclusively from epidemiological
studies. The strongest evidence for germline epigenetic inheritance
comes from the work of Horsthemke and colleagues (Buiting et al.,
2003) where they have shown that the presence of epimutations
and not genetic mutations, at the SNRPN–SNURF upstream reading
frame locus was inherited from the paternal grandmother (Buiting
et al., 2003). Furthermore, Kagami et al. (2007) showed that defective
methylation at the DMR of MEST in sperm may have been inherited by
an ART born baby with SRS. More recently, Kobayashi et al. showed
abnormal DNA methylation at many imprinted loci in 17 of 78 assisted
reproductive technology (ART) embryos (21.8%) tested. Although
some of the imprinting errors identified may have risen during the
ART process, however, in seven cases hypomethylation at H19 and
GTL2 was present both in the sperm and in the embryo, suggesting
that abnormal hypomethylation may be paternally inherited (Kobaya-
shi et al., 2009). In summary, human transgenerational epigenetic
inheritance is uncertain, but is possible if altered DNA methylation
is inefficiently cleared between generations or if methylation pattern
are not properly reestablished due to refractory elements such as ret-
rotransposons or certain histone modifications in the embryo and
PGCs.
Structural and in vitro data show that certain modified nucleosmes
such as H3K4 methylation can deter DNA methylation in mice (Ooi
et al., 2007). This interdependency or cooperativity relationship can
have potential implications in reprogramming, especially at imprinted
loci. Recent studies have shown that maternally and paternally
imprinted alleles retain differential histone modifications (methylation
and acetylation) to promote either allele activation or repression in
somatic cells (Fournier et al., 2002; Delaval and Feil, 2004; Delaval
et al., 2007). Consistent with the findings in somatic cells, imprinted
genes (imprints are established in the gametes) in human sperm
used similar poising mechanisms: H3K4me3 associated with many of
the paternally expressed DMRs (Hammoud et al., 2009a, b),
whereas, maternally imprinted (paternally repressed) loci lacked
H3K4me3 and had moderate levels of H3K9me3, a repressive chro-
matin signature, residing at a few tested loci by qPCR. The presence
of modified nucleosomes in the germline may serve as an epigenetic
cellular memory to help reestablish and maintain parent of origin iden-
tity. However, in the cases of male infertility with altered histone
retention this may be problematic at the time of reprogramming
if the retained nucleosomes in the mature sperm are improperly
placed or modified. Whether this is one of the underlying factors
that contributes to the poor embryo outcome in patients with an
abnormal histone to protamine ratio is unknown.
Conclusion and future directions
Sperm chromatin state is highly dynamic and retains important chro-
matin attributes that help facilitate the proper progression of sperma-
togenesis as well as being a potential contributor to early
developmental processes. This continual epigenetic remodeling state
may make sperm cells susceptible to impediments of environmental
factors, aging process, or diseases such as infertility, but the ramifica-
tions of the altered chromatin states in the germ-line are not entirely
known. Future studies are needed to establish perdurance of pater-
nally retained modified nucleosomes in the early embryo, and their
potential effects if abnormally retained.
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Distinctive chromatin in human sperm
packages genes for embryo development
Saher Sue Hammoud1,2, David A. Nix3, Haiying Zhang1, Jahnvi Purwar1, Douglas T. Carrell2 & Bradley R. Cairns1
Because nucleosomes are widely replaced by protamine in mature human sperm, the epigenetic contributions of sperm
chromatin to embryo development have been considered highly limited. Here we show that the retained nucleosomes are
significantly enriched at loci of developmental importance, including imprinted gene clusters, microRNA clusters, HOX gene
clusters, and the promoters of stand-alone developmental transcription and signalling factors. Notably, histone
modifications localize to particular developmental loci. Dimethylated lysine 4 on histone H3 (H3K4me2) is enriched at
certain developmental promoters, whereas large blocks of H3K4me3 localize to a subset of developmental promoters,
regions in HOX clusters, certain noncoding RNAs, and generally to paternally expressed imprinted loci, but not paternally
repressed loci. Notably, trimethylated H3K27 (H3K27me3) is significantly enriched at developmental promoters that are
repressed in early embryos, including many bivalent (H3K4me3/H3K27me3) promoters in embryonic stem cells.
Furthermore, developmental promoters are generally DNA hypomethylated in sperm, but acquire methylation during
differentiation. Taken together, epigenetic marking in sperm is extensive, and correlated with developmental regulators.
During spermiogenesis canonical histones are largely exchanged for
protamines1,2, small basic proteins that form tightly packed DNA
structures important for normal sperm function3. We find about
4% of the haploid genome retained in nucleosomes (Supplemen-
tary Fig. 1a). The rare retained nucleosomes in sperm consist of either
canonical or histone variant proteins, including a testes-specific his-
tone H2B (TH2B) with an unknown specialized function4,5. Their
presence may simply be due to inefficient protamine replacement,
leading to a low randomdistribution genome-wide with no impact in
the embryo. Alternatively, these retained nucleosomes, along with
attendant modifications, might be enriched at particular genes/loci.
This latter possibility would raise the possibility for programmatic
retention for an epigenetic function in the embryo. To address these
questions, we localized the nucleosomes retained in mature sperm
from fertile donors using high-resolution genomic approaches.
Developmental loci bear nucleosomes
To address donor variability, we examined nucleosome retention in a
single donor (D1) and/or a pool of four donors (donor pool). Sperm
chromatin was separated into protamine-bound and histone-bound
fractions. In brief, mononucleosomes were isolated (.95% yield) by
sequential MNase digestion and sedimentation (Supplementary
Fig. 1b–e). This mononucleosome pool was used for chromatin
immunoprecipitation (ChIP; to select modified nucleosomes), or
the DNA was isolated from the mononucleosome pool to represent
all nucleosomes. Purified DNA was subjected to high-throughput
sequencing (Illumina GAII), or alternatively, was labelled and hybri-
dized to a high-density promoter-tiling array (9 kilobase (kb) tiled;
Supplementary Fig. 2, schematic).
Our initial array approach examined three replicas of D1 (pairwise
average R25 0.85). Notably, Gene Ontology analysis revealed nucleo-
somes significantly enriched at promoters that guide embryonic
development—primarily developmental transcription factors and
signalling molecules (Gene Ontology term false discovery rate
(FDR), 0.01; Box 1 and Supplementary Table 1; for all extended
Gene Ontology categories see Supplementary Tables and Supplemen-
taryDataSet 1).Toconduct genome-wideprofiling,weperformedhigh-
throughput sequencing of nucleosomes from D1 or the donor pool.
Regions significantly enriched for histone relative to the input control
(sheared total sperm DNA) were identified using a 300-base-pair (bp)
window metric6. For display, we depict the normalized difference score
and FDR window scores (Fig. 1a, FDR transformation (210 log10 (q-
value FDR)), 205 0.01, 255 0.003, 305 0.001, and 405 0.0001).
Histone-enriched loci for one individual (D1) were well correlated with
a donor pool (r5 0.7). Globally, 76% of the top 9,841 histone-enriched
regions (FDR 40 cutoff) intersect genic regions, whereas the expected
intersection given random distribution is 36% (P, 0.001).
Interestingly, sequencing of D1 or the donor pool revealed signifi-
cant (FDR, 0.001) histone retention at many loci important for
embryo development, including embryonic transcription factors and
signalling pathway components (Box 1, Supplementary Tables 2
and 3). We show this enrichment at HOX loci (Fig. 1, Supplemen-
tary Fig. 3), but also observe this at stand-alone developmental tran-
scription factors (Supplementary Fig. 4) and signalling factors
(Supplementary Fig. 5). An FDR of 60 yields 4,556 genes, of which
1,683 are grouped with developmental Gene Ontology categories
(2,848 total developmental genes). The magnitude of nucleosome
enrichment at developmental loci is modest, with high significance
provided by a moderate average increase at a large number of loci.
Histones are also significantly enriched at the promoters of
microRNAs (miRNAs) (P, 0.05; Supplementary Fig. 6) and at the
class of imprinted genes (P, 0.0001; Fig. 2), addressed in detail later.
Selected loci were tested and confirmed by quantitative PCR (qPCR;
Supplementary Fig. 7a–e). Outside of these enriched regions, we
observe sequencing reads at low levels distributed genome-wide (for
example, Figs 1a and 2a), an observation consistent with low levels
of nucleosomes genome-wide, although contributions from non-
nucleosomal contamination cannot be ruled out.
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Protamine occupancy (two replicas, R25 0.89, arrays only) yielded
7,151 enriched regions (.2.5-fold), but failed to identify any enriched
Gene Ontology term categories, although a few segments of the Y
chromosome were notably enriched (including the testis-specific
TSPY genes, data not shown). Regions of histone enrichment did
not exclude protamine, consistent with a nucleosome-protamine
mixture existing even at histone-enriched loci.However, as protamine
fragments averaged ,750 bp, protamine depletion would have to be
extensive (regions.2 kb) to be apparent on our arrays. Taken
together, nucleosomes are significantly enriched in sperm at genes
important for embryonic development, with transcription factors
the most enriched class.
Localization of modified nucleosomes
Because histones replace protamines genome-wide at fertilization7,8,
unmodified histones retained in sperm would seem insufficient to
influence gene regulation in embryos. Therefore, we examined three
further chromatin properties in sperm: (1) histone variants, (2)
histone modifications, and (3) DNA methylation. ChIP combined
with promoter microarray analysis (termed ChIP-chip) of TH2B
(two replicas, R25 0.93) shows 0.3% of gene promoters with rela-
tively high levels of TH2B (.twofold enrichment). Gene Ontology
analysis showed significant (FDR, 0.06) enrichment at genes
important for sperm biology, capacitation and fertilization
(Supplementary Table 4), but not at developmental categories.
ChIP sequencing (ChIP-seq) analysis with H2A.Z nucleosomes (at
standard conditions, 150–250mM salt) did not show significant
enriched Gene Ontology categories, with high enrichment limited
to pericentric heterochromatin (Supplementary Fig. 8), consistent
with prior immunostaining9.
Modified nucleosomes were localized by performing ChIP on
mononucleosomes, followed by either array analysis or sequencing
(Supplementary Fig. 2, schematic). We normalized the data set for
each modification to the data set derived from input mononucleo-
somes, determined enriched regions (array.twofold; sequencing
FDR 40), found the nearest neighbouring gene, and performed
GeneOntology analysis. In somatic cells, H3K4me2 is correlated with
euchromatic regions. In sperm, H3K4me2 was enriched at many
promoters, and at significant levels at promoters for developmental
transcription factors (two replicas R25 0.94; Gene Ontology term
FDR, 0.06; Box 1 and Supplementary Table 5). In somatic cells,
H3K4me3 is localized to: (1) the transcription start sites (TSS) of
active genes, (2) genes bearing ‘poised’ RNA polymerase II (Pol II),
and (3) the proximal promoter of inactive developmental regulators
in embryonic stem (ES) cells—promoters that also bear the silencing
mark H3K27me3 (refs 10, 11), and thus termed bivalent. Mature
sperm are transcriptionally inert, and Pol II protein levels are barely
detectable (data not shown), so the highH3K4me3 levels we observed
in sperm chromatin (Supplementary Fig. 1f) seemed surprising.
H3K4me3 was localized by both ChIP-chip (three replicas,
R25 0.96) and ChIP-seq. The raw data sets were similar (r5 0.7)
and the thresholded data sets were very similar (array twofold;
sequencing, FDR 40; 96% intersection, P, 0.001). With both data
sets, simple inspection showed small peaks atmany 59 gene ends, with
high levels and broader blocks at a subset of genes (that is,HOX loci;
Fig. 1 and Supplementary Fig. 3). Gene Ontology term analyses with
either data set yielded genes that are important for changing nuclear
architecture, RNA metabolism, spermatogenesis, and also selected
transcription factors important for embryonic development
(FDR, 0.01, Box 1, Supplementary Tables 6 and 7 and Supplemen-
tary Fig. 9). H3K4me3 at genes related to nuclear architecture and
spermatogenesis can presumably be attributed to their prior activa-
tion during gametogenesis. RNA metabolism occurs both in game-
togenesis and the early embryo, so attribution to a prior program as
opposed to a potential poising for a future program cannot be
unambiguously attributed. However, several transcription and
signalling factors of importance in embryo development exhibited
high levels and a broad distribution of H3K4me3, including EVX1/2,
ID1, STAT3, KLF5, FGF9, SOX7/9, certain HOX genes, and certain
noncoding RNAs (Fig. 1 and Supplementary Figs 3 and 6).
Interestingly, ChIP-seq analysis showed significant levels of
H3K27me3 at developmental promoters in sperm (Box 1, Fig. 1b,
Supplementary Table 8 and Supplementary Figs 3 and 4), and over-
lapped significantly with H3K27me3-occupied genes in ES cells
(P, 0.01), which are silent before differentiation. Furthermore,
bivalent genes (bearing H3K4me3 and H3K27me3) in ES cells had
a significant overlap with bivalent genes in sperm (FDR, 0.001 for
each mark). Of the 1,999 genes identified as bivalent in ES cells, 861
were bivalent in sperm (P, 0.01; Supplementary Table 9). Also
notable but not explored further were many blocks of high
H3K4me3 or H3K27me3 in regions lacking annotation (Fig. 1a,
oval). Furthermore, H3K9me3 was not detected at the small set
developmental promoters tested, but was high at pericentric regions
(qPCR only, Supplementary Fig. 7d). Taken together, our results
demonstrate extensive histone modification patterns in sperm, and
significant similarities to patterns observed in ES cells.
DNA methylation profiles
DNAmethylation profiles examined two fertile donors (D2 and D4)
using a methylated DNA immunoprecipitation (MeDIP) procedure
Box 1 | Developmental genes are associated with particular
chromatin attributes in human sperm
GoMiner was used to identify enriched categories, and all categories
displayed have an FDR,0.01. The top five general categories are
listed, after omitting nearly identical/redundant classes. An expanded
gene ontology table with the unfiltered top 30–60 categories, the total
genes, number of changed genes, enrichment, and FDR are provided in
the Supplementary Information.
Nucleosomes, Array D1
(1) Sequence-specific DNA binding; (2) multicellular organismal
development; (3) regulation of transcription; (4) developmental
process; (5) regulation of metabolic process.
Nucleosomes, Illumina GAII pooled donors
(1) Transcription factor activity; (2) cell fate commitment; (3) WNT
receptor signalling; (4) neuron development; (5) embryonic
development.
H3K4me2, Array D1
(1) Multicellular organismal development; (2) developmental process;
(3) sequence-specific DNA binding; (4) anatomical structure
development; (5) system development.
H3K4me3, Array D1
(1)mRNAprocessing; (2) RNAbinding; (3) cell cycle; (4) transcription;
(5) RNA splicing.
H3K4me3, Illumina GAII pooled donors
(1) RNA splicing; (2) translation; (3) cell cycle; (4) RNA metabolic
process; (5) transcription.
H3K27me3, Illumina GAII pooled donors
(1) WNT receptor signalling; (2) embryonic organ development and
morphogenesis; (3) cell fate commitment; (4) neuron differentiation;
(5) sequence-specific DNA binding.
DNA hypomethylated promoters D1 and D2
(1) Embryonic development; (2) multicellular organismal
development; (3) system development; (4) RNA biosynthetic process;
(5) transcription factor activity.
DNA methylated promoters omitting CpG islands, array
(1) Transcription; (2) RNA biosynthetic process; (3) regulation of
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and promoter arrays (individual replicates average D2 R25 0.97 and
D4 R25 0.89). Their methylation patterns were highly similar (pair-
wise R25 0.86), and extensive qPCR validated our array threshold
(Supplementary Fig. 7e). Gene Ontology analysis of genes with pro-
nounced DNA hypomethylation yielded transcription and signalling
factors that guide embryo development (FDR, 0.05; Box 1 and
Supplementary Table 10) including HOX loci (Fig. 3, blue bars,
and Supplementary Figs 4 and 10).Hypomethylation also overlapped
very significantly with histone-enriched promoters (P, 0.02;
Supplementary Table 11). Bisulphite sequencing verified the
MeDIP results, revealing extensive hypomethylation at develop-
mental promoters in sperm (Supplementary Fig. 10b, c).
Notably, DNA-hypomethylated promoters in mature sperm over-
lap greatly with developmental promoters bound by the self-renewal
network of transcription factors in human ES cells (for example,
OCT4 (also known as POU5F1), SOX2, NANOG, KLF4 and
FOXD3 proteins12; intersection of OCT4 protein occupancy and
DNA hypomethylation, P, 0.01). In ES cells, these proteins pro-
mote self-renewal and also work with repressive polycomb com-
plexes (PRC2; containing core component SUZ12) to help repress
a large set of developmental regulators (including HOX genes) to
prevent differentiation10,13–20. However, the hypomethylation of
developmental genes in sperm is extensive (Fig. 3 and Supplemen-
tary Fig. 4). In fact, when CpG islands are omitted from the data sets,
Gene Ontology term analysis of hypomethylated promoters still
yields developmental genes (Box 1 and Supplementary Table 12).
Notably, many of these developmental genes become methylated
after differentiation; differential analysis of sperm and primary
human fibroblasts (MeDIP, two replicas R25 0.86) showed that
many promoters occupied by PRC2 in human ES cells acquire
methylation in fibroblasts (FDR, 0.01, Supplementary Tables 13
and 14; HOXD illustrated in Fig. 3, Supplementary Figs 4 and 5).
Furthermore, the promoters driving several key members of the self-
renewal network are themselves markedly hypermethylated in sperm
(OCT4, NANOG and FOXD3, bisulphite sequencing in
Supplementary Fig. 10c), whereas their developmental target genes
are hypomethylated (bisulphite sequencing in Supplementary Fig.
10b), consistent with recent studies in mice21–24.
Attributes of HOX clusters and miRNAs
Nucleosome enrichment was clear across HOX loci and proximal
flanking regions, but falls off precipitously outside (HOXD, Fig. 1a;
HOXA, Supplementary Fig. 3a). Histone-enriched HOXD regions
with a single donor (D1) were largely shared with the donor pool
(Fig. 1a; D1 versus donor pool, r5 0.7). Notably, retained nucleo-
somes have regional covalent modifications. For example, distinct
and very large (5–20 kb) blocks of H3K4me3 are clearly observed at
allHOX loci, and also at certain imprinted genes (addressed later). At
HOXD, high H3K4me3 extends for ,20 kb, encompassing all of
EVX2 and extending to the 39 region of HOXD13 (Fig. 1b).
Remarkably, a similar profile is observed at the related HOXA locus
(Supplementary Fig. 3a). At HOXD a second block of H3K4me3 is
observed in the region between HOXD4 and HOXD8 (Fig. 1b), a
region that encodes several noncoding RNAs expressed during
development. This region represents a marked difference from the
chromatin status in ES cells; in ES cellsHOXD8–D11 are all bivalent.
The distribution of H3K4me2 (determined from two replicas of D1)
is clearly different from H3K4me3 at HOX loci (Fig. 1b and
Supplementary Fig. 3). For example, atHOXD, H3K4me2 is enriched
in HOXD8–D11, a region deficient in H3K4me3 (Fig. 1b). Notably,
high H3K27me3 encompasses all HOX loci and their proximal
flanking regions. In contrast, high levels of H3K9me (a mark of
heterochromatin; Supplementary Fig. 7d) or H2A.Z were not
detected at the HOX loci tested.
Histones are enriched at manymiRNAs, especially miRNA clusters
(Supplementary Fig. 6). For example, 16 of the 29 miRNA clusters on
autosomes were significantly enriched (P, 0.05). Clusters include
































































Figure 1 | Profiling of nucleosomes and their modifications at HOXD. For
high-throughput sequencing, we show the mapped sequencing reads from
D1 or a donor pool (red or orange bars, respectively; normalized difference
score), and their significance (green or blue bars; FDR of 20 is,1% and FDR
of 30 is,0.1%). a, The HOXD locus (black box) and an uncharacterized
flanking locus (green oval). b, Profiling of nucleosome modifications at
HOXD (in part a). The y axis is signal intensity (log2, for ChIP-chip), or the
normalized difference score for sequencing. The regions not tiled on the
array are underlined in red. Chr, chromosome.
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b, as well as the stand-alonemiRNAsmir-153-1,mir-488 andmir-760.
Notably, many histone-occupiedmiRNAs are associated with embry-
onic development25 (P, 0.01), and their promoters were largely
hypomethylated (Supplementary Fig. 10d). Furthermore, 7 of the
12 miRNAs on autosomes that are occupied by OCT4, NANOG
and SOX2 in human ES cells17 are also significantly occupied by his-
tone (from pooled sequencing data). However, we do not at present
understand the logic for their modification status; certain miRNA
clusters have high histone and bivalent status, whereas others lack
either modification (Supplementary Fig. 6).
Attributes of primary and secondary imprinted genes
Nucleosomes are significantly enriched at most imprinted genes in
sperm, but at both paternally andmaternally expressed loci. However,
we observemarked specificity ofH3K4me3 localization, with high and
broad levels present at genes and noncoding RNAs that are paternally
expressed. Locus 11p15.5 (Fig. 2a) is a large imprinted cluster with
IGF2,H19 and KCNQ1 and several miRNAs. Here, increased levels of
histone are present throughout the imprinted region (up toOSBPL5),
but not in the large adjacent region lacking imprinted genes (Fig. 2a).
Notably, the paternally silencedH19 locus upstream of KCNQ1 has a
methylated DMR (Supplementary Fig. 10a) that lacks H3K4me3
(Fig. 2b). In contrast, MEST (a paternally expressed gene) has high
H3K4me3 that extends from its promoter and first exon (containing
the demethylated differentially methylated region (DMR); Fig. 2c and
Supplementary Fig. 10a) through the second exon. The antisense non-
coding RNAMESTIT1 (also paternally expressed) is transcribed from
the first intron, and is also very high in H3K4me3 (Fig. 2c).
Furthermore, the promoter region of the paternally expressed anti-
sense noncoding RNA KCNQ1OT1 displays H3K4me3 (Fig. 2a and
data not shown), and theDMR isDNAdemethylated (Supplementary
Fig. 10a). Several other examples of paternally expressed loci with
blocks of H3K4me3 are provided in Supplementary Fig. 11, including
PEG3, the noncoding RNAs AIRN (antisense to IGF2R) andGNASAS
(antisense to GNAS). In contrast, genes flanking KCNQ1 that are
repressed by the noncoding RNA KCNQOT1 (such as OSBPL5,
TSSC4 andCD81; Fig. 2a, expanded in Supplementary Fig. 11) contain
histone, but lack H3K4me3. Notably, several paternally silenced genes
(bearing DNAmethylation) bore moderate (2–3-fold) enrichment of
H3K9me3, a mark absent at paternally expressed genes (Supplemen-
tary Fig. 7d).
The 14q32.33 region (DLK-DIO3) is complex and interesting;
paternally expressed genes such as DLK1 and RTL1 have moderate
levels of H3K4me3 in their promoters, and the imprinting control
locus (IG-DMR) lacks H3K4me3 (Fig. 2d) and is DNA methy-
lated26–28. Notably, the promoter ofMEG3 (also known as GTL2; just
downstream of the IG-DMR) lacks DNA methylation in sperm, but
acquires DNA methylation in the embryo26–28, termed secondary
imprinting. Notably, the MEG3 promoter region that later acquires
DNA methylation initially bears both H3K4me3 and H3K27me3 in
sperm; it is bivalent. One interpretation is that for mature sperm and
early embryos, H3K4me3 prevents DNA methylation while
H3K27me3 promotes silencing, with subsequent H3K4me removal
enabling tissue-specific DNA methylation and secondary imprinting.
Furthermore, our examination of the X chromosome inactivation
centre showed an apparent bivalent status (and DNA hypomethyla-




































































































Figure 2 | Nucleosome enrichment at imprinted gene clusters, with high
H3K4me3 at paternally expressed noncoding RNAs, and paternally
demethylated regions. a, Histone enrichment at the 11p15.5 imprinted
cluster (ending near OSBPL5), but not in the adjacent region. b, c, An
expanded view of the DMRs (yellow rectangles) of H19 (paternally
methylated) (b) andMEST (paternally demethylated) (c). d, Moderate
H3K4me3 at the promoters of the paternally expressed genes BEGAIN,
DLK1 and RTL, and the lack of H3K4me3 at the methylated intergenic-
differentially methylated region (IG-DMR) ofMEG3 in sperm. Notably,
bothH3K4me3 andH3K27me3 reside at the promoter ofMEG3, which later
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Figure 3 | Developmental promoters in sperm lack DNA methylation, but
acquire methylation during development. DNA methylation of the HOXD
locus in the mature sperm (blue bars) or primary fibroblasts (orange line
overlay). The y axis is the signal intensity (log2) and the x axis is the
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although future studies are required todeterminewhether thesemarks
influence the regulation of this locus in the embryo (Supplementary
Figs 6 and 10d; note that sequence reads on theX chromosomeare half
that on autosomes, as it is only present in 50% of sperm).
Modifications and expression timing
Transcriptome analysis has been performed in 4-cell and 8-cell human
embryos,with 29 or 65messenger RNAs identified as enriched, respect-
ively29. Notably, genes in sperm bearing H3K4me3 but not H3K27me3
correlated with genes expressed at the 4-cell stage (14 out of 24,
P5 0.059). Also, genes bearing high H3K4me2 were significantly
enriched at genes expressed in the 4–8-cell stage (23 out of 49,
P, 0.02; only 49 tiled on our array). In contrast, no significant correla-
tion was observed withH3K27me3, which instead associates with tran-
scription factors required for differentiation and organogenesis
(discussed earlier). Furthermore, we verified by qPCR the presence of
H3K4me2 or H3K4me3 at a subset of these stage-specific gene promo-
ters (Supplementary Fig. 12). Thus, these findings reveal correlations of
H3K4me2/3 enrichment, but not H3K27 enrichment, with early
expression.
Conclusion
We provide several lines of evidence that the parental genome is pack-
aged and covalently modified in a manner consistent with influencing
embryo development. Previous analyses of DNAmethylation in sperm
identifiedhypomethylatedpromoters23,24,30,31, showed similarities to the
pattern in ES cells24,31, and overlap between PRC2 and CpG
islands15,17,21,22.We add that hypomethylated developmental promoters
in human sperm overlap significantly with developmental promoters
(in ES cells) occupied by the self-renewal network. Also, the promoters
that acquire methylation in fibroblasts are primarily developmental
transcription factors that are bound by PRC2 in human ES cells, con-
sistent with recent work linking PRC2 toDNAmethylation in develop-
ment and neuronal differentiation in mice21,32,33. Thus, components of
the self-renewal network emerge as candidates for helping to direct
DNA hypomethylation in the germ line, and also to guide DNAhyper-
methylation to particular loci during differentiation, possibly to help
‘lock in’ differentiation decisions, although this remains to be tested.
The central findings of our work involve the significant enrich-
ment of modified nucleosomes in the sperm genome at genes for
embryo development, and a specificity to their modification patterns
that might be instructive for the regulation of developmental genes,
noncoding RNAs and imprinted loci. For example, histone retention
and modification were clear at HOX loci and most of the targets of
the self-renewal network in ES cells. One key concept in ES cell
chromatin is the prevalence of developmental promoters with a biva-
lent status—bearing both H3K27me3 and H3K4me3 (ref. 10). Many
promoters bivalent in ES cells are also bivalent in sperm, although
some bear only H3K27me3 in sperm. Notably, H3K27me3 covers
essentially all of the four HOX loci in sperm, whereas H3K4me3 is
present in large blocks at only a subset of locations inHOX loci. Our
work also provides correlations between H3K4me, but not
H3K27me, and early expression in the embryo. In contrast, prot-
amine-enriched loci did not show any significant Gene Ontology
categories. However, there were certain segments of the Y chro-
mosome with protamine enrichment, including the testis-specific
TSPY genes, although the significance is not known.
We also find histones enriched at imprinted gene clusters, and a
notable correlation between H3K4me3 and paternally expressed non-
coding RNAs and genes; loci that lack DNA methylation in sperm. In
contrast, maternally expressed noncoding RNAs/genes, and especially
paternally methylated regions, lack H3K4me3 and (for the selected
genes tested) contain moderate H3K9me3. Consistent with these
observations, recent structural and in vitro data show that H3K4
methylation deters DNA methylation by DNMT3A2 and DNMT3L
in mice34. However, experiments in model organisms are needed to
address whether the modification patterns we report influence
imprinting patterns in vivo. Taken together, we reveal chromatin
features in sperm that may contribute to totipotency, developmental
decisions and imprinting patterns, and open new questions about
whether ageing and lifestyle affects chromatin in amanner that impacts
fertility or embryo development.
METHODS SUMMARY
Biological samples. Sperm samples were obtained from four men of known
fertility attending the University of Utah Andrology laboratory, consented for
research. Samples were collected after 2–5 days abstinence and subjected to a
density gradient (to purify viable, motile, mature sperm) and treated with so-
matic cell lysis buffer (0.1% SDS, 0.5% Triton X-100 in DEPC H2O) for 20min
on ice to eliminate white blood cell contamination. Samples were centrifuged at
10,000g for 3min, and the sperm pellet was resuspended in PBS and used imme-
diately for chromatin preparation. Clontech human fibroblast cells (Lonza cc-
2251) were cultured (37 uC and 5% CO2) in DMEM containing 10% FBS and
supplemented with penicillin and streptomyocin.
Chromatin immunoprecipitation. Standard ChIPmethods were used35, but we
omitted crosslinking and used the following salt concentrations in the numbered
buffers35: (1) 150mM NaCl, (2) 250mM NaCl, (3) 200mM LiCl, and (4)
150mM NaCl (the PBS wash). Antibodies used were: anti-H3K27me3
(Upstate 07-449), H3K4me3 (Abcam 8580), H3K4me2 (Abcam 32356), TH2B
(Upstate 07-680), H2A.Z (Abcam 4174) andH3K9me3 (Abcam 8898). For each,
4 ml of antibody was coupled to 100ml of Dynabeads (Invitrogen). After ChIP,
samples for sequencing were not amplified, whereas for arrays the DNA was
amplified (WGA, Sigma) before hybridization.
Methylation profiling usingMeDIP.MeDIP procedures for sperm and primary
human fibroblasts (Clonetech) were performed as described previously30.
Sequencing. Sequencing used the Illumina GAII (Illumina Inc.) with standard
protocols. Read numbers are final mapped microsatellite filtered reads (26–36
bases). Nucleosomes fromD1: 19,658,110, D2–D4: 18,842,467, D1–4: 25,933,196
with equal contribution from each donor (random sub-sampling). Input, human
sperm DNA: 17,991,622, H3K4me3: 13,337,105, H3K27me3:10,344,413, and
H2A.Z: 5,449,000. All genomics data sets have been deposited in the Gene
Expression Omnibus (GEO) under the SuperSeries GSE15594.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Partitioning of histone- and protamine-associated DNA. Chromatin was
prepared from 40million sperm as described previously36 in the absence of
crosslinking reagent, treated with sequential and increasing MNase (10–
160U), and centrifuged to sediment protamine-associated DNA, releasing
mononucleosomes. The pooled mononucleosomes were used for ChIP, or the
DNA was extracted and gel purified (,140–155 bp) for sequencing and array
analysis.
ChIP and preparation for genomics methods. All ChIPs for sequencing were
performed using the same pool of mononucleosomes from pooled donors. For
arrays, a single pool was used from D1. ChIP methods were as described previ-
ously35 but were performedwithout a crosslinking agent and slightmodifications
to the salt levels (250mM NaCl, 200mM LiCl), and the TE wash was replaced
with a 150mM PBS wash. ChIP methods used anti-H3K27me3 (Upstate 07-
449), H3K4me3 (Abcam 8580), H3K4me2 (Abcam 32356), TH2B (Upstate 07-
680), or H2A.Z (Abcam 4174) antibodies. For each, 4ml of antibody was coupled
to 100ml of Dynabeads (Invitrogen). After the ChIP procedure, the DNA was
amplified (WGA, Sigma) before hybridization to arrays, whereas samples used
for Solexa were not amplified. For sequencing, DNA lengths corresponding to
mononucleosomes with adapters (220–280 bp) were gel purified after the addi-
tion of the Illumina adaptors. This size selection was also performed for the
nucleosomal DNA from pooled donors not subjected to ChIP.
Methylation profiling using MeDIP. This procedure was described previ-
ously30. In brief, sonicated sperm DNA was obtained from two different donors
and sonicated fibroblast DNA was obtained from Clontech primary human
fibroblasts (Lonza CC-2251) (4mg, 300–1,000-bp fragments). Immuno-
precipated DNA was washed, subjected to whole genome amplification
(Sigma Aldrich). Amplified DNA (6mg) was labelled with Cy5, and input
DNA (6mg) was labelled with Cy3 (Bio labs) by standardmethods. Samples were
hybridized to Agilent expanded promoter arrays, treated according to standard
Agilent conditions, and scanned in an Agilent scanner.
Computational analytical methods. The software used in this analysis are open
source and available from the TIMAT2 (http://timat2.sourceforge.net) andUSeq
(http://useq.sourceforge.net) project websites. Human annotation and genomic
sequence (May 2004, NCBI Build 35, HG17 and March 2006, NCBI Build 36.1,
HG18) were obtained from the UCSC Genome Bioinformatic website.
Low-level ChIP-chip analysis. Processing of the Agilent microarray promoter
data was performed in three basic steps: data normalization, sliding window
summaries, and enriched region identification. For each data set, the median
unadjusted signal intensities from the Cy3 and Cy5 channels were extracted.
Probes were then mapped to the HG17 or HG18 builds. Biological replicas were
quantile normalized and median scaled to 100 (ref. 37). This normalization was
applied to the treatment (ChIP samples) and control (whole genomic input
DNA for the MeDIP and protamine data sets or DNA derived from mononu-
cleosomes) replicas separately (see later for replica-averaged R2). Probe level
‘Oligo’ summaries were calculated by taking the log2 ratio (mean treatment
replicas/mean control replicas). ‘Window’ level summaries were generated by
identifyingwindows of a particular size (100 bp for data sets derived frommono-
nucleosomes, 675 bp for MeDIP and protamine data sets) containing a mini-
mum number of oligonucleotide start positions (one for the data sets derived
from mononucleosomes, three for the MeDIP and protamine data sets), and
calculating an all pair (treatment versus control) relative difference pseudo
median. This window summary score was assigned to the centre position of
the window ‘Pse’ or represented as heat map ‘PseHM’ data. Extended regions
of high-scoring windows, called ‘intervals’, were identified by merging windows
that exceed a set threshold and are locatedwithin 250 bp of one another. Intervals
were then ranked by their best window score. Relative difference pseudo median
scores were converted to log2 ratio values.
The averageR2 values formicroarray datawere as follows: 0.85 for the threeD1
MNase replicas; 0.89 for the three Protamine replicas; 0.96 for the two H3C
replicas; 0.94 for the two H3K4me2 replicas; 0.93 for the two TH2B replicas;
0.96 for the three H3K4me3 replicas; and 0.93 for the two H3K27me3 replicas.
The averageMeDIPR2 values for the three replicas of each donorwere as follows:
D2 average R25 0.97 and D45 0.89, and the correlation between D2 versus D4
was 0.87. The average R2 for the two primary human fibroblast MeDIP replicas
was 0.86.
Low-level Chip-seq analysis. The DNA samples derived from mononucleo-
somes, and the sonicated control input genomicDNAwere prepared for sequen-
cing using Illumina’s ChIP-seq kit. The 26-bp and 36-bp reads were generated
using Illumina’s Genome Analyser II and their standard software pipeline. Reads
were mapped to the March 2006 NCBI Build 36.1 human genome using the
pipeline’s eland_extended aligner.
The USeq package6 was used to identify regions of histone enrichment relative
to input control. This entailed selecting reads that mapped with an alignment
score$13 (210log10(0.05)), shifting their centre position 73 bp 39 to accommo-
date the 146-bpmononucleosome fragment length, and using a slidingwindowof
300 bp to score each region in the genome for significant histone enrichment.
Significance was determined by calculating a binomial P value for each 300-bp
window and controlled for multiple testing by applying Storey’s q value FDR
estimation38,39.
Read numbers. Note the sperm genome has only 4% of the genome in nucleo-
somes. For nucleosome enrichment D1 had 19,658,110 reads, and the pool of
three additional donors had 18,842,467 reads. The raw correlation for D1 versus
the donor pool was r5 0.7. For all the analysis containing pool donors (D1, and a
pooled sample of three additional individuals D2, D3 and D4) we used
25,933,196 mapped filtered reads with equal contribution from each donor
(random subsampling). A total of 17,991,622 reads were generated from control
input human sperm DNA, 3,337,105 reads from the H3K4me3 sample,
10,344,413 reads for H3K27me3, and 5,449,000 reads for H2Az. The raw
unfiltered reads (fastq format) are deposited at GEO under the superseries
GSE15594, which encompasses the Subseries entries GSE15690 for ChIP-seq
and GSE15701 for ChIP-chip data.
To assess histone enrichment consistency, theQCSeqs application in theUSeq
package6 was used to correlate the read counts between the D1 and pooled
sample by calculating a Pearson correlation on the basis of the number of
mapped reads falling within 500-bp windowed regions stepped every 250 bp
across all chromosomes. Only windows with five or more reads in either of
the samples were included in the correlation.
To create lists of candidate histone enriched regions, q-value thresholds of 20
(0.01) and 30 (0.001) (210log10(q value)) were selected. Overlapping windows
that pass a given threshold were merged and scores from the best window
assigned to the enriched region. The normalized window score was then used
to rank and sort the regions.
Amodification wasmade to score gene promoters andmiRNAs for significant
histone enrichment. The first step was to define regions for scoring. For gene
promoters, the start of the first exonwas used to define its hypothetical promoter
by selecting a region 9 kb upstream and 2 kb downstream. For miRNAs, the
centre position of each was expanded 6300 bp. These defined regions were
scored for significant enrichment using the window statistics above.
High-level ChIP-chip and ChIP-seq analysis. Intersect regions. To identify
regions of significant intersection between enriched region lists from various
data sets, the USeq IntersectRegions application was used. This application
counts the number of intersections between two lists of genomic coordinates
that occur within a minimum ‘max gap’ distance. To estimate confidence in the
intersections, a thousand ‘random’ data sets are generated that were matched to
the chromosome and size of the original regions, and randomly picked from the
interrogated regions on the array or sequenced regions in the genome. These
randomized data sets were used to calculate a P value for the intersection and fold
enrichment (fraction real intersection/fraction average random data set inter-
section) over random. Initial pilots that imposed a fraction GC match when
picking random regions showed little difference with non-GC-matched random
data sets and were thus subsequently dropped.
Find neighbouring genes (FNG). Genes associating with histones or histone
modifications were determined using the FNG application in the USeq package.
The gene lists were uploaded in GoMiner (http://discover.nci.nih.gov/gominer/
htgm.jsp) to identify over represented Gene Ontology terms.
Intersect lists. To determine whether the 4- and 8-cell transcripts identified in
early human embryo correlated with any of our histone modifications we used
The IntersectLists USeq applicationwhich uses randompermutation to calculate
the significance of intersection between two lists of genes.
Aggregate plots. The USeq AggregatePlots application was used to compare
the degree of enrichment and distribution of histone reads surrounding the TSS
of developmental and non developmental genes. The gene classes were derived
on the basis of Gene Ontology term categories.
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Supplemental Figure Legends: 
Supplemental Fig. 1: Composition of human sperm chromatin. a, Quantifying histone 
content of primary fibroblast or human sperm cells by immunoblot analysis with the H3C 
terminus antibody. b, Sequential digestion of sperm chromatin with increasing 
concentrations of micrococal nuclease (MNase) releases mononucleosomes (lanes 1 and 
2), whereas protamine-packaged chromatin resists MNase (lane 6). c, Characterizing the 
mononucleosome fraction released into the MNase supernatant pool from panel b. d, Gel-
purified mononucleosomal DNA used for array hybridization or sequencing. e,
Quantification of the amount of histone released by MNase treatment.  Supernatants were 
pooled. Here, cell equivalents were loaded in each lane; 4% of the total supernatant or 
protamine pellet. The gel was subjected to immunoblotting and quantified on a Typhoon 
(Amersham). f, Western analysis, involving titrations for bulk levels of H3K4me3, 
H3K4me2, H3K27me3 in primary fibroblast cells and mature sperm cells.  Quanitation 
by Typhoon (Amersham) reveals that sperm bear ~4% of the histone H3 present in a 
primary fibroblast. 
Supplemental Fig. 2: Schematic representation of experimental procedures. Two fertile 
donors were used for methylation studies, one donor (D1) was used for all histone 
modifications studied on the arrays. A pool of fertile donors were utilized for 
mononucleosome localization and characterization and to extend the analysis genome-
wide using Illumina GAII. 
Supplemental Fig. 3:  Chromatin attributes of the HOXA, HOXB, and HOXC loci. 
Histone enrichment (red bars), or histone modifications (H3K4me3 array results (ruby), 
H3K4me3 sequencing normalized difference scores (grey), H3K27me3 sequencing 
normalized difference scores (teal blue) or H3K4me2 (violet)). The y-axis is the signal 
intensity (log2 for array data, or normalized difference score for Illumina GAII 
sequencing) and the x-axis is the annotated physical map (HG18).  a, The HOXA locus. 
b, The HOXC locus c, The HOXB locus.
Supplemental Fig. 4: Certain self-renewal genes as well as genes required for embryonic 
development generally lack DNA methylation and are bivalent. a, SOX2 and FOXD3 are 
member of the pluripotency netwok. SOX2 is demethylated and characterized by the 
presence of H3K4me3 and H3K27me3, whereas FOXD3 is hypermethylated near their 
transcription start sites. OCT4 and NANOG are also hypermethylated (Supplementary 
Fig. 10c). b, Genes involved in embryonic development are typically DNA 
hypomethylated, and have high levels of H3K4me2/3  and H3K27me3 around their start 
sites The red asterisks indicate the region amplified for bisulfite sequencing in 
Supplementary Fig. 10. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or 
normalized difference for Illumina GAII sequencing score) and the x-axis is the 
annotated physical map (HG18). 
Supplemental Fig 5: Developmental and signaling factors are deficient in DNA 
methylation, although Notch pathway members are hypermethylated. a, Notch signaling 
pathway members, DKK1 (hypomethylated) and NOTCH1 (hypermethylated). b, FGF 
64
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donors were used for methylation studies, one donor (D1) was used for all histone 
modifications studied on the arrays. A pool of fertile donors were utilized for 
mononucleosome localization and characterization and to extend the analysis genome-
wide using Illumina GAII. 
Supplemental Fig. 3:  Chromatin attributes of the HOXA, HOXB, and HOXC loci. 
Histone enrichment (red bars), or histone modifications (H3K4me3 array results (ruby), 
H3K4me3 sequencing normalized difference scores (grey), H3K27me3 sequencing 
normalized difference scores (teal blue) or H3K4me2 (violet)). The y-axis is the signal 
intensity (log2 for array data, or normalized difference score for Illumina GAII 
sequencing) and the x-axis is the annotated physical map (HG18).  a, The HOXA locus. 
b, The HOXC locus c, The HOXB locus.
Supplemental Fig. 4: Certain self-renewal genes as well as genes required for embryonic 
development generally lack DNA methylation and are bivalent. a, SOX2 and FOXD3 are 
member of the pluripotency netwok. SOX2 is demethylated and characterized by the 
presence of H3K4me3 and H3K27me3, whereas FOXD3 is hypermethylated near their 
transcription start sites. OCT4 and NANOG are also hypermethylated (Supplementary 
Fig. 10c). b, Genes involved in embryonic development are typically DNA 
hypomethylated, and have high levels of H3K4me2/3  and H3K27me3 around their start 
sites The red asterisks indicate the region amplified for bisulfite sequencing in 
Supplementary Fig. 10. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or 
normalized difference for Illumina GAII sequencing score) and the x-axis is the 
annotated physical map (HG18). 
Supplemental Fig 5: Developmental and signaling factors are deficient in DNA 
methylation, although Notch pathway members are hypermethylated. a, Notch signaling 

































































































































Supplemental Figure Legends: 
Supplemental Fig. 1: Composition of human sperm chromatin. a, Quantifying histone 
content of primary fibroblast or human sperm cells by immunoblot analysis with the H3C 
terminus antibody. b, Sequential digestion of sperm chromatin with increasing 
concentrations of micrococal nuclease (MNase) releases mononucleosomes (lanes 1 and 
2), whereas protamine-packaged chromatin resists MNase (lane 6). c, Characterizing the 
mononucleosome fraction released into the MNase supernatant pool from panel b. d, Gel-
purified mononucleosomal DNA used for array hybridization or sequencing. e,
Quantification of the amount of histone released by MNase treatment.  Supernatants were 
pooled. Here, cell equivalents were loaded in each lane; 4% of the total supernatant or 
protamine pellet. The gel was subjected to immunoblotting and quantified on a Typhoon 
(Amersham). f, Western analysis, involving titrations for bulk levels of H3K4me3, 
H3K4me2, H3K27me3 in primary fibroblast cells and mature sperm cells.  Quanitation 
by Typhoon (Amersham) reveals that sperm bear ~4% of the histone H3 present in a 
primary fibroblast. 
Supplemental Fig. 2: Schematic representation of experimental procedures. Two fertile 
donors were used for methylation studies, one donor (D1) was used for all histone 
modifications studied on the arrays. A pool of fertile donors were utilized for 
mononucleosome localization and characterization and to extend the analysis genome-
wide using Illumina GAII. 
Supplemental Fig. 3:  Chromatin attributes of the HOXA, HOXB, and HOXC loci. 
Histone enrichment (red bars), or histone modifications (H3K4me3 array results (ruby), 
H3K4me3 sequencing normalized difference scores (grey), H3K27me3 sequencing 
normalized difference scores (teal blue) or H3K4me2 (violet)). The y-axis is the signal 
intensity (log2 for array data, or normalized difference score for Illumina GAII 
sequencing) and the x-axis is the annotated physical map (HG18).  a, The HOXA locus. 
b, The HOXC locus c, The HOXB locus.
Supplemental Fig. 4: Certain self-renewal genes as well as genes required for embryonic 
development generally lack DNA methylation and are bivalent. a, SOX2 and FOXD3 are 
member of the pluripotency netwok. SOX2 is demethylated and characterized by the 
presence of H3K4me3 and H3K27me3, whereas FOXD3 is hypermethylated near their 
transcription start sites. OCT4 and NANOG are also hypermethylated (Supplementary 
Fig. 10c). b, Genes involved in embryonic development are typically DNA 
hypomethylated, and have high levels of H3K4me2/3  and H3K27me3 around their start 
sites The red asterisks indicate the region amplified for bisulfite sequencing in 
Supplementary Fig. 10. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or 
normalized difference for Illumina GAII sequencing score) and the x-axis is the 
annotated physical map (HG18). 
Supplemental Fig 5: Developmental and signaling factors are deficient in DNA 
methylation, although Notch pathway members are hypermethylated. a, Notch signaling 
pathway members, DKK1 (hypomethylated) and NOTCH1 (hypermethylated). b, FGF 
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Supplemental Fig. 1: Composition of human sperm chromatin. a, Quantifying histone 
content of primary fibroblast or human sperm cells by immunoblot analysis with the H3C 
te minus antibody. b, Sequential digestion of sperm chromatin with increasing 
concentrations of micrococal nuclease (MNase) releases m nonucleosomes (lanes 1 and 
2), whereas protamine-packaged chromatin resists MNase (lane 6). c, Characterizing the 
mononucleosome fraction released into the MNase supernatant pool from panel b. d, Gel-
purified mononucleosomal DNA used for array hybridization or sequencing. e,
Quantification of the amount of histone released by MNase treatment.  Supernatants were 
pooled. Here, cell equivalents were loaded in each lane; 4% of the total supernatant or 
protamine pellet. The gel was subjected to immunoblotting and quantified on a Typhoon 
(Amersham). f, Western analysis, involving titrations for bulk levels of H3K4me3, 
H3K4me2, H3K27me3 in primary fibroblast cells and mature sperm cells.  Quanitation 
by Typhoon (Amersham) reveals that sperm bear ~4% of the histone H3 present in a 
primary fibroblast. 
Supplemental Fig. 2: Schematic representation of experi ntal procedures. Two fertile 
donors were used for methylation studies, one donor (D1) was used for all histone 
modifications studied on the arrays. A pool of fertile donors were utilized for 
mononucleosome localization and characterization and to extend the analysis genome-
wide using Illumina GAII. 
Supplemental Fig. 3:  Chromatin attributes of the HOXA, HOXB, and HOXC loci. 
Hist ne enrichment (red bars), or histone modifications (H3K4me3 array results (ruby), 
H3K4me3 sequencing normalized difference scores (grey), H3K 7me3 sequencing 
normalized difference scores (teal blue) or H3K4me2 (violet)). The y-axis is the signal 
intensity (log2 for array data, or normalized difference score for Illumina GAII 
sequencing) and the x-axis is the annotated physical map (HG18).  a, The HOXA locus. 
b, The HOXC locus c, The HOXB locus.
Supplemental Fig. 4: Certain self-renewal genes as well as genes required for embryonic 
development generally lack DNA methylation and are bivalent. a, SOX2 and FOXD3 are 
member of the pluripotency netwok. SOX2 is demethylated and characterized by the 
presence of H3K4me3 and H3K27me3, whereas FOXD3 is hypermethylated near their 
transcription start sites. OCT4 and NANOG are also hypermethylated (Supplementary 
Fig. 10c). b, Genes involved in embryonic development are typically DNA 
hypomethylated, and have high levels of H3K4me2/3  and H3K27me3 around their start 
sites The red asterisks indicate the region amplified for bisulfite sequencing in 
Supplementary Fig. 10. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or 
normalized difference for Illumina GAII sequencing score) and the x-axis is the 
annotated physical map (HG18). 
Supplemental Fig 5: Developmental and signaling factors are deficient in DNA 
methylation, although Notch pathway members are hypermethylated. a, Notch signaling 
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Supplemental Fig. 1: Composition of human sperm chromatin. a, Quantifying histone 
content of primary fibroblast or human sperm cells by immunoblot analysis with the H3C 
terminus antibody. b, Sequential digestion of sp rm chromatin with increasing 
concentrations of micrococal nuclease (MNase) releases mononucleosomes (lanes 1 and 
2), whereas protamine-packaged chromatin resists MNase (lane 6). c, Characterizing the 
mononucleosome fraction released into the MNase supernatant pool from panel b. d, Gel-
purified mononucleosomal DNA used for array hybridization or sequencing. e,
Quantification of the amount of histone released by MNase treatment.  Supernatants were 
pooled. Here, cell equivalents were loaded in each lane; 4% of the total supernatant or 
protamine pellet. The gel was subjected to immunoblotting and quantified on a Typhoon 
(Amersham). f, Western analysis, involving titrations for bulk levels of H3K4me3, 
H3K4me2, H3K27me3 in primary fibroblast cells and mature sperm cells.  Quanitation 
by Typhoon (Amersham) reveals that sperm bear ~4% of the histone H3 present in a 
primary fibroblast. 
Supplemental Fig. 2: Schematic representation of experimental procedures. Two fertile 
donors were used for methylation studies, one donor (D1) was used for all histone 
modifications studied on the arrays. A pool of fertile donors were utilized for 
mononucleosome localization and characterization and to extend the analysis genome-
wide using Illumina GAII. 
Supplemental Fig. 3:  Chromatin attributes of the HOXA, HOXB, and HOXC loci. 
Histone enrichment (red bars), or histone modifications (H3K4me3 array results (ruby), 
H3K4me3 sequencing normalized difference scores (grey), H3K27me3 sequencing 
normalized difference scores (teal blue) or H3K4me2 (violet)). The y-axis is the signal 
intensity (log2 for array data, or normalized difference score for Illumina GAII 
sequencing) and the x-axis is the annotated physical map (HG18).  a, The HOXA locus. 
b, The HOXC locus c, The HOXB locus.
Supplemental Fig. 4: Certain self-renewal genes as well as genes required for embryonic 
development generally lack DNA methylation and are bivalent. a, SOX2 and FOXD3 are 
member of the pluripotency netwok. SOX2 is demethylated and characterized by the 
presence of H3K4me3 and H3K27me3, whereas FOXD3 is hypermethylated near their 
transcription start sites. OCT4 and NANOG are also hypermethylated (Supplementary 
Fig. 10c). b, Genes involved in embryonic development are typically DNA 
hypomethylated, and have high levels of H3K4me2/3  and H3K27me3 around their start 
sites The red asterisks indicate the region amplified for bisulfite sequencing in 
Supplementary Fig. 10. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or 
normalized difference for Illumina GAII sequencing score) and the x-axis is the 
annotated physical map (HG18). 
Supplemental Fig 5: Developmental and signaling factors are deficient in DNA 
methylation, although Notch pathway members are hypermethylated. a, Notch signaling 
pathway members, DKK1 (hypomethylated) and NOTCH1 (hypermethylated). b, FGF 
signaling pathway members, FGF9 (hypomethylated) and regulator SHH
(hypermehylated). The red asterisks indicates the region amplified for bisulfite 
sequencing. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or normalized 
difference for Illumina GAII score) and the x-axis is the annotated physical map (HG18). 
Supplemental Fig6: Histone retention at miRNAs and non-coding RNAs. a, A miRNA 
cluster with high H3K4me3 and H3K27me3. b, A miRNA cluster region with high levels 
of histone in the promoter region of the pri-miRNA, but lacking H3K4me3 and 
H3K27me3. c, The non-coding RNA XIST is enriched for H3K4me3 and H3K27me3 at 
the TSS. The read counts for the X-chromosome are half of those on autosomes due to the 
presence of either X or Y in sperm. The y-axis is the normalized difference score for 
sequencing. Asterisks (*) note the locations tested by bisulphite sequencing in 
Supplementary Fig. 10. 
Supplemental Fig 7: qPCR testing of epigenetically modified loci enriched by Illumina 
GAII sequencing and/or array analysis. a, qPCR testing of histone occupancy at both 
maternally and paternally imprinted genes (KCNQ1, IGF2, MEST, and IG-DMR), 
miRNAs and noncoding RNA (miR-196, miR-9.2, miR-153-1, miR-17, and HOTAIR),
and at a subset of developmental genes. Negative controls (NCs) (PRKACB and ZP4) are 
regions that had very low levels of histone by Illumina GAII sequencing and/or array 
data. Fold enrichment of histone at these promoters was determined by MNase signal 
divided by the total genomic DNA signal b, Fold enrichment of H3K4me3 was 
determined by normalizing signal from the H3K4me3 IP eluate to the signal from MNase 
(histone pool). Two maternally-imprinted loci in sperm were used as negative controls. c,
H3K27me3 and d, H3K9me3 enrichment were determined as described above. H3K9me3 
positive controls (PCs) were two pericentromeric heterochromatin loci. e, qPCR testing 
of MeDIP data. Enriched loci from MeDIP arrays were binned into the top 100 regions or 
400 enriched regions. qPCR of MeDIP eluates were performed for the bottom 10 regions 
in each of the top 100 and 400 bins. Since all 20 regions enriched for DNA methylation, a 
cutoff of the top 400 genes (approximately 2-fold) was our stringent cutoff for DNA 
methylation.  qPCR fold enrichment was compared to input (total sheared genomic 
DNA). Positive controls were two known methylated (imprinted) regions and negative 
controls were regions that are demethylated in sperm when compared to fibroblast.
Supplemental Fig 8: H2A.Z localizes to pericentric heterochromatin in the mature 
human sperm. Brown bars are the normalized difference scores for pooled donor H2A.Z 
across chromosome 16, and in orange is the FDR.  Other chromosomes showed similar 
peaks flanking the centromere. Pericentric heterochromatin was highly enriched with 
H2A.Z (FDR <0.05). 
Supplemental Fig 9: Genes required for sperm development generally lack DNA 
methylation and are bound by H3K4me3. a, Four genes expressed at different stages of 
spermatogenesis remain DNA demethylated and retain H3K4me3 enrichment. b, Gene 
promoters involved in RNA processing, a process utilized intensely during 
spermiogenesis, are also demethylated and H3K4me3 bound.
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signaling pathway members, FGF9 (hypomethylated) and regulator SHH
(hypermehylated). The red asterisks indicates the region amplified for bisulfite 
sequencing. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or normalized 
difference for Illumina GAII score) and the x-axis is the annotated physical map (HG18). 
Supplemental Fig6: Histone retention at miRNAs and non-coding RNAs. a, A miRNA 
cluster with high H3K4me3 and H3K27me3. b, A miRNA cluster region with high levels 
of histone in the promoter region of the pri-miRNA, but lacking H3K4me3 and 
H3K27me3. c, The non-coding RNA XIST is enriched for H3K4me3 and H3K27me3 at 
the TSS. The read counts for the X-chromosome are half of those on autosomes due to the 
presence of either X or Y in sperm. The y-axis is the normalized difference score for 
sequencing. Asterisks (*) note the locations tested by bisulphite sequencing in 
Supplementary Fig. 10. 
Supplemental Fig 7: qPCR testing of epigenetically modified loci enriched by Illumina 
GAII sequencing and/or array analysis. a, qPCR testing of histone occupancy at both 
maternally and paternally imprinted genes (KCNQ1, IGF2, MEST, and IG-DMR), 
miRNAs and noncoding RNA (miR-196, miR-9.2, miR-153-1, miR-17, and HOTAIR),
and at a subset of developmental genes. Negative controls (NCs) (PRKACB and ZP4) are 
regions that had very low levels of histone by Illumina GAII sequencing and/or array 
data. Fold enrichment of histone at these promoters was determined by MNase signal 
divided by the total genomic DNA signal b, Fold enrichment of H3K4me3 was 
determined by normalizing signal from the H3K4me3 IP eluate to the signal from MNase 
(histone pool). Two maternally-imprinted loci in sperm were used as negative controls. c,
H3K27me3 and d, H3K9me3 enrichment were determined as described above. H3K9me3 
positive controls (PCs) were two pericentromeric heterochromatin loci. e, qPCR testing 
of MeDIP data. Enriched loci from MeDIP arrays were binned into the top 100 regions or 
400 enriched regions. qPCR of MeDIP eluates were performed for the bottom 10 regions 
in each of the top 100 and 400 bins. Since all 20 regions enriched for DNA methylation, a 
cutoff of the top 400 genes (approximately 2-fold) was our stringent cutoff for DNA 
methylation.  qPCR fold enrichment was compared to input (total sheared genomic 
DNA). Positive controls were two known methylated (imprinted) regions and negative 
controls were regions that are demethylated in sperm when compared to fibroblast.
Supplemental Fig 8: H2A.Z localizes to pericentric heterochromatin in the mature 
human sperm. Brown bars are the normalized difference scores for pooled donor H2A.Z 
across chromosome 16, and in orange is the FDR.  Other chromosomes showed similar 
peaks flanking the centromere. Pericentric heterochromatin was highly enriched with 
H2A.Z (FDR <0.05). 
Supplemental Fig 9: Genes required for sperm development generally lack DNA 
methylation and are bound by H3K4me3. a, Four genes expressed at different stages of 
spermatogenesis remain DNA demethylated and retain H3K4me3 enrichment. b, Gene 
promoters involved in RNA processing, a process utilized intensely during 




























































































































































































































































































































































signaling pathway members, FGF9 (hypomethylated) and regulator SHH
(hypermehylated). The red asterisks indicates the region amplified for bisulfite 
sequencing. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or normalized 
difference for Illumina GAII score) and the x-axis is the annotated physical map (HG18). 
Supplemental Fig6: Histone retention at miRNAs and non-coding RNAs. a, A miRNA 
cluster with high H3K4me3 and H3K27me3. b, A miRNA cluster region with high levels 
of histone in the promoter region of the pri-miRNA, but lacking H3K4me3 and 
H3K27me3. c, The non-coding RNA XIST is enriched for H3K4me3 and H3K27me3 at 
the TSS. The read counts for the X-chromosome are half of those on autosomes due to the 
presence of either X or Y in sperm. The y-axis is the normalized difference score for 
sequencing. Asterisks (*) note the locations tested by bisulphite sequencing in 
Supplementary Fig. 10. 
Supplemental Fig 7: qPCR testing of epigenetically modified loci enriched by Illumina 
GAII sequencing and/or array analysis. a, qPCR testing of histone occupancy at both 
maternally and paternally imprinted genes (KCNQ1, IGF2, MEST, and IG-DMR), 
miRNAs and noncoding RNA (miR-196, miR-9.2, miR-153-1, miR-17, and HOTAIR),
and at a subset of developmental genes. Negative controls (NCs) (PRKACB and ZP4) are 
regions that had very low levels of histone by Illumina GAII sequencing and/or array 
data. Fold enrichment of histone at these promoters was determined by MNase signal 
divided by the total genomic DNA signal b, Fold enrichment of H3K4me3 was 
determined by normalizing signal from the H3K4me3 IP eluate to the signal from MNase 
(histone pool). Two maternally-imprinted loci in sperm were used as negative controls. c,
H3K27me3 and d, H3K9me3 enrichment were determined as described above. H3K9me3 
positive controls (PCs) were two pericentromeric heterochromatin loci. e, qPCR testing 
of MeDIP data. Enriched loci from MeDIP arrays were binned into the top 100 regions or 
400 enriched regions. qPCR of MeDIP eluates were performed for the bottom 10 regions 
in each of the top 100 and 400 bins. Since all 20 regions enriched for DNA methylation, a 
cutoff of the top 400 genes (approximately 2-fold) was our stringent cutoff for DNA 
methylation.  qPCR fold enrichment was compared to input (total sheared genomic 
DNA). Positive controls were two known methylated (imprinted) regions and negative 
controls were regions that are demethylated in sperm when compared to fibroblast.
Supplemental Fig 8: H2A.Z localizes to pericentric heterochromatin in the mature 
human sperm. Brown bars are the normalized difference scores for pooled donor H2A.Z 
across chromosome 16, and in orange is the FDR.  Other chromosomes showed similar 
peaks flanking the centromere. Pericentric heterochromatin was highly enriched with 
H2A.Z (FDR <0.05). 
Supplemental Fig 9: Genes required for sperm development generally lack DNA 
methylation and are bound by H3K4me3. a, Four genes expressed at different stages of 
spermatogenesis remain DNA demethylated and retain H3K4me3 enrichment. b, Gene 
promoters involved in RNA processing, a process utilized intensely during 
spermiogenesis, are also demethylated and H3K4me3 bound.
70
8www.nature.com/nature



















signaling pathway members, FGF9 (hypomethylated) and regulator SHH
(hypermehylated). The red asterisks indicates the region amplified for bisulfite 
sequencing. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or normalized 
difference for Illumina GAII score) and the x-axis is the annotated physical map (HG18). 
Supplemental Fig6: Histone retention at miRNAs and non-coding RNAs. a, A miRNA 
cluster with high H3K4me3 and H3K27me3. b, A miRNA cluster region with high levels 
of histone in the promoter region of the pri-miRNA, but lacking H3K4me3 and 
H3K27me3. c, The non-coding RNA XIST is enriched for H3K4me3 and H3K27me3 at 
the TSS. The read counts for the X-chromosome are half of those on autosomes due to the 
presence of either X or Y in sperm. The y-axis is the normalized difference score for 
sequencing. Asterisks (*) note the locations tested by bisulphite sequencing in 
Supplementary Fig. 10. 
Supplemental Fig 7: qPCR testing of epigenetically modified loci enriched by Illumina 
GAII sequencing and/or array analysis. a, qPCR testing of histone occupancy at both 
maternally and paternally imprinted genes (KCNQ1, IGF2, MEST, and IG-DMR), 
miRNAs and noncoding RNA (miR-196, miR-9.2, miR-153-1, miR-17, and HOTAIR),
and at a subset of developmental genes. Negative controls (NCs) (PRKACB and ZP4) are 
regions that had very low levels of histone by Illumina GAII sequencing and/or array 
data. Fold enrichment of histone at these promoters was determined by MNase signal 
divided by the total genomic DNA signal b, Fold enrichment of H3K4me3 was 
determined by normalizing signal from the H3K4me3 IP eluate to the signal from MNase 
(histone pool). Two maternally-imprinted loci in sperm were used as negative controls. c,
H3K27me3 and d, H3K9me3 enrichment were determined as described above. H3K9me3 
positive controls (PCs) were two pericentromeric heterochromatin loci. e, qPCR testing 
of MeDIP data. Enriched loci from MeDIP arrays were binned into the top 100 regions or 
400 enriched regions. qPCR of MeDIP eluates were performed for the bottom 10 regions 
in each of the top 100 and 400 bins. Since all 20 regions enriched for DNA methylation, a 
cutoff of the top 400 genes (approximately 2-fold) was our stringent cutoff for DNA 
methylation.  qPCR fold enrichment was compared to input (total sheared genomic 
DNA). Positive controls were two known methylated (imprinted) regions and negative 
controls were regions that are demethylated in sperm when compared to fibroblast.
Supplemental Fig 8: H2A.Z localizes to pericentric heterochromatin in the mature 
human sperm. Brown bars are the normalized difference scores for pooled donor H2A.Z 
across chromosome 16, and in orange is the FDR.  Other chromosomes showed similar 
peaks flanking the centromere. Pericentric heterochromatin was highly enriched with 
H2A.Z (FDR <0.05). 
Supplemental Fig 9: Genes required for sperm development generally lack DNA 
methylation and are bound by H3K4me3. a, Four genes expressed at different stages of 
spermatogenesis remain DNA demethylated and retain H3K4me3 enrichment. b, Gene 
promoters involved in RNA processing, a process utilized intensely during 












































































































































































signaling pathway members, FGF9 (hypomethylated) and regulator SHH
(hypermehylated). The red asterisks indicates the region amplified for bisulfite 
sequencing. The y-axis is the signal intensity (log2 for ChIP-chip arrays, or normalized 
difference for Illumina GAII score) and the x-axis is the annotated physical map (HG18). 
Supplemental Fig6: Histone retention at miRNAs and non-coding RNAs. a, A miRNA 
cluster with high H3K4me3 and H3K27me3. b, A miRNA cluster region with high levels 
of histone in the promoter region of the pri-miRNA, but lacking H3K4me3 and 
H3K27me3. c, The non-coding RNA XIST is enriched for H3K4me3 and H3K27me3 at 
the TSS. The read counts for the X-chromosome are half of those on autosomes due to the 
presence of either X or Y in sperm. The y-axis is the normalized difference score for 
sequencing. Asterisks (*) note the locations tested by bisulphite sequencing in 
Supplementary Fig. 10. 
Supplemental Fig 7: qPCR testing of epigenetically modified loci enriched by Illumina 
GAII sequencing and/or array analysis. a, qPCR testing f histone occupancy at both 
maternally and paternally imprinted genes (KCNQ1, IGF2, MEST, and IG-DMR), 
miRNAs and noncoding RNA (miR-196, miR-9.2, miR-153-1, miR-17, and HOTAIR),
and at a subset of developmental genes. Negative controls (NCs) (PRKACB and ZP4) are 
regions that had very low levels of histone by Illumina GAII sequencing and/or array 
data. Fold enrichment of histone at these promoters was determined by MNase signal 
divided by the total genomic DNA signal b, Fold enrichment of H3K4me3 was 
determined by normalizing signal from the H3K4me3 IP eluate to the signal from MNase 
(histone pool). Two maternally-imprinted loci in sperm were used as negative controls. c,
H3K27me3 and d, H3K9me3 enrichment were determined as described above. H3K9me3 
positive controls (PCs) were two pericentromeric heterochromatin loci. e, qPCR testing 
of MeDIP data. Enriched loci from MeDIP arrays were binned into the top 100 regions or 
400 enriched regions. qPCR of MeDIP eluates were performed for the bottom 10 regions 
in each of the top 100 and 400 bins. Since all 20 regions enriched for DNA methylation, a 
cutoff of the top 400 genes (approximately 2-fold) was our stringent cutoff for DNA 
methylation.  qPCR fold enrichment was compared to input (total sheared genomic 
DNA). Positive controls were two known methylated (imprinted) regions and negative 
controls were regions that are demethylated in sperm when compared to fibroblast.
Supplemental Fig 8: H2A.Z localizes to pericentric heterochromatin in the mature 
human sperm. Brown bars are the normalized difference scores for pooled donor H2A.Z 
across chromosome 16, and in orange is the FDR.  Other chromosomes showed similar 
peaks flanking the centromere. Pericentric heterochromatin was highly enriched with 
H2A.Z (FDR <0.05). 
Supplemental Fig 9: Genes required for sperm development generally lack DNA 
methylation and are bound by H3K4me3. a, Four genes expressed at different stages of 
spermatogenesis remain DNA demethylated and retain H3K4me3 enrichment. b, Gene 
promoters involved in RNA processing, a process utilized intensely during 
spermiogenesis, are also demethylated and H3K4me3 bound.
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Supplemental Figure 10: DNA hypomethylation at developmental promoters and 
miRNAs were verified by bisulfite sequencing. a, bisulfite sequencing of promoters 
known to bear (H19) or lack (LIT1, PEG3 and MEST) paternal methylation in sperm 
chromatin. CpGs are represented as open dots (if unmethylated) or filled dots (if 
methylated). b, Hypomethylation at developmental transcription factors and c, a subset of 
the pluripotency network promoters. d, The TSS of the miRNAs tested were generally 
hypomethylated. 
Supplemental Figure 11: H3K4me3 is generally present at paternally-expressed genes 
and non-coding RNAs. a, OSBPL-5 (a maternally-expressed gene) lacks H3K4me3, 
whereas PEG3 (a paternally-expressed gene) has high and broad H3K4me3 . b, The TSS 
of the AIR transcript localizes with H3K4me3, whereas promoters silenced by AIR
(SLCs) lack H3K4me3 c, Similarly, the GNASAS is paternally expressed and has 
H3K4me3, whereas the remaining promoters are maternally expressed and lack 
H3K4me3. 
Supplemental Fig 12: H3K4me2/3 chromatin modifications are correlated with early 
embryonic genes expression at the 4 and 8 cell stage. a, A subset of genes enriched at the 
4 cell stage have significant levels of H3K4me3 b, whereas genes enriched at the 8-cell 
stage were associated with high levels of H3K4me2. Fold enrichment for H3K4me3/2 








































































































Supplemental Figure 10: DNA hypomethylation at developmental promoters and 
miRNAs were verified by bisulfite sequencing. a, bisulfite sequencing of promoters 
known to bear (H19) or lack (LIT1, PEG3 and MEST) paternal methylation in sperm 
chromatin. CpGs are represented as open dots (if unmethylated) or filled dots (if 
methylated). b, Hypomethylation at developmental transcription factors and c, a subset of 
the pluripotency network promoters. d, The TSS of the miRNAs tested were generally 
hypomethylated. 
Supplemental Figure 11: H3K4me3 is generally present at paternally-expressed genes 
and non-coding RNAs. a, OSBPL-5 (a maternally-expressed gene) lacks H3K4me3, 
whereas PEG3 (a paternally-expressed gene) has high and broad H3K4me3 . b, The TSS 
of the AIR transcript localizes with H3K4me3, whereas promoters silenced by AIR
(SLCs) lack H3K4me3 c, Similarly, the GNASAS is paternally expressed and has 
H3K4me3, whereas the remaining promoters are maternally expressed and lack 
H3K4me3. 
Supplemental Fig 12: H3K4me2/3 chromatin modifications are correlated with early 
embryonic genes expression at the 4 and 8 cell stage. a, A subset of genes enriched at the 
4 cell stage have significant levels of H3K4me3 b, whereas genes enriched at the 8-cell 
stage were associated with high levels of H3K4me2. Fold enrichment for H3K4me3/2 
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Supplemental Figure 10: DNA hypomethylation at developmental promoters and 
miRNAs were v rified by bisulfite sequencing. a, bisulfite sequencing of promoters 
known to bear (H19) or lack (LIT1, PEG3 and MEST) paternal methylation in sperm 
chromatin. CpGs are represented as open dots (if unmethylated) or filled dots (if 
methylated). b, Hypomethylation at developmental transcription factors and c, a subset of 
the pluripotency network promoters. d, The TSS of the miRNAs tested were generally 
hypomethylated. 
Supplemental Figure 11: H3K4me3 is generally present at paternally-expressed genes 
and non-coding RNAs. a, OSBPL-5 (a maternally-expressed gene) lacks H3K4me3, 
whereas PEG3 (a paternally-expressed gene) has high and broad H3K4me3 . b, The TSS 
of the AIR transcript localizes with H3K4me3, whereas promoters silenced by AIR
(SLCs) lack H3K4me3 c, Similarly, the GNASAS is paternally expressed and has 
H3K4me3, whereas the remaining promoters are maternally expressed and lack 
H3K4me3. 
Supplemental Fig 12: H3K4me2/3 chromatin modifications are correlated with early 
embryonic genes expression at the 4 and 8 cell stage. a, A subset of genes enriched at the 
4 cell stage have significant levels of H3K4me3 b, whereas genes enriched at the 8-cell 
stage were associated with high levels of H3K4me2. Fold enrichment for H3K4me3/2 
was determined by signal from IP eluate divided the signal derived from the pooled 
mononucleosomes. 
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Supplemental Table 1: Histone enriched promoters (D1 array) 
Go Category Total Genes Changed 
Genes 
Enrichment FDR 
Sequence-specific DNA binding 425 32 4.601991 0 
Transcription factor activity 755 38 3.076248 0 
Transcription regulator activity 1090 46 2.579384 0 
Multicellular organismal development 1620 59 2.225982 0 
DNA binding 1522 54 2.168522 0 
Regulation of transcription DNA-dependent 1467 51 2.124833 0 
Transcription DNA-dependent 1510 52 2.104801 0 
RNA biosynthetic process 1512 52 2.102017 0 
Regulation of transcription 1580 52 2.011551 0 
Transcription 1623 53 1.995915 0 
Developmental process 1644 53 1.97042 0 
RNA metabolic process 2265 73 1.969878 0 
Regulation of cellular metabolic process 1827 58 1.940324 0 
Regulation of metabolic process 1772 55 1.897071 0 
Regulation of cellular process 1839 57 1.894427 0 
Regulation of biological process 2889 84 1.777119 0 
Multicellular organismal process 3134 89 1.735704 0 
Biological regulation 2648 73 1.68496 0 
System development 3396 93 1.673786 0 
Nucleobase nucleoside metabolic process 1231 40 1.986034 0.0015 
Nucleic acid binding 2489 66 1.620704 0.001905 
Transcription from RNA polymerase II promoter 2348 63 1.639937 0.002174 
Anatomical structure development 460 21 2.79027 0.002273 
Organ development 1465 44 1.835692 0.0025 
Skeletal development 869 31 2.180352 0.002692 
Urogenital system development 174 12 4.215186 0.0028 
Kidney development 31 5 9.858096 0.004545 
Wnt receptor activity 29 5 10.537964 0.005 






Supplemental Table 2: D1 Histone-enriched loci (Illumina GAII FDR< 0.0001) 





Cell fate commitment 75 60 1.59848 0 
Sequence-specific DNA binding 424 337 1.588112 0 
Cellular morphogenesis during differentiation 125 99 1.582495 0 
Cell projection organization and biogenesis 169 131 1.548823 0 
Cell part morphogenesis 169 131 1.548823 0 
Embryonic morphogenesis 88 68 1.543986 0 
Regionalization 82 63 1.535126 0 
Neurogenesis 221 168 1.518918 0 
Wnt receptor signaling pathway 107 80 1.493907 0 
Regulation of cell differentiation 119 88 1.477587 0 
Regulation of transcription from RNA polymerase II 
promoter 
99 72 1.453164 0 
Organ morphogenesis 304 221 1.452566 0 
Embryonic development 226 164 1.449949 0 
Regulation of developmental process 191 138 1.443653 0 
Voltage-gated ion channel activity 171 123 1.43723 0 
Nervous system development 604 433 1.432413 0 
Cation channel activity 228 162 1.419703 0 
Transcription factor activity 791 552 1.394376 0 
Muscle development 136 94 1.38104 0 
Central nervous system development 190 129 1.356605 0 
Skeletal development 193 130 1.34587 0 
Anatomical structure morphogenesis 855 575 1.343751 0 
System development 1396 934 1.336838 0 
Multicellular organismal development 1868 1248 1.334919 0 
Channel or pore class transporter activity 363 242 1.332067 0 
Enzyme linked receptor protein signaling pathway 228 152 1.332067 0 
Positive regulation of transcription  DNA-dependent 180 120 1.332067 0 
Cell morphogenesis 374 249 1.330286 0 
Cell Differentiation 1437 874 1.330286 0 
Positive regulation of transcription 227 151 1.329133 0 
Anatomical structure development 1679 1107 1.317389 0 
Positive regulation of cell proliferation 192 126 1.311253 0 
Organ development 996 650 1.303981 0 
Cell fate commitment 75 60 1.59848 0 
Sequence-specific DNA binding 424 337 1.588112 0 
Cellular morphogenesis during differentiation 125 99 1.582495 0 
Positive regulation of biological process 850 513 1.548823 0 
51674 localization of cell 324 203 1.251896 0 
32502 developmental process 2619 1639 1.250434 0 
06812 cation transport 432 270 1.248812 0 
15075 ion transporter activity 622 387 1.243191 0 
42127 regulation of cell proliferation 383 238 1.241639 0 
65009 regulation of a molecular function 400 246 1.228831 0 
06366 transcription from RNA polymerase II 
promoter 
532 326 1.2244 0 
50790 regulation of catalytic activity 381 233 1.221935 0 
05576 extracellular region 1056 596 1.127716 0 
06351 transcription  DNA-dependent 1866 1050 1.124333 0 
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Supplemental Table 2 continued: D1 Histone-enriched loci (Illumina GAII FDR< 0.0001) 





RNA biosynthetic process 1869 1051 1.123597 0 
Extracellular region 1056 596 1.127716 0 
Guanyl-nucleotide exchange factor activity 123 84 1.364556 0.000073 
Blood vessel development 133 90 1.352098 0.000074 
Ras protein signal transduction 176 115 1.305577 0.000074 
Negative regulation of developmental process 65 49 1.50626 0.000075 
Transport 2094 1134 1.082066 0.000075 
Embryonic development ending in birth or egg 
hatching 
81 59 1.455406 0.000076 
Extracellular matrix structural constituent 84 61 1.451001 0.000076 
Transporter activity 1090 611 1.120036 0.000077 
Cyclic nucleotide metabolic process 34 29 1.704262 0.000078 
Positive regulation of developmental process 49 39 1.590324 0.000078 
Vasculature development 135 92 1.361668 0.000079 
Anion transport 161 107 1.32793 0.000079 
Extracellular matrix organization and biogenesis 44 36 1.634809 0.00008 
Heart development 80 59 1.473599 0.000081 
Extracellular matrix organization and biogenesis 44 36 1.634809 0.00008 
Heart development 80 59 1.473599 0.000081 
Voltage-gated potassium channel complex 80 59 1.473599 0.000081 
Chordate embryonic development 80 59 1.473599 0.000081 
Developmental maturation 48 38 1.581829 0.000145 
Kidney development 29 25 1.7225 0.000201 
Transcriptional activator activity 243 152 1.24984 0.000203 
Anterior posterior pattern formation 50 39 1.558518 0.000204 
Cyclic nucleotide biosynthetic process 26 23 1.76755 0.000205 
Establishment of localization 2154 1162 1.077898 0.000207 
Extracellular region part 697 400 1.146686 0.000211 
Anatomical structure formation 132 89 1.347204 0.000213 
Sensory organ development 56 43 1.534255 0.000214 
Metanephros development 23 21 1.824352 0.000216 
Blood vessel morphogenesis 120 81 1.348717 0.00025 
Ionotropic glutamate receptor activity 18 17 1.887094 0.000252 
Glutamate-gated ion channel activity 18 17 1.887094 0.000252 
Muscle contraction 149 98 1.314187 0.000255 
Brain development 101 70 1.384822 0.000256 
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Supplemental Table 3: Donor pool of histone-enriched loci (Illumina GAII FDR< 0.0001) 
 





RNA polymerase II transcription factor activity 25 22 2.187319 0 
Cell fate commitment 69 53 1.909221 0 
Regionalization 86 60 1.734133 0 
Wnt receptor signaling pathway 121 84 1.725534 0 
Pattern specification process 123 85 1.717684 0 
Embryonic morphogenesis 93 64 1.710514 0 
Sensory organ development 80 55 1.708843 0 
Negative regulation of cell differentiation 67 46 1.706525 0 
Cellular morphogenesis during differentiation 124 85 1.703832 0 
Neurogenesis 257 171 1.653836 0 
Embryonic development 93 61 1.630333 0 
Chordate embryonic development 93 61 1.630333 0 
Brain development 133 87 1.625912 0 
Sequence-specific DNA binding 488 311 1.584054 0 
Positive regulation of transcription from RNA polymerase II 
promoter 
145 92 1.577064 0 
Embryonic development 221 140 1.574582 0 
Cell projection organization and biogenesis 193 121 1.558323 0 
Cell part morphogenesis 193 121 1.558323 0 
Regulation of cell differentiation 157 98 1.551515 0 
Cell morphogenesis 256 158 1.534075 0 
Cellular structure morphogenesis 256 158 1.534075 0 
Central nervous system development 227 140 1.532963 0 
Nervous system development 675 408 1.502401 0 
Positive regulation of RNA metabolic process 229 138 1.497867 0 
Skeletal development 203 121 1.481559 0 
Vasculature development 165 96 1.446162 0 
Organ morphogenesis 355 205 1.435341 0 
Cell migration 222 128 1.433133 0 
Anatomical structure morphogenesis 823 457 1.380212 0 
Transcription activator activity 284 157 1.374076 0 
System development 1538 817 1.320369 0 
Multicellular organismal development 2093 1104 1.31108 0 
Positive regulation of cellular process 952 501 1.308068 0 
Anatomical structure development 1768 930 1.307465 0 
Cell development 1089 565 1.289585 0 
Cell differentiation 1636 835 1.268623 0 
Cellular developmental process 1636 835 1.268623 0 
Organ development 1106 564 1.267516 0 
Developmental process 2848 1443 1.259377 0 
Intracellular signaling cascade 1291 653 1.257235 0 
                                       Regulation of developmental process 729 367 1.251319 0 
Regulation of RNA metabolic process 2115 1049 1.232806 0 
Regulation of transcription  DNA-dependent 2103 1043 1.232749 0 
Regulation of transcription 2228 1104 1.231639 0 
Regulation of gene expression 2358 1159 1.221713 0 
Transcription  DNA-dependent 2159 1061 1.221497 0 
RNA biosynthetic process 2163 1061 1.219238 0 




Supplemental Table 3 continued: Donor pool of histone-enriched loci (Illumina GAII FDR< 0.0001) 
 





Regulation of metabolic process 2629 1285 1.214904 0 
Transcription 2315 1129 1.212195 0 
Anatomical structure formation 152 89 1.455378 0.000072 
Transmembrane receptor protein tyrosine kinase activity 62 43 1.723877 0.000074 
Small GTPase regulator activity 201 112 1.385005 0.000136 
Respiratory tube development 43 32 1.849741 0.000138 
Insulin receptor signaling pathway 31 25 2.004508 0.000139 
Appendage morphogenesis 37 28 1.880987 0.000189 
Limb morphogenesis 37 28 1.880987 0.000189 
Appendage development 37 28 1.880987 0.000189 
Limb development 37 28 1.880987 0.000189 
Regulation of anatomical structure morphogenesis 69 45 1.621037 0.000485 
Transcription corepressor activity 106 64 1.500734 0.000491 
BMP signaling pathway 18 16 2.209413 0.000539 
Regulation of neuron differentiation 26 21 2.007592 0.000595 
Localization of cell 365 184 1.25301 0.000694 
Protein-tyrosine kinase activity 159 89 1.391305 0.000706 
Rho protein signal transduction 101 61 1.501198 0.00071 
Small conjugating protein ligase activity 137 78 1.415153 0.000769 
Forebrain development 46 32 1.729106 0.000773 
Voltage-gated cation channel activity 141 80 1.410264 0.000778 
Blood vessel morphogenesis 145 82 1.405644 0.000787 
Tube development 114 67 1.460829 0.000795 
Cartilage development 35 26 1.846438 0.0008 
Regulation of cellular component organization and biogenesis 241 127 1.309834 0.00082 
Mesoderm formation 14 13 2.308048 0.000851 
Heart development 93 56 1.496699 0.000947 
Regulation of neurogenesis 41 29 1.7581 0.000952 
Negative regulation of developmental process 314 159 1.258627 0.000964 
Regulation of cell proliferation 456 223 1.215541 0.000984 
Voltage-gated ion channel activity 189 102 1.34143 0.00099 
Voltage-gated channel activity 189 102 1.34143 0.00099 
Actin filament-based process 206 109 1.315191 0.001133 
Regulation of anatomical structure morphogenesis 69 45 1.621037 0.000485 
Transcription corepressor activity 106 64 1.500734 0.000491 
BMP signaling pathway 18 16 2.209413 0.000539 
Regulation of neuron differentiation 26 21 2.007592 0.000595 
Localization of cell 365 184 1.25301 0.000694 
Protein-tyrosine kinase activity 159 89 1.391305 0.000706 
Rho protein signal transduction 101 61 1.501198 0.00071 
Small conjugating protein ligase activity 137 78 1.415153 0.000769 
Forebrain development 46 32 1.729106 0.000773 
Voltage-gated cation channel activity 141 80 1.410264 0.000778 
Blood vessel morphogenesis 145 82 1.405644 0.000787 
Tube development 114 67 1.460829 0.000795 
Cartilage development 35 26 1.846438 0.0008 
Regulation of cellular component organization and biogenesis 241 127 1.309834 0.00082 
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Supplemental Table 4: TH2B Enriched Promoters (D1 array) 
GO CATEGORY TOTAL GENES CHANGED GENES ENRICHMENT FDR 
Beta DNA polymerase activity 3 3 22.225524 0.018333 
Multidrug transport 3 3 22.225524 0.018333 
Cation transport 380 35 2.047088 0.023333 
Metal ion transport 310 30 2.150857 0.0275 
Voltage-gated potassium channel 72 11 3.395566 0.0325 
Potassium ion transport 141 17 2.679673 0.03375 
Alpha-type channel activity 333 32 2.135786 0.035 
Voltage-gated ion channel activity 161 18 2.484841 0.035455 
Potassium ion binding 106 14 2.935447 0.036 
Transporter activity 1067 73 1.520584 0.037143 
Adenylate cyclase activity 14 5 7.937687 0.04 
Channel or pore class transporter 
activity 
338 33 2.169948 0.06 
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Supplemental Table 5: H3K4me2 enriched promoters (D1 array) 





Multicellular organismal development 1620 148 1.394279 0.005 
Developmental process 2265 197 1.327398 0.01 
Sequence-specific DNA binding 425 50 1.795495 0.026667 
Anatomical structure development 1465 132 1.375116 0.03 
System development 1231 113 1.400953 0.031429 
Cell-cell signaling 525 57 1.656985 0.035 
Organ development 869 84 1.47524 0.035 
Menstrual cycle 30 9 4.578511 0.04 
Multicellular organism reproduction 45 10 3.39149 0.065294 
Reproductive process in a multicellular 
organism 
45 10 3.39149 0.065294 
Multicellular organismal process 2648 212 1.221859 0.067333 
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Supplemental Table 6: H3K4me3 enriched promoters (D1 array) 





Nuclear pore 44 15 3.620699 0 
mRNA metabolic process 198 44 2.36016 0 
mRNA processing 165 35 2.25288 0 
Chromosome 204 40 2.082494 0 
RNA processing 266 51 2.036303 0 
Nuclear part 596 109 1.94238 0 
RNA binding 481 78 1.722279 0 
Cell cycle 606 98 1.717542 0 
Cell cycle process 530 82 1.643205 0 
RNA metabolic process 1827 256 1.488179 0 
Transcription  DNA-dependent 1510 199 1.399684 0 
RNA biosynthetic process 1512 199 1.397833 0 
Regulation of transcription  DNA-dependent 1467 193 1.397272 0 
Transcription 1644 216 1.395423 0 
DNA binding 1522 199 1.388648 0 
Regulation of transcription 1580 206 1.384727 0 
Regulation of nucleobase  nucleoside   
nucleotide and nucleic acid metabolic 
process 
1623 211 1.380759 0 
Regulation of cellular metabolic process 1772 229 1.372542 0 
Regulation of metabolic process 1839 237 1.368739 0 
Regulation of cellular process 2889 341 1.253605 0 
Regulation of biological process 3134 362 1.226771 0 
RNA splicing 137 30 2.325705 0.000227 
Macromolecule localization 548 83 1.608612 0.000233 
Intracellular transport 494 75 1.612457 0.0004 
Cellular protein metabolic process 2294 271 1.254671 0.000417 
RNA localization 36 13 3.835259 0.000426 
Ligase activity 238 42 1.874244 0.000727 
Establishment of cellular localization 596 86 1.53252 0.000741 
Specific RNA polymerase II transcription 
factor activity 
29 11 4.028548 0.000755 
Translation initiation factor activity 46 14 3.232393 0.000833 
Spliceosome 88 21 2.53449 0.000847 
Nucleic acid transport 35 12 3.641389 0.000862 
RNA transport 35 12 3.641389 0.000862 
Establishment of RNA localization 35 12 3.641389 0.000862 
Ribonucleoprotein complex 328 53 1.716153 0.001475 
Nuclear membrane part 54 15 2.9502 0.001791 
Pore complex 54 15 2.9502 0.001791 
Tricarboxylic acid cycle 22 9 4.344839 0.001846 
Acetyl-CoA catabolic process 22 9 4.344839 0.001846 
Cellular localization 611 86 1.494897 0.001905 
Ubiquitin cycle 267 45 1.790009 0.001935 
Translation regulator activity 99 21 2.25288 0.004405 
Spermatogenesis 141 27 2.033755 0.004444 
Male gamete generation 141 27 2.033755 0.004444 
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Supplemental Table 6 continued: H3K4me3 enriched promoters (D1) 





Transcription regulator activity 1090 136 1.325154 0.004458 
RNA export from nucleus 20 8 4.248287 0.004512 
Translation factor activity  nucleic acid 
binding 
86 19 2.346438 0.004828 
Protein transport 460 66 1.523842 0.004884 
Microtubule-based process 136 26 2.030431 0.005114 
Protein modification process 1218 149 1.29925 0.006517 
Nuclear chromosome 55 14 2.703456 0.007444 
Acetyl-CoA metabolic process 27 9 3.540239 0.00828 
Transcription from RNA polymerase II 
promoter 
460 65 1.500754 0.00837 
Nucleobase  nucleoside  nucleotide and 
nucleic acid transport 
44 12 2.89656 0.008404 
Organelle organization and biogenesis 711 93 1.389208 0.008438 
Microtubule cytoskeleton organization and 
biogenesis 
57 14 2.608598 0.008454 
Sexual reproduction 218 36 1.75388 0.008526 
Meiotic recombination 18 7 4.130279 0.010918 
Tricarboxylic acid cycle intermediate 
metabolic process 
23 8 3.694163 0.01101 
Nuclear export 29 9 3.296085 0.018762 
Cofactor catabolic process 29 9 3.296085 0.018762 
Gamete generation 184 31 1.78936 0.018835 
Protein complex 1361 161 1.256382 0.01902 
Intracellular protein transport 289 44 1.616995 0.019208 
Endomembrane system 331 49 1.572251 0.0194 
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Supplemental Table 7: H3K4me3-enriched loci as determined from donor pool (Illumina GAII FDR< 0.001) 
 





RNA splicing 64 46 1.622 0 
spliceosome 119 85 1.612 0 
ATP-dependent helicase activity 88 62 1.59 0 
mRNA processing 235 156 1.48 0 
Protein folding 151 99 1.48 0 
Helicase  activity 129 84 1.4699 0 
ribonucleoprotein complex biogenesis and  
assembly 
186 134 1.468 0 
mRNA metabolic process 272 177 1.463 0 
RNA processing 404 253 1.413636 0 
Ribonucleoprotein complex 400 250 1.41 0 
nucleolus 158 97 1.385 0 
Microtubule-based process 190 116 1.378 0 
Ligase activity 338 204 1.362 0 
Translation 351 210 1.350 0 
Mitotic cell cycle 295 168 1.285 0 
Cell cycle phase 323 183 1.285 0 
Nucleoplasm 442 250 1.279302 0 
Nucleoplasm part 381 215 1.272843 0 
Cell cycle process 395 253 1.257553 0 
Transcription factor binding 390 214 1.238 0 
RNA metabolic process 2624 1411 1.213 0 
Transcription from RNA polymerase II promoter 610 326 1.206 0 
Nucleobase nucleoside nucleotide metabolic process 3279 1734 1.19 0 
DNA binding 2080 1099 1.199734 0 
Cell cycle 691 364 1.18 0 
Gene expression 3028 1878 1.18 0 
Transcription 2315 1207 1.173 0 
Transcription  DNA-dependent 2159 1121 1.172 0 
RNA biosynthetic process 2163 1222 1.171 0 
Regulation of gene expression 2358 1223 1.1698 0 
Transcription regulator activity 1309 678 1.169 0 
Regulation of transcription  DNA-dependent 2103 1089 1.1689 0 
Regulation of transcription 2228 1146 1.161 0 
Post-translational protein modification 1346 777 1.133388 0 
Ribonucleotide binding 1537 879 1.12284 0 




Supplemental Table 7 continued: H3K4me3-enriched loci as determined from donor pool (Illumina GAII FDR< 0.001) 
 





M phase 261 148 1.28 0.000098 
Mitochondrion 807 413 1.15 0.00099 
Ribosome biogenesis and assembly 86 57 1.49 0.0001 
Regulation of cell cycle 272 154 1.278 0.000102 
Ubiquitin-dependent protein catabolic process 164 98 1.3489 0.000185 
RNA helicase activity 28 24 1.85 0.000187 
Protein RNA complex Assembly 105 67 1.440 0.000189 
Spindle 70 48 1.547 0.000192 
Spermatogenesis 202 106 1.296 0.00082 
Male gamete generation 202 106 1.296 0.00082 
Response to DNA damage stimulus 278 152 1.234 0.003 
Mitosis 198 112 1.276 0.003 
Flagellum 30 23 1.73 0.00331 
Regulation of translation 99 61 1.347 0.00349 
Centrosome 124 74 1.347 0.00349 
Gamete generation 247 136 1.24 0.00353 
Regulation of RNA cellular biosynthetic process 128 76 1.3403 0.00357 
Negative regulation of cell cycle 138 81 1.323143 0.00038 
mRNA splice site selection 13 12 2.08 0.00397 
rRNA processing 61 40 1.48839 0.00515 
nuclear chromosome part 61 40 1.488 0.00515 
Translation initiation factor activity 58 44 1.489455 0.0056 
Negative regulation of cellular process 1023 579 1.111234 0.00057 
Chromosome organization and biogenesis 345 211 1.200787 0.000606 
Regulation of protein metabolic process 301 184 1.200201 0.001384 
RNA splicing  via transesterification reactions 64 47 1.441852 0.001392 
RNA splicing  via transesterification reactions with 
bulged adenosine as nucleophile 
64 47 1.441852 0.001392 
Nuclear mRNA splicing  via spliceosome 64 47 1.441852 0.001392 
rRNA metabolic process 64 47 1.441852 0.001392 
Establishment of cellular localization 766 439 1.125223 0.0012 
Transcription factor complex 161 105 1.28046 0.001208 
Establishment of protein localization 674 389 1.133163 0.00125 
Regulation of cyclin-dependent protein kinase activity 48 37 1.513433 0.001258 
Protein tyrosine phosphatase activity 97 67 1.356144 0.001438 
Regulation of translation 99 68 1.348579 0.001657 
Interphase of mitotic cell cycle 84 59 1.379036 0.001667 
G1 S transition of mitotic cell cycle 33 27 1.606396 0.001677 
Nucleolar part 39 31 1.56063 0.001718 
Embryonic developmemt 220 120 1.225 0.01 
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Supplemental Table 8: Donor pool H3K27me3-enriched loci (Illumina GAII FDR <0.0001) 
 





Wnt receptor signaling 20 18 2.706 0 
Embryonic organ development 20 18 2.706 0 
Transmembrane receptor protein 18 16 2.706 0 
Inner ear morphogenesis 27 24 2.619 0 
Mesenchymal cell development and 
differentiation 
23 19 2.484 0 
Cell fate commitment 69 54 2.353 0 
Embryonic morphogenesis 93 71 2.295 0 
Lung development 42 31 2.219 0 
Cyclic nucleotide metabolic process 37 27 2.194 0 
Appendage morphogenesis 37 27 2.1943 0 
Limb morphogenesis 37 27 2.1943 0 
Appendage development 37 27 2.1943 0 
Limb development 37 27 2.1943 0 
Sensory organ development 80 58 2.1800 0 
Potassium ion binding 123 89 2.171 0 
Regionalization 86 62 2.16 0 
Anterior posterior pattern formation 54 38 2.116 0 
Axonogenesis 112 77 2.06 0 
Pattern specification process 123 84 2.0535 0 
Regulation of anatomical  structure 
morphogenesis 
69 47 2.048 0 
Neuron differentiation 206 139 2.029 0 
Forebrain development 46 31 2.026 0 
Developmental maturation 52 35 2.02 0 
Neuron morphogenesis during differentiation 118 79 2.013 0 
Skeletal development 203 133 1.970 0 
Neurite development 133 87 1.966 0 
Neurogenesis 265 165 1.930 0 
Cell migration 222 142 1.9217 0 
Brian development 133 85 1.921 0 
Embryonic development 221 40 1.904 0 
Sequence specific DNA binding 488 309 1.904 0 
Tube Development 114 70 1.86 0 
Vasculature development 165 101 1.846 0 
Organ morphogenesis 335 215 1.821 0 
Blood vessel development 162 98 1.819 0 
Central nervous system development 227 137 1.814 0 
Heart development 93 56 1.8106 0 
Anatomical structure formation 152 91 1.8002 0 
Bone remodeling 96 57 1.785 0 
Chordate embryonic development 93 55 1.778 0 




Supplemental Table 8: Donor pool H3K27me3-enriched loci (Illumina GAII FDR <0.0001) 
 





System process 1264 504 1.1989 0 
Ligand gated ion channel 97 54 1.674 0 
Embryonic limb morphogenesis 33 24 2.186 0.000044 
Embryonic appendage morphogenesis 33 24 2.186 0.00044 
Neural crest cell development and differentiation 14 13 2.792 0.00082 
Metanephros development 23 18 2.3533 0.000114 
Voltage-gated calcium channel complex 21 17 2.434 0.000115 
Eye morphogenesis 21 17 2.434 0.000115 
Eye development 42 28 2.004 0.000116 
Transcription 2315 570 1.183421 0.000153 
Dorsal ventral pattern formation 28 18 3.089797 0.000154 
Endoderm development 9 9 4.806351 0.000155 
Negative regulation of cell differentiation 67 32 2.295571 0.000155 
Developmental maturation 52 27 2.495605 0.000156 
Ligand-gated ion channel activity 97 42 2.081101 0.000158 
Morphogenesis of an epithelium 63 29 2.212447 0.00018 
Neuron fate commitment 14 11 3.776419 0.000181 
Regulation of heart contraction 42 22 2.517613 0.000182 
Tube morphogenesis 82 35 2.051491 0.000183 
Tissue remodeling 105 42 1.92254 0.000183 
Positive regulation of transcription  DNA-
dependent 
227 76 1.609175 0.000184 
Somitogenesis 16 12 3.604763 0.000185 
Biological process 12711 2729 1.031904 0.000186 
Growth factor activity 164 59 1.729114 0.000187 
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Supplemental Table 9: Loci enriched for H3K4me3 and H3k27me3 derived from donor pool sequencing data (Illumina GAII 
FDR< 0.0001) 
 





Cell fate determination 27 14 4.239878 0 
Endocrine system development 33 17 4.212346 0 
Cell fate commitment 69 34 4.0292 0 
Neuron migration 36 16 3.634181 0 
Embryonic morphogenesis 93 41 3.604873 0 
Appendage morphogenesis 37 16 3.53596 0 
Limb morphogenesis 37 16 3.53596 0 
Appendage development 37 16 3.53596 0 
Limb development 37 16 3.53596 0 
Forebrain development 46 19 3.377418 0 
Sensory organ development 80 30 3.06634 0 
Anterior posterior pattern formation 54 20 3.028484 0 
Brain development 133 47 2.889584 0 
Regionalization 86 30 2.852409 0 
Heart development 93 32 2.813559 0 
Embryonic development 221 74 2.737969 0 
Pattern specification process 123 41 2.725636 0 
Homophilic cell adhesion 133 43 2.643662 0 
Sequence-specific DNA binding 488 155 2.597173 0 
Central nervous system development 227 69 2.485491 0 
Chordate embryonic development 93 28 2.461864 0 
Neurogenesis 257 73 2.322623 0 
Tube development 114 32 2.295272 0 
Skeletal development 203 56 2.255698 0 
Organ morphogenesis 355 97 2.234253 0 
Positive regulation of transcription from RNA 
polymerase II promoter 
145 39 2.199306 0 
Circulatory system process 157 42 2.187453 0 
Blood circulation 157 42 2.187453 0 
Regulation of cell differentiation 157 42 2.187453 0 
Muscle development 166 42 2.068856 0 
Transcription factor activity 881 221 2.051188 0 
Neuron development 152 38 2.044227 0 
Nervous system development 675 168 2.035141 0 
Vasculature development 165 41 2.031837 0 
Anatomical structure morphogenesis 823 186 1.848001 0 
Organ development 1106 249 1.840913 0 
Positive regulation of transcription  DNA-dependent 227 51 1.837102 0 
System development 1538 340 1.807639 0 
Positive regulation of transcription 278 60 1.7648 0 
Transcription regulator activity 1309 281 1.755318 0 
Multicellular organismal development 2093 446 1.742427 0 
Anatomical structure development 1768 376 1.73898 0 
Positive regulation of metabolic process 408 84 1.683481 0 




Supplemental Table 9 continued: Loci enriched for H3K4me3 and H3k27me3 derived from donor pool sequencing data 
(Illumina GAII FDR< 0.0001) 
 





Positive regulation of cellular metabolic process 396 81 1.672549 0 
Regulation of transcription from RNA polymerase II 
promoter 
424 87 1.677809 0 
Biological adhesion 683 139 1.664114 0 
Cell-cell signaling 611 119 1.592556 0 
Developmental process 2848 537 1.541783 0 
Transcription from RNA polymerase II promoter 610 113 1.514738 0 
Cell differentiation 1636 292 1.459448 0 
Cellular developmental process 1636 292 1.459448 0 
Multicellular organismal process 3267 567 1.419133 0 
Positive regulation of cellular process 952 164 1.408627 0 
Cell development 1089 186 1.396607 0 
Positive regulation of biological process 1046 177 1.383664 0 
Negative regulation of cellular process 1023 171 1.366814 0 
DNA binding 2080 347 1.364128 0 
Regulation of transcription 2228 368 1.350584 0 
Regulation of RNA metabolic process 2115 348 1.34542 0 
Regulation of transcription  DNA-dependent 2103 346 1.345321 0 
Regulation of nucleobase  nucleoside  nucleotide and 
nucleic acid metabolic process 
2282 374 1.340124 0 
Transcription  DNA-dependent 2159 351 1.329363 0 
RNA biosynthetic process 2163 351 1.326904 0 
Regulation of gene expression 2358 382 1.324673 0 
Transcription 2315 373 1.317489 0 
Biological regulation 4522 682 1.233227 0 
Regulation of biological process 4060 605 1.21848 0 
Cell communication 3573 524 1.199188 0 
Positive regulation of nucleobase  nucleoside  
nucleotide and nucleic acid metabolic process 
291 61 1.714059 0.000085 
Negative regulation of biological process 1089 179 1.344046 0.000086 
Embryonic limb morphogenesis 33 14 3.468991 0.000088 
Embryonic appendage morphogenesis 33 14 3.468991 0.000088 
Positive regulation of RNA metabolic process 229 51 1.821058 0.000089 
Substrate specific channel activity 365 73 1.635381 0.00009 
Signal transduction 3247 466 1.173526 0.000164 
Blood vessel development 162 39 1.968515 0.000165 
Neurotransmitter binding 101 28 2.266865 0.000167 
Positive regulation of heart contraction 5 5 8.176907 0.000244 
Morphogenesis of an epithelium 63 20 2.595843 0.000317 
Regulation of developmental process 729 124 1.390859 0.000347 
Cellular morphogenesis during differentiation 124 31 2.044227 0.00035 
Anatomical structure formation 152 36 1.936636 0.000362 
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Supplemental Table 10: Promoters deficient in DNA methylation (D2 and D4 array) 





Embryonic development 199 22 3.061998 0 
Multicellular organismal development 1620 102 1.743896 0 
System development 1231 83 1.867478 0 
Nucleus 2828 153 1.498468 0 
RNA biosynthetic process 1512 95 1.740232 0 
Transcription 1644 202 1.70159 0 
Transcription regulator activity 1090 75 1.905768 0 
Anatomical structure development 1465 92 1.739344 0 
Regulation of transcription 1580 97 1.700396 0 
RNA metabolic process 1827 108 1.637271 0 
Nucleobase  nucleoside  nucleotide and 
nucleic acid metabolic process 
2489 136 1.513385 0 
Regulation of cellular metabolic process 1772 105 1.641198 0 
Nucleic acid binding 2348 130 1.533489 0 
Regulation of transcription  DNA-dependent 1467 91 1.718093 0 
DNA binding 1522 93 1.692402 0 
Regulation of metabolic process 1839 106 1.596465 0 
Organ development 869 61 1.94422 0 
Biopolymer metabolic process 3392 170 1.388125 0 
Developmental process 2265 123 1.504085 0 
Transcription factor activity 755 54 1.980989 0 
Transcription from RNA polymerase II promoter 460 38 2.288027 0 
Regulation of transcription from RNA 
polymerase II promoter 
297 26 2.424668 0.000588 
Female pronucleus 3 3 27.697168 0.001081 
Nervous system development 553 39 1.953326 0.001053 
Central nervous system development 179 18 2.78519 0.00125 
Dorsal ventral pattern formation 22 6 7.553773 0.001463 
Positive regulation of nucleobase nucleoside 
 nucleotide and nucleic acid metabolic process 
199 19 2.644453 0.002381 
Gamete generation 184 18 2.709506 0.002558 
Anatomical structure formation 122 14 3.178364 0.002727 
Anatomical structure morphogenesis 730 46 1.745301 0.003556 
Notch signaling pathway 34 7 5.702358 0.003478 
Pronucleus 4 3 20.772876 0.004681 
M phase 175 17 2.690582 0.005417 
Multicellular organismal process 2648 127 1.328376 0.0054 
Regionalization 72 10 3.846829 0.00549 
Cell cycle phase 214 19 2.459094 0.005385 
Negative regulation of cellular process 776 47 1.677535 0.006038 
Sequence-specific DNA binding 425 30 1.955094 0.006667 
Negative regulation of cellular metabolic 
process 
256 21 2.272033 0.007636 
Cell cycle process 530 35 1.829058 0.007544 
Negative regulation of biological process 807 48 1.647415 0.007414 
Chromosome 204 18 2.443868 0.007288 
Brain development 93 11 3.276009 0.011 
Positive regulation of transcription 192 17 2.452353 0.011148 
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Supplemental Table 10 continued : Promoters deficient in DNA methylation (D1 and D2 array) 





Positive regulation of cellular metabolic process 264 21 2.203184 0.010968 
Gastrulation 31 6 5.360742 0.013492 
Positive regulation of transcription DNA-
dependent 
147 14 2.637826 0.019692 
Meiosis 44 7 4.406368 0.020149 
M phase of meiotic cell cycle 44 7 4.406368 0.020149 
Sexual reproduction 218 18 2.286922 0.021618 
Meiotic cell cycle 45 7 4.308448 0.022754 
Mitosis 135 13 2.667135 0.023714 
Cellular protein complex disassembly 14 4 7.913477 0.026197 
Positive regulation of metabolic process 280 21 2.077288 0.025833 
Male pronucleus 2 2 27.697168 0.042405 
Regulation of translational elongation 2 2 27.697168 0.042405 
Heart development 75 9 3.32366 0.042683 
Heart morphogenesis 7 3 11.870215 0.045833 
Vasculature development 122 12 2.724312 0.045412 
Forebrain development 25 5 5.539434 0.046292 
Spermatogenesis 141 13 2.55364 0.045495 
Male gamete generation 141 13 2.55364 0.045495 
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Supplemental Table 11: Promoters that share histone enrichment and DNA hypomethylation (array) 
 





Sequence-specific DNA binding 425 35 5.037969 0 
Developmental process 2265 37 2.186039 0 
Multicellular organismal development 1620 30 2.478168 0 
DNA binding 1522 27 2.373961 0 
Anatomical structure development 1465 26 2.374981 0.002 
Transcription factor activity 755 17 3.013189 0.003333 
RNA metabolic process 1827 29 2.124144 0.002857 
Nucleic acid binding 2348 34 1.937784 0.0025 
Regulation of transcription 1467 25 2.280522 0.003333 
Neural tube patterning 2 2 133.821053 0.006 
System development 1231 22 2.391603 0.007273 
Transcription DNA-dependent 1510 25 2.21558 0.0075 
RNA biosynthetic process 1512 25 2.21265 0.006923 
Transcription regulator activity 1090 20 2.455432 0.009286 
Transcription from RNA polymerase II 
promoter 
460 12 3.490984 0.008667 
Regulation of transcription 1580 25 2.117422 0.0225 
Heart development 75 5 8.921404 0.022353 
Regulation of nucleobase  nucleoside  
nucleotide 
and nucleic acid metabolic process 
1623 25 2.061322 0.022778 
Regulation of metabolic process 1839 27 1.964746 0.0235 
Skeletal development 174 7 5.383606 0.023333 
Transcription 1644 25 2.034992 0.022273 
Nucleobase and nucleic acid metabolic 
process 
2489 33 1.774245 0.032609 
Regulation of cellular metabolic process 1772 26 1.963514 0.035 
Regulation of bone remodeling 21 6 19.117293 0.0368 
Cell-cell signaling 525 12 3.058767 0.035385 
Multicellular organismal process 2648 34 1.718246 0.034074 
Voltage-gated potassium channel activity 93 5 7.19468 0.040345 
Regulation of biological process 3134 38 1.622591 0.039 
Biological regulation 3396 40 1.57622 0.04 
Nervous system development 553 12 2.903893 0.046875 
Alpha-type channel activity 333 9 3.616785 0.045758 
Channel or pore class transporter activity 338 9 3.563282 0.046176 
Anatomical structure morphogenesis 730 14 2.566431 0.045143 
Positive regulation of cell differentiation 28 3 14.33797 0.058056 
Regulation of cellular process 2889 35 1.621231 0.057568 
Cellular morphogenesis during 
differentiation 
108 5 6.195419 0.056053 
Positive regulation of cellular process 671 13 2.592658 0.056154 
Cell development 859 15 2.336805 0.065854 
Potassium channel activity 118 5 5.670384 0.067674 
Organ development 869 15 2.309915 0.066136 
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Supplemental Table 12: Sperm DNA demethylation extends beyond CpGs 





Nucleus 2665 103 1.668257 0 
Transcription  DNA-dependent 1398 64 1.97604 0 
RNA biosynthetic process 1399 64 1.974627 0 
Regulation of transcription  DNA-
dependent 
1353 62 1.977957 0 
Regulation of RNA metabolic process 1365 62 1.960568 0 
Transcription regulator activity 996 50 2.166874 0 
Transcription 1518 65 1.848266 0 
Regulation of transcription 1457 63 1.866396 0 
RNA metabolic process 1698 70 1.77944 0 
Regulation of nucleobase  nucleoside  
nucleotide and nucleic acid metabolic 
process 
1500 64 1.841669 0 
Regulation of gene expression 1540 65 1.821862 0 
Regulation of cellular process 2683 97 1.560537 0 
Regulation of cellular metabolic 
process 
1708 69 1.74375 0 
Regulation of biological process 2873 101 1.51743 0 
Intracellular 6181 180 1.257004 0 
Gene expression 2015 77 1.649448 0 
DNA binding 1398 59 1.821662 0 
Biopolymer metabolic process 3194 108 1.459526 0 
Regulation of metabolic process 1757 69 1.695119 0 
Intracellular part 5850 171 1.26172 0 
Nucleobase  nucleoside  nucleotide and 
nucleic acid metabolic process 
2249 82 1.573792 0 
Embryonic development 183 15 3.538043 0.00037 
Transcription factor activity 688 34 2.133111 0.000385 
Biological regulation 3250 107 1.421096 0.0004 
Nucleic acid binding 2071 76 1.584004 0.000417 
Embryonic morphogenesis 78 10 5.533862 0.000435 
Macromolecule metabolic process 4200 131 1.34631 0.000455 
Positive regulation of transcription 214 16 3.227224 0.00069 
Anatomical structure morphogenesis 643 32 2.148137 0.000714 
Positive regulation of nucleobase  
nucleoside  nucleotide and nucleic acid 
metabolic process 
225 16 3.069449 0.000857 
Positive regulation of metabolic process 324 20 2.664452 0.000882 
Cellular component organization and 
biogenesis 
1639 62 1.63281 0.000909 
Membrane-bounded organelle 4209 129 1.32292 0.000938 
Intracellular membrane-bounded 
organelle 
4207 129 1.323549 0.000968 
Positive regulation of cellular metabolic 
process 
312 20 2.766931 0.001 
Positive regulation of RNA metabolic 
process 
171 13 3.281483 0.003864 
Primary metabolic process 4979 145 1.257039 0.003902 
RNA polymerase II transcription factor 
activity 
170 13 3.300786 0.003953 
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Supplemental Table 12 continued: Sperm DNA demethylation extends beyond CpGs 





Positive regulation of transcription  
DNA-dependent 
170 13 3.300786 0.003953 
Embryonic development ending in birth 
or egg hatching 
83 9 4.680447 0.004 
Chordate embryonic development 83 9 4.680447 0.004 
Transcription from RNA polymerase II 
promoter 
450 24 2.302087 0.004211 
Positive regulation of transcription 
from RNA polymerase II promoter 
109 10 3.960011 0.004222 
Pattern specification process 102 10 4.231777 0.004324 
Anatomical structure development 1378 52 1.628835 0.004681 
 
doi: 10.1038/nature08162 SUPPLEMENTARY INFORMATION
www.nature.com /nature 20
95
Supplemental Table 13: Gene promoters occupied by Suz12 in ES cell are DNA demethylated and histone bound in sperm 
GO CATEGORY TOTAL GENES CHANGED 
GENES 
ENRICHMENT FDR 
Sequence-specific DNA binding 425 51 10.377959 0 
Transcription factor activity 755 65 7.445556 0 
Transcription regulator activity 1090 69 5.471537 0 
Multicellular organismal development 1620 41 4.407517 0 
DNA binding 1522 72 4.348046 0 
Regulation of transcription  DNA-dependent 1467 72 4.112349 0 
Transcription  DNA-dependent 1510 37 4.267268 0 
RNA biosynthetic process 1512 37 4.261624 0 
developmental process 2265 84 3.38306 0 
Regulation of transcription 1580 72 4.078212 0 
                                   RNA metabolic process 1827 39 3.717502 0 
Regulation of nucleobase  nucleoside 
  Nucleotide and nucleic acid metabolic 
process 
1623 37 3.970163 0 
Regulation of metabolic process 1839 39 3.693245 0 
Transcription 1644 72 3.78945 0 
Regulation of cellular metabolic process 1772 38 3.734608 0 
Nucleic acid binding 2348 42 3.115132 0 
Regulation of biological process 3134 48 2.667273 0 
Regulation of cellular process 2889 45 2.712627 0 
Multicellular organismal process 2648 43 2.827976 0 
Biological regulation 3396 48 2.461494 0 
Nucleobase  nucleoside  nucleotide and 
nucleic acid metabolic process 
2489 40 2.798725 0 
System development 1231 58 4.07 0 
Anatomical structure development 1465 36 3.776226 0 
Organ development 869 44 4.408878 0 
Nucleus 2828 39 2.401654 0 
Nervous system development 553 16 5.038718 0 
Transcription from RNA polymerase II 
promoter 
460 13 4.92165 0 
Anatomical structure morphogenesis 730 36 4.264915 0 
                             Cellular metabolic process 5390 50 1.615498 0 
Skeletal development 174 8 8.006928 0 
Primary metabolic process 5420 50 1.606556 0 
Lung development 32 4 21.768836 0.00027 
Neural tube patterning 2 2 174.150685 0.000263 
Respiratory tube development 33 4 21.109174 0.000256 
Cellular process 8815 65 1.284151 0.000476 
Central nervous system development 179 7 6.810362 0.000465 
Positive regulation of transcription from RNA 
polymerase II promoter 
80 5 10.884418 0.000455 
Cell differentiation 1210 38 2.590671 0.001957 
Cellular developmental process 1210 18 2.590671 0.001957 
Brain development 93 11 10.2294 0.00383 
Positive regulation of transcription  DNA-
dependent 
147 6 7.108191 0.00551 
Metabolic process 6020 50 1.446434 0.0054 




Supplemental Table 13: Gene promoters occupied by Suz12 in ES cell are DNA demethylated and histone bound in sperm  
GO CATEGORY TOTAL GENES CHANGED 
GENES 
ENRICHMENT FDR 
Regulation of transcription from RNA 
polymerase II promoter 
297 8 4.690928 0.006923 
Neuron fate specification 5 2 69.660274 0.009811 
Pattern specification process 111 15 7.844625 0.012321 
Kidney development 29 3 18.015588 0.01614 
Tube development 70 4 9.951468 0.019483 
Urogenital system development 31 3 16.853292 0.020339 
Positive regulation of cellular metabolic 
process 
264 7 4.617632 0.020667 
positive regulation of transcription 192 6 5.442209 0.020984 
         Cell fate commitment 74 7 8.13551 0.021452 
Embryonic limb morphogenesis 34 3 15.366237 0.023231 
Embryonic appendage morphogenesis 34 3 15.366237 0.023231 
Organ morphogenesis 274 7 4.449105 0.022879 
Embryonic development 199 36 15.250774 0.022206 
Positive regulation of nucleobase  nucleoside 
 Nunucleotide and nucleic acid metabolic 
process 
199 6 5.250774 0.022206 
Cell development 859 24 2.41575 0.022899 
Positive regulation of metabolic process 280 7 4.353767 0.022571 
                Appendage morphogenesis 36 4 14.512557 0.022055 
Limb morphogenesis 36 4 14.512557 0.022055 
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Supplemental Table 14: Promoters that acquire methylation in fibroblasts compared to sperm 





Embryonic development 199 43 2.393575 0 
Anatomical structure morphogenesis 730 105 1.593302 0 
Regulation of transcription  DNA-
dependent 
1467 205 1.547945 0 
Transcription  DNA-dependent 1510 208 1.525872 0 
RNA biosynthetic process 1512 208 1.523854 0 
Regulation of transcription 1580 216 1.514357 0 
Transcription 1644 220 1.482356 0 
RNA metabolic process 1827 241 1.461202 0 
Multicellular organismal development 1620 201 1.374399 0 
Tube development 70 20 3.164927 0.000526 
Negative regulation of cell differentiation 49 15 3.390993 0.001034 
Transcription from RNA polymerase II 
promoter 
460 69 1.661587 0.001071 
Negative regulation of developmental 
process 
60 17 3.138553 0.001111 
Cellular component organization and 
biogenesis 
1763 209 1.313184 0.00125 
Developmental process 2265 259 1.266669 0.001304 
System development 1231 155 1.394779 0.001364 
Anatomical structure development 1465 180 1.361027 0.001429 
Regulation of cell differentiation 105 23 2.426444 0.001935 
Embryonic morphogenesis 78 19 2.698303 0.002 
Organ morphogenesis 274 45 1.819255 0.0025 
Nervous system development 553 77 1.542401 0.003529 
Lung development 32 11 3.807803 0.003636 
Synapse organization and biogenesis 23 9 4.334574 0.003889 
Respiratory tube development 33 11 3.692415 0.004 
Nucleosome assembly 41 12 3.24212 0.005405 
Chromosome organization and biogenesis 236 38 1.783624 0.005417 
Tube morphogenesis 43 12 3.091324 0.005532 
Calcium-dependent cell-cell adhesion 20 8 4.430898 0.005641 
Formation of primary germ layer 21 8 4.219903 0.005652 
Gastrulation 31 10 3.573305 0.005682 
Regulation of developmental process 162 29 1.982963 0.005714 
Organ development 869 108 1.376689 0.005778 
Branching morphogenesis of a tube 30 10 3.692415 0.005789 
Chromosome organization and biogenesis 226 37 1.813531 0.005814 
Chromatin assembly or disassembly 87 19 2.419168 0.005854 
Macromolecular complex assembly 359 53 1.635359 0.006 
Pattern specification process 111 22 2.19549 0.006327 
Morphogenesis of a branching structure 32 10 3.461639 0.0064 
Mesoderm morphogenesis 22 8 4.028089 0.008039 
Protein-DNA complex assembly 86 18 2.318493 0.008393 
Cellular component assembly 389 55 1.566191 0.008462 
Positive regulation of cell differentiation 28 9 3.560543 0.008491 
Regionalization 72 16 2.46161 0.008545 
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Supplemental Table 14: Promoters that acquire methylation in fibroblasts compared to sperm 





Chromatin assembly 52 13 2.769311 0.008704 
Synaptogenesis 18 7 4.307817 0.009298 
DNA packaging 180 30 1.846207 0.009483 
Embryonic arm morphogenesis 3 3 11.077244 0.012623 
Arm morphogenesis 3 3 11.077244 0.012623 
Positive regulation of osteoblast 
differentiation 
3 3 11.077244 0.012623 
Heart development 75 16 2.363145 0.015625 
Response to hypoxia 19 7 4.08109 0.016 
Chordate embryonic development 69 15 2.408097 0.016866 
Anatomical structure formation 122 22 1.997536 0.018169 
Mesoderm formation 20 7 3.877035 0.018378 
Embryonic development ending in birth or 
egg hatching 
70 15 2.373695 0.018429 
Mitotic sister chromatid segregation 15 6 4.430898 0.018933 
Sensory organ development 57 13 2.526389 0.019211 
Mesoderm development 44 11 2.769311 0.019221 
Cell cycle phase 214 33 1.708173 0.019367 
Cell differentiation 1210 138 1.263355 0.019634 
Cell cycle 606 76 1.389225 0.020814 
Sister chromatid segregation 16 6 4.153967 0.025057 
Cell fate determination 27 8 3.282146 0.025455 
Protein catabolic process 185 29 1.736433 0.025495 
Regulation of transcription from RNA 
polymerase II promoter 
297 42 1.566479 0.025556 
Cell fate commitment 74 15 2.245387 0.02573 
Macromolecule catabolic process 326 45 1.529067 0.025895 
Embryonic limb morphogenesis 34 9 2.932212 0.025957 
Embryonic appendage morphogenesis 34 9 2.932212 0.025957 
Dorsal ventral pattern formation 22 7 3.524578 0.025978 
Regulation of gliogenesis 4 3 8.307933 0.033469 
RNA interference 4 3 8.307933 0.033469 
Regulation of glial cell differentiation 4 3 8.307933 0.033469 
Tissue morphogenesis 55 12 2.416853 0.0372 
Mesodermal cell fate commitment 8 4 5.538622 0.04181 
Mitotic chromosome condensation 8 4 5.538622 0.04181 
Pancreas development 8 4 5.538622 0.04181 
Mesodermal cell differentiation 8 4 5.538622 0.04181 
Appendage morphogenesis 36 9 2.769311 0.042364 
Cell cycle process 530 66 1.37943 0.044123 
Chromosome condensation 13 5 4.260479 0.044554 
Positive regulation of developmental 
process 
43 10 2.576103 0.044696 
Anterior posterior pattern formation 44 10 2.517556 0.048103 
Sex differentiation 66 13 2.181881 0.050168 
Embryonic pattern specification 25 7 3.101628 0.050339 
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Objective: To evaluate the associations between proper protamine incorporation and DNA methylation at
imprinted loci.
Design: Experimental research study.
Setting: Research laboratory.
Patient(s): Three populations were tested—abnormal protamine patients, oligozoospermic patients, and fertile
donors.
Intervention(s): The CpG methylation patterns were examined at seven imprinted loci sequenced: LIT1, MEST,
SNRPN, PLAGL1, PEG3, H19, and IGF2.
Main OutcomeMeasure(s): The DNAmethylation patterns were analyzed using bisulfite sequencing. The percent-
age of methylation was compared between fertile and infertile patients displaying abnormal protamination.
Result(s): At six of the seven imprinted genes, the overall DNA methylation patterns at their respective differen-
tially methylated regions were significantly altered in both infertile patient populations. When comparing the
severity of methylation alterations among infertile patients, the oligozoospermic patients were significantly
affected at mesoderm-specific transcript (MEST), whereas abnormal protamine patients were affected at
KCNQ1, overlapping transcript 1 (LIT1), and at small nuclear ribonucleoprotein polypeptide N (SNRPN).
Conclusion(s): Patients withmale factor infertility had significantly increasedmethylation alteration at six of seven
imprinted loci tested, with differences in significance observed between oligozoospermic and abnormal protamine
patients. This could suggest that risk of transmission of epigenetic alterations may be different with diagnoses.
However, this study does not provide a causal link for epigenetic inheritance of imprinting diseases, but does
show significant association between male factor infertility and alterations in sperm DNAmethylation at imprinted
loci. (Fertil Steril! 2010;94:1728–33. "2010 by American Society for Reproductive Medicine.)
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Genomic imprinting is established and inherited during gametogen-
esis and preimplantation to ensure parent-of-origin monoallelic
gene expression (1, 2). The mechanism by which either one of the
two alleles are differentially expressed is not completely under-
stood; however, it is known that the majority of imprinted genes
are clustered and are predominately regulated by imprinting control
regions (ICRs) (3, 4). At present, approximately 80 imprinted genes
have been identified, many of which are implicated in tumorigene-
sis, fetal growth regulation, and embryonic development (5–8).
Pathological perturbation in the methylation imprints during game-
togenesis or development can give rise to growth-related syndromes
and is frequently observed in cancer (9–20).
After fertilization, both parental genomes are globally demethy-
lated through active or passive demethylation mechanisms, whereas
the methylation patterns at imprinted genes are maintained and only
erased and re-established in the primordial germ cell. The presence
of abnormal methylation patterns residing in gametes raises con-
cerns, as these may be inherited and maintained in the embryo.
Meta-analysis showed that children born from assisted reproductive
technology (ART) have a fourfold increased incidence of Beckwith-
Weidemann syndrome compared with children conceived naturally
(21–24). In addition, imprinting syndromes such as Angelman,
Prader-Willi, and Silver-Russell have been associated with ART,
although no strong correlations were established. Currently, it is un-
clear whether imprinting abnormalities arise from the ART proce-
dure itself or from pre-existing methylation aberrations in the
gametes of infertile patients (25–27).
Recent studies have shown that epigenetic abnormalities are com-
mon in the sperm of severely oligozoospermic patients, favoring the
latter hypothesis (26, 27). Whether epigenetic alterations at im-
printed loci of infertile men are limited to oligozoospermic patients
or whether epigenetic alterations extend beyond oligozoospermic
patients is unknown. In this study we examine methylation changes
in patients with an alternative cause for their male factor infertility—
patients with abnormal sperm protamine replacement of histones.
Protamines 1 and 2 are sperm-specific nuclear proteins that are in-
corporated into the DNA in a 1:1 ratio and ensure chromatin
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condensation. The average P1:P2 ratio in fertile men is!1, whereas
in some infertile patients this ratio is significantly altered (28, 29)
and consequently associated with severe sperm defects that can usu-
ally be addressed through ART (30, 31). It has been proposed that
chromatin packaging may have a role in properly establishing and
maintaining methylation patterns, hence, hypothetically, patients
with abnormal protamine ratios may be at an increased risk of con-
ceiving an ART offspring with imprinting disease (32, 33). This
study evaluates the relationship between protamine ratios and meth-
ylation patterns at seven imprinted loci in the sperm of abnormal
protamine patients or oligozoospermic patients. We reveal signifi-
cant changes in the overall DNA methylation patterns at six of these
loci, with varying impact on methylation patterns within each class
of infertility: oligozoospermic or abnormal protamine levels
(p-value< 0.05, Figure 1). These data suggest that aberrant imprint-
ing patterns are observed in patients with abnormal protamine ratios,
and that the abnormal patterns may vary among different patholo-
gies, providing a spectrum of risks for transmitting epigenetic abnor-
malities to the embryo.
MATERIALS AND METHODS
Patient Population
Of the seven tested imprinted loci, six are paternally demethylated and ex-
pressed: KCNQ1 overlapping transcript 1 (LIT1), insulin-like growth factor
2 (IGF2), paternally expressed gene 3 (PEG3), pleiomorphic adenoma gene-
like 1 (PLAGL1 also known as ZAC), small nuclear ribonucleoprotein
FIGURE 1
The overall methylation patterns at both paternally and maternally imprinted genes were altered in the sperm of infertile patients. (A,B,C) The
mean percentage of methylation with standard error. P< .05 is significant. (A) The percentage of methylated CpGs at normally paternally
demethylated loci. (B) The percentage of demethylation at a paternally methylated DMRofH19. (C) Comparingmethylation changes between
the two infertile patient populations. (D) Methylation status at the differentially methylated region of LIT1 for fertile donors, oligozoospermic
patients, and abnormal protamine patients.
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polypeptide N (SNRPN), and mesoderm-specific trancript (MEST), and one
is maternally expressed and is normally DNA methylated in sperm (H19).
For each locus 10 oligozoospermic (sperm count%10" 106/mL), 10 abnor-
mal protamine replacement patients (average sperm count of 73 " 106 # 60
SD/mL), and 5 known fertile donors were evaluated. For LIT1 only, eight oli-
gozoospermic patients and nine abnormal protamine patients were evaluated.
Sample Collection and Bisulfite Treatment
Institutional Review Board (IRB) approval was obtained before initiation of
this study. Frozen sperm DNA samples were treated with sodium bisulfite to
convert unmethylated cytosines to uracil and leaving methylated cytosines
unchanged, as previously described by Clark et al. (34). DNA was purified
using Qiagen DNeasy clean up kit (Qiagen, Valencia, CA) and eluted twice,
each time with 100 mL of elution buffer. The purified DNAwas desulfonated
by the addition of 20 mL NaOH and incubated at 37$C for 15 minutes. After
incubation, 22 mL of 4 M NaOAC, glycogen, and two volumes of ethanol
were added to precipitate the DNA overnight at -20$C. Precipitated DNA
was washed twice with 70% ethanol and eluted in 30 mL of elution buffer.
PCR Amplification of Bisulfite Converted DNA
Primer sequences and temperatures for SNRPN, PEG3, ZAC, MEST, LIT1,
H19 ICR, and IGF2 are available upon request (35, 36). The polymerase
chain reaction (PCR) reactions were performed in 50-mL volume reactions
containing 5 mL of 10 " PCR buffer–MgCl2 (Invitrogen, Carlsbad, CA), 5
mL of 10 " Enhancer Buffer (Invitrogen), 1.5 mL of MgCl2, 1 mL of 10
mM dNTPs, 0.5 mL of Taq (Invitrogen), 2.5 mL of each forward and reverse
primer (10 mM stock), and 30 mL of water. The PCR results were analyzed on
a 1% agarose gel, and gel purified if multiple products were detected.
TOPO TA Cloning and Sequencing
The PCR products were cloned into a TOPO 2.1 pCR vectors (Invitrogen)
and plated onto KAN-X-GAL plates for blue-white screening. Positive col-
onies were reinoculated into LB-KAN (50 mg/mL), cultured overnight, and
plasmids were purified using the Qiagen 96-well clean-up kit. To address
sperm sample heterogeneity five or more clones/alleles were sequenced
per patient for each of the imprinted loci (sequencing done at Genewiz San
Diego Laboratory).
Data Visualization and Analysis
The CG/TG-analyzer, a Perl program, was used to examine the methylation
status of a bisulfite-converted sequence and provides an output in the form of
1s and 0s, where 1s represent methylated cytosines and 0s represent unme-
thylated cytosines (thymine). The CpG positions were defined in a multifasta
file, text-based file containing multiple DNA or protein sequences, which in-
cludes the CpG position number flanked by four nucleotides on each side.
The output was used to calculate the percentage of CpG methylation
(program is be available upon request). To compare the overall methylation
profile in infertile patients versus fertile donors (Fig. 1), theWilcoxon-Mann-
Whitney test was used. This test is a nonparametric significance test for as-
sessing whether two independent samples of observations came from the
same distribution. To determine significance between fertile donors and oli-
gozoospermic patients or fertile and abnormal protamine patients the per-
centage of methylated CpGs represented in columns 2 and 3 (in Tables 1,
2, and 3) were compared as independent sample populations. A P value
< .05 was considered significant. The c2 analysis was used to compare the
percentage of methylated CpGs in the abnormal protamine or oligozoosper-
mic patients with known fertile donors.
RESULTS
Six imprinted genes, that are normally paternally demethylated,
were examined: LIT1, SNRPN, MEST, ZAC, PEG3, and IGF2.
Here, all except IGF2, showed significant hypermethylation in
oligozoospermic and abnormal protamine patients compared with
fertile donors (Fig. 1A). Furthermore, the differentially methylated
region (DMR) of H19 (a paternally methylated locus) was
TABLE 1












CpG 1 25.882 18.181 0 0.0003 0.0035
CpG 2 20 18.181 0 0.0021 0.0035
CpG 3 20 10.909 0 0.0021 0.0271
CpG 4 20 10.909 2.38 0.0066 0.17
CpG 5 21.176 10.909 0 0.0015 0.0271
CpG 6 20 10.909 0 0.0021 0.0271
CpG 7 21.176 10.909 0 0.0015 0.0271
CpG 8 20 10.909 0 0.0021 0.0271
CpG 9 20 10.909 0 0.0021 0.0271
CpG 10 20 10.909 0 0.0021 0.0271
CpG 11 21.176 12.277 0 0.0015 0.0186
CpG 12 20 10.909 0 0.0021 0.0271
CpG 13 21.176 10.909 0 0.0015 0.0271
CpG 14 20 14.454 0 0.0021 0.0101
CpG 15 20 10.909 0 0.0021 0.0271
CpG 16 20 7.272 0 0.0021 0.0742
CpG 17 20 10.909 0 0.0021 0.0271
CpG 18 21.176 12.272 0 0.0015 0.0093
CpG 19 20 10.909 0 0.0021 0.0271
CpG 20 20 10.909 0 0.0021 0.0271
CpG 21 21.176 16.363 0 0.0015 0.0059
CpG 22 21.176 16.363 0 0.0015 0.0059
Note: DMR ¼ differentially methylated region.
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significantly hypomethylated in both infertile classes (P<.006 for all
except ZAC, P<.002) (Fig. 1B). Thus, these infertile patients show
methylation alterations at six of seven loci tested. However, when
comparing overall methylation changes between the two infertile
populations, abnormal protamine patients show more extensive
hypermethylation at the DMRs of LIT1 and SNRPN in comparison
with oligozoospermic patients. In contrast, hypermethylation at
MEST is significantly higher in oligozoospermic patients (p-value
< 0.006, Fig. 1C).
Notably, in both patient populations, the locus that displays the
highest number of affected CpGs is LIT1. In the DMR of LIT1,
the percentage of methylated CpGs ranged from 7%–18% or
20%–25% for oligozoospermic or abnormal protamine patients, re-
spectively (Table 1). In contrast, for fertile donors, virtually all CpGs
were demethylated. The percentages of methylated CpGs in oligo-
zoospermic and abnormal protamine patients were statistically
significant when compared with fertile donors (p-value < 0.05,
Table 1). To address the uniformity of methylation changes at
LIT1 in individual sperm from a single patient, we sequenced mul-
tiple alleles (5–12) from each patient, and found striking heteroge-
neity. In three of the eight oligozoospermic patients, LIT1 was
completely methylated in 20%–30% of the alleles, whereas in
the other five patients, only sporadic increases were observed
(Fig. 1D). Similarly, in the abnormal protamine category one
patient always displayed complete methylation, a second displayed
methylation on 50% of his alleles, and the remainder (seven)
displayed little or no increase.
Consistent with the findings reported previously, the DMR of
SNRPN was also susceptible to acquiring methylation in infertile
men. Abnormal protamine patients had a significant increase in
CpG methylation (methylation at individual CpGs typically ranged
from 4%–20%) (p-value < 0.05 Table 2). Alterations were also
observed in oligozoospermic patients (range of methylation,
4%–8%), but the increase lacked statistical significance (Table 2).
At SNRPN, alterations in methylation were common (observed at
a majority of the alleles) but typically involved only a moderate
number of CpGs acquiring methylation. However, in both patient
categories, a small number of patients displayed complete methyla-
tion at 10% of the alleles tested.
Methylation levels in the DMR of MEST (for each CpG) ranged
from 7%–19%or 1%–3% in oligozoospermic or abnormal protamine
patients, respectively (Table 3). The changes in methylation at many
of the CpGs in oligozoospermic patients were near the range of statis-
tical significance (P¼.07; Table 3). In addition, 3 of 10 oligozoosper-
mic patients had 12%–33% of their alleles completely methylated,
whereas the remaining 7 patients displayed very little change. Like-
wise, in the abnormal protamine class, one patient had 14% of his al-
leles completely methylated and in the remaining nine patients, there
was virtually no change observed. In contrast, very few individual
CpGs were significantly (P<.05) affected in PEG3, ZAC, IGF2 pro-
moter 3, and H19 in infertile patients (data not shown).
DISCUSSION
In this study we evaluated the methylation status of seven imprinted
loci in two patient populations: oligozoospermic and abnormal prot-
amine ratio patients. The overall methylation patterns in sperm of in-
fertile patients were significantly altered at all imprinted loci (except
IGF2) when compared with fertile donors. However, when compar-
ing the two infertile patient populations, oligozoospermic patients
were hypermethylated at MEST, an imprinted gene associated with
Silver-Russell syndrome, whereas abnormal protamine patients
had significant changes at LIT1 and SNRPN (Figure 1), genes that
may be associated with cases of transient neonatal diabetes mellitus
and Angelman syndrome. These data suggest that risk of transmis-
sion of epigenetic alterations may be different with diagnoses.
TABLE 2












CpG 1 4.3 4.0 0 0.152 0.169
CpG 2 5.8 5.0 0 0.09 0.123
CpG 3 5.8 5.0 0 0.09 0.123
CpG 4 5.8 5.0 0 0.09 0.123
CpG 5 5.8 5.0 0 0.09 0.123
CpG 6 10.6 5.0 0 0.026 0.123
CpG 7 14.8 8.0 4.3 0.08 0.413
CpG 8 8.7 5.0 0 0.04 0.123
CpG 9 13.0 5.0 4.3 0.10 0.864
CpG 10 23.1 16 6.5 0.05 0.114
CpG 11 10.1 6.0 0 0.026 0.09
CpG 12 11.6 6.1 8.7 0.618 0.526
CpG 13 15.9 8.0 6.5 0.1 0.753
CpG 14 47.8 10 2.2 0.0001 0.09
CpG 15 11.6 6.1 0 0.017 0.08
CpG 16 5.8 4.0 2.2 0.351 0.566
CpG 17 11.6 13 2.2 0.065 0.039
CpG 18 15.9 12.2 6.5 0.130 0.295
CpG 19 15.9 5.1 6.7 0.140 0.705
CpG 20 17.4 5.1 0 0.003 0.119
CpG 21 17.6 4.1 2.2 0.011 0.560
Note: DMR ¼ differentially methylated region.
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Our data evaluate and demonstrate abnormal imprinting in a dif-
ferent class of abnormal spermatogenesis, abnormal replacement of
nuclear proteins by protamine 1 and protamine 2. It was our hypoth-
esis that abnormal chromatin packaging may be associated with
methylation defects, which is supported by the data presented
from this study. These data, along with previously published data
from oligozoospermic patients, reveal that alteration in DNA meth-
ylation patterns are common at a handful of imprinted loci tested,
suggesting that imprinting abnormalities may reside in the sperm
of infertile patients (25–27), but whether these alterations can be in-
herited is uncertain. Remarkably, when examining normally deme-
thylated DMRs, the alleles of infertile patients are often either
unaffected or entirely methylated, suggesting a bistable status, and
a susceptibility to complete methylation. Clearly, complete methyl-
ation of a normally unmethylated locus may lead to an imprinting
disorder in the embryo if proper imprint reestablishment mecha-
nisms are not implemented. Also of note are the small differences
in the degree of methylation within some genes and alleles. It is im-
portant to determine whether this abnormal methylation has reached
a threshold level that might lead to complete methylation in the
embryo (at a certain unknown probability) and confer disease, or
whether there is a gradual continuum with a threshold for disease.
Whether imprinting diseases in ARToffspring arise as a result of
abnormal methylation of gametes, or acquire methylation changes
during in vitro culture, or both, is still unknown. Current human
data suggest that methylation alteration at imprinted loci may reside
in gametes and may be inherited by the embryo. Supporting evi-
dence comes from two reports showing that a gain in methylation
on the paternal alleles of LIT1 or MEST in sperm is maintained in
the baby and associated with transient neonatal diabetes (37) or
Silver-Russell syndrome (38). The findings suggest that paternal
imprints in sperm may be needed for a healthy and uncomplicated
pregnancy. The need to study sperm from fathers of children with
imprinting diseases is imperative.
This study does not report a causal link between abnormal meth-
ylation of imprinted genes and disease. The relative risk of the
defects reported in our study to patients is unknown. However, we
demonstrate a link between abnormal spermatogenesis and abnor-
mal methylation of genes associated with rare imprinting diseases
previously reported to have elevated incidences in ART offspring
(21–24). This suggests that such a link may be strengthened in infer-
tile men with known abnormalities in chromatin packaging. Charac-
terizing these epigenetic alterations in the sperm of infertile men
may help predict the likelihood of IVF success rate.
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Abstract 
Background 
The sperm chromatin of fertile men retains a small number of nucleosomes that 
are enriched at developmental gene promoters and imprinted gene loci. This unique 
chromatin packaging at certain gene promoters provides these genomic loci the ability to 
convey instructive epigenetic information to the zygote, potentially expanding the role 
and significance of the sperm epigenome in embryogenesis. In this study, we hypothesize 




Seven patients with reproductive dysfunction were recruited: three had 
unexplained poor embryogenesis during IVF and four were diagnosed with male 
infertility and previously shown to have altered protamination. Genome-wide analysis of 
the location of histones and histone modifications was analyzed by isolation and 
purification of DNA bound to histones and protamines. The histone bound fraction of 
DNA was analyzed using high throughput sequencing, both initially and following 
chromatin immunoprecipation.  The protamine-bound fraction was hybridized to Agilent 




Unlike fertile men, six of seven infertile men had non-programmatic (randomly 
distributed) histone retention genomewide. Interestingly, in contrast to the total histone 
pool, the localization of H3K4me or H3K27me was mostly similar in the gametes of 
108
     
infertile men compared to fertile men. However, there was a reduction in the amount of 
H3K4me or H3K27me retained at developmental transcription factors and certain 
imprinted genes. Finally, the methylation status of candidate developmental promoters 




This initial genome-wide analysis of epigenetic markings in the sperm of infertile 
men demonstrates differences in composition and epigenetic markings compared to 
fertile men, especially at certain imprinted and developmental loci. Although no single 
locus displays a complete change in chromatin packaging or DNA modification, the data 
suggest that moderate changes throughout the genome exist and may have a cumulative 





The incidence of infertility is rising and estimated to affect one of six couples. As 
a result, the use of assisted reproductive technologies (ART) is rising and it is now 
estimated that ART accounts for 1-2% of all births in developed countries.1 Although 
ART has become a widely accepted and implemented therapy for many forms of 
infertility, there have been concerns about safety of ART for resulting offspring. 
Recently, a series of reports raised the concern that ART is associated with an increased 
incidence of major congenital malformations, chromosomal aberrations, miscarriage 
rates, intrauterine growth restriction, early childhood cancers, and imprinting disorders 
(such as Angelmann’s syndrome, Beckwith-Weidmann’s syndrome, and 
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Retinoblastoma).2,3,4 These reports suggest that many of the effects of ART on offspring 
are genetic or epigenetic in nature.5,6 
The precedence for epigenetic abnormalities in ART stems from earlier work on 
animal models which suggests an increased incidence of imprinting errors in offspring 
conceived by ART compared to natural conception.7 This rise in imprinting errors was 
attributed to embryo or gamete manipulation, in-vitro culture conditions, hormonal 
stimulation, or ovulation induction.8-12 However, a currently accepted alternative notion 
is that the increased incidence of imprinting disorders may be due to facilitation of 
conception using gametes of infertile couples that may have elevated risk of epigenomic 
errors. This view aligns with the limited number of reports showing abnormal 
methylation patterns at imprinted loci in the gametes of infertile men.13-19  
Recently, the understanding of the germline epigenome has expanded. We, and 
others, have shown that the sperm genome is hypomethylated with respect to a 
differentiated somatic cell,20,21 and that the small percentage of nucleosomes retained in 
the mature sperm of human and mouse are enriched at developmental promoters (i.e. 
HOX clusters), miRNA genes, and imprinted loci.21-23 Furthermore, the promoters of 
genes involved in spermatogenesis, cell cycle, and cell metabolism were associated with 
H3 Lysine 4 methylation (H3K4me3: an activating histone modification), while lacking 
H3 Lysine 27 methylation (H3K27me3: a repressive histone modification), in keeping 
with their activation during gametogenesis.  In contrast, many of the promoters for genes 
encoding transcripton factors important for embryonic development and morphogenesis 
bear two marks with antagonistic roles: H3K4me3 and H3K27me3 - termed ‘bivalent’ 
chromatin.  Here, large regions of H3K27me3 often overlap with smaller regions of 
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H3K4me3. This bivalent chromatin observed in sperm was first described in embryonic 
stem cell (ESC), and is believed to help poise genes for either activation or repression 
later in development.24 These findings suggest that the sperm genome may be packaged 
and poised for two programs: the first is a reminiscent gametogenesis program (active 
chromatin marks), and the second is a future embryonic program (bivalent domains). 
The conservation in epigenomic packaging in both the mouse and humans 
suggests a potential role for paternal histones in early developing embryos.21-23 It is 
understood that some cases of IVF failure appear to be due to paternal factors, and one 
current focus of research is to determine whether abnormal epigenetics in gametes could 
account for failure of embryogenesis25,26 and subsequent infertility. We hypothesized that 
the retained nucleosomes in the male gamete exhibit a functional role in early 
embryogenesis and that changes in histone retention and histone modifications may have 
important clinical ramifications on embryo outcome and/or fertility potential. Therefore, 
we studied the epigenome of two classes of infertility, men with abnormal semen 
parameters (also previously shown to have altered P1/P2 ratios) and men with 
unexplained, poor embryogenesis during IVF therapy. This is the first report to show 
alterations genome-wide in the epigenomic landscape of infertile men.  
 
 
Materials and Methods 
 
Study Participants 
Sperm samples were obtained from seven infertility patients and four donors of 
known fertility attending the University of Utah Andrology and IVF Laboratories. All 
patients were consented under an IRB approved protocol. The first four patients (patients 
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1-4) had presumed male factor infertility who had an abnormal semen analysis and an 
abnormal protamine 1-to-protamine 2 (P1/P2) ratio (2 had lower than normal P1/P2 ratio 
(<0.8) and 2 with an elevated P1/P2 ratio (>1.2)). Two of the patients had previously 
undergone IVF without obtaining a pregnancy, although morphologically normal 
embryos were transferred. The other two patients had undergone intrauterine 
inseminations without obtaining a pregnancy. 
The remaining three patients had unexplained embryo arrest during IVF. Two of 
the poor embryo patients had good quality embryos on day 2 of embryo culture, but all 
embryos arrested on day 3.  The third patient had pronuclear arrest of all embryos. 
Electron microscopy revealed normal sperm centrosome morphology in this patient. 
Sperm aneuploidy testing for five chromosomes was also performed on this patient and 
the aneuploidy rate was not elevated.  
 
 
Semen Sample Collection and Clinical Parameters 
Semen samples were collected after 2-5 days of abstinence and subjected to 
somatic cell lysis  (0.1% SDS, 0.5% Triton-X in DEPC H2O) for 20 minutes on ice and 
washed with 1X PBS to eliminate white blood cell contamination. Semen parameters 
were measured following WHO criteria.27 Sperm count, motility, morphology, DNA 
damage, P1/P2 ratio, and percentage of histone retention are summarized in Table 7.1. 
DNA damage was assessed using the TUNNEL assay28,29 and P1/P2 ratio were 
determined as previously described.30 
Partitioning of histone and protamine associated DNA was performed as 
previously described.21 Briefly, 10-20 million sperm cells were treated with an increasing 
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concentration of micrococcal nuclease (MNase 10-240U). The histone fraction was either 
used directly for chromatin immunoprecipitation (ChIP) or the DNA was purified and 
mononucleosomal length fragments (~140-155 bp) were gel purified and subjected to 
Illumina GAIIx, ~10-20 million reads were mapped for each sample. The protamine 
associated DNA was hybridized to the agilent expanded promoter arrays, a two-slide set 
(244k X2).21  
 
 
Chromatin IP and Preparation for Genomics Methods 
ChIP and sequencing methods were as described previously.21 ChIPs used the 
following antibodies: anti-H3K27me3 (Upstate 07-449) and H3K4me3 (Abcam 8580). 
For each modification ~10-20 million reads were aligned.  
Methylation Profiling using Bisulfite Sequencing: Sperm DNA was extracted as 
previously described.19 1ug of genomic DNA was converted using the epitect bisulfite kit 
(Qiagen, Valencia, CA). PCR products were cloned into TOPO2.1 vector (Invitrogen), 
and bacterial cells were grown on kanamyocin (50ug/ml) and X-gal (25ug/ml) plates 
overnight. Colony PCR was used to screen 10-20 colonies, however, 8-10 positive clones 
were submitted to sequencing.  
 
 
Computational Data Analysis 
Low and high level Agilent array and Illumina GAIIx sequencing data analysis 
were performed as previously described.21 Both Timat2 and Useq analysis packages are 
available at the SourceForge projects (http://useq.sourceforge.net/, 
http://timat2.sourceforge.net/). For the array data, the relative difference pseudo median 
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scores were converted to log2 ratio values and a Log2 value of 1 (2-fold enrichment) was 
the selected threshold for all analysis. For the sequencing data, 36 bp reads were 
generated using Illumina’s Genome Analyser IIx and processed according to their 
standard software pipeline.  Reads were mapped to the March 2006 NCBI Build 36.1 
human genome and analyzed using the USeq ChIP-Seq application where a q-value 





Histone Localization is Altered in the Gametes of Infertile Men 
To better understand the relationship between the sperm epigenome and infertility 
we localized nucleosomes in the gametes of seven men with infertility.  All sperm 
samples were subjected to sequential increasing amounts of micrococcal nuclease 
digestion, and mononucleosomal length fragments were gel purified and submitted to 
high-throughput sequencing to determine histone localization. Interestingly, unlike the 
consistent and repeated pattern of histone localization noted in fertile men, all four men 
with abnormal semen parameters/protamine ratios and two of the three men from couples 
with embryo failure couples (6 of 7 infertile) had dispersed histone localization patterns 
genome-wide suggesting that histone retention in infertile men maybe random (Figure 
7.1). For fertile donors and all infertile patients, we depict both sequencing read scores 
and the results of a statistical windowing program that quantifies the significance of 
read/histone enrichment (Qval, see methods). This distribution of nucleosomes is 
illustrated across the HOXD cluster (Figure 7.1); however, the observation of random 
histone localization for six of the seven patients extended genomewide.  
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An altered histone localization profile in infertile men might be related to the 
percentage of the genome packaged in histone, as the failure to efficiently remove histone  
from the bulk genome will obscure the observation of relative retention patterns at 
developmental loci. Previous work from this laboratory showed that the histone retention 
in normal subjects was estimated to be in the range of 3-5% (Table 7.1). In contrast to 
fertile men, three of the four men with abnormal semen parameters/abnormal protamine 
ratios, and all of the men from couples with embryonic failure, had elevated histone 
retention in their bulk genome.  Histone levels in infertile men were variable and ranged 
from 5-32% (Table 7.1). This supports the notion that greater histone retention overall 
obscures observation of specific enrichment at developmental loci. However, one of the 
embryo failure subjects (patient 7), despite a markedly elevated histone retention (16%: 
Figure 7.1, Table 7.1) retained relative histone enrichment at expected promoters. 
Furthermore, a patient with an abnormal protamine ratio (patient 2), although retaining a 
normal range of histone (5%: Table 7.1, Figure 7.1), did not display a normal retention 
profile. Therefore, measuring bulk nucleosome retention is insufficient to conclude 
nucleosomes are properly placed – one must determine the localization. 
The loss of apparent histone enrichment at particular promoters may be due to 
excess histone across the genome, or instead due to the loss of histone from promoters at 
developmental and gametogenesis genes. To test this, we examined the level and 
placement of histone modifications, reasoning that if these attributes are retained, then 
properly marked histones remain.  Here, we performed chromatin immunoprecipitation 
(ChIP) experiments for two histone modifications, H3K4me3 and H3K27me3 in our 
seven study subjects.  The ChIP data was normalized to each subject’s mononucleosome 
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input and a 300 bp window was used to identify enriched regions. We found that 
H3K4me and H3K27me methylation patterns in infertile men were generally similar to 
that of fertile donors (Figures 7.2, 7.3 and Table 7.2).  Therefore, it seems likely that the 
abnormal histone localization pattern in infertile men is because of an incomplete 
replacement of histone by protamine in the genome as whole, resulting in an increased 
background of abnormally retained histone that obscures the pattern of appropriately 
retained histones seen in normal sperm.  
 
 
The Sperm Epigenome of Infertile Men 
 
This genome-wide similarity in H3K4me3 and H3K27me3 datasets observed in 
fertile subjects and in subjects with evidence for reproductive dysfunction (Figure 7.2 and 
7.3) was substantiated using gene ontology analysis (Figure 7.4) and Pearson correlations 
(Table 7.2). Similar to fertile controls, H3K4me gene ontology analysis revealed that 
H3K4me localization in subjects with sperm/protamine abnormalities or embryonic 
failure was enriched at the promoters of cell cycle genes, cellular metabolic processes, 
RNA processing and splicing, spermatogenesis gene promoters, and developmental 
transcription factors (FDR 40 = < 1/1000). In contrast to H3K4me localization, 
H3K27me localization in control and abnormal subjects was similar, showing enrichment 
only at developmental gene promoters (FDR 40 = < 1/1000). These results imply that as 
in normal fertile men, sperm from men with reproductive disorders exhibit H3K4me 
enrichment at the gametogenesis program and H3K27me represses loci in the future 
embryonic program.   The similarity in modification datasets for the two groups of 
subjects was also confirmed by the Pearson correlation coefficients on raw datasets  
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(Summarized in Table 7.2). The correlation coefficients (r) for many of the datasets were 
estimated 0.7 or greater. These findings confirm that modification profiles for the fertile  
subjects and subjects with reproductive dysfunction are highly correlated, but not 
completely so, such that differences exist between individuals and classes (Summarized 
in Table 7.2). An illustrative gene specific difference for H3K4me comparing normal and 
abnormal subjects can be observed at imprinted loci (Figure 7.5). In fertile subjects, 
nearly all paternally expressed imprinted genes were enriched with H3K4me, while 
maternally imprinted loci lacked H3K4me3. In contrast, among the seven subjects with 
evidence for reproductive dysfunction, three (patients 3, 5, 6) showed absence of 
H3K4me3 at the promotors of 3 paternally expressed imprinted loci (PEG10, SGCE, and 
NAP1L5), and 6 showed a gain of H3K4me3 at a maternally imprinted gene (ZNF264) 
(Figure 7.5). 
Although the localization of modified nucleosomes was similar to controls in all 
seven subjects with evidence for reproductive abnormalities, a differential analysis was 
performed to identify loci that bear differences in the amount of H3K4me/H3K27me 
enrichment (read count at promoters). The analysis outputs 1) enriched regions: which 
are regions enriched in the patient and reduced in controls and/or 2) reduced regions: 
which are regions deficient in patients and elevated in controls. These regions are 
subsequently submitted for gene ontology analysis to identify altered programs or 
pathways in infertile men. Interestingly, the top 300 genes with reduced H3K4me3 were 
predominately genes of bivalent promoters involved in embryonic processes such as 
multicellular oragnismal development, system development, organ development, pattern 
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specification and not the promoters of cell cycle or spermatogenesis (FDR 40 < 1/1000). 
Similarily, the top 300 genes with reduced H3K27me3 promoters in the subjects were  
developmental promoters. This latter finding is expected because H3K27me3 is enriched 
only at developmental promoters in patients and controls (FDR 40 < 1/1000).  
 
 
Changes in Chromatin Modifications Do Not Generally Result in  
Dramatic Changes in DNA Methylation  
Recently, structural and in vitro data showed that H3K4 methylation deters DNA 
methylation by DNMT3A2 and DNMT3L in mice.31 To examine whether a change in 
chromatin modifications might result in a change in DNA methylation, bisulfite 
sequencing of several candidate developmental loci that lacked or had significantly 
reduced levels of H3K4me3 were assessed in three infertile men (patients 1, 4, 6). As 
seen in fertile control subjects, the developmental promoters tested in the three infertile 
men were generally unmethylated with very few changes in methylation observed 
relative to controls (Figure 7.6). Expanding the DNA methylation analysis to imprinted 
loci and including all subjects with evidence for reproductive dysfunction revealed more 
pronounced changes at the imprinted loci of patients 2 and 3. However, the remainder of 
the subjects showed very limited changes in methylation (Figure 7.7). The gain of DNA 
methylation did not always correlate with a loss of K4me. Subjects 2 and 3 had reduced 
or lost K4me at PEG10 whereas 30-70% of their alleles gained methylation (Figures 7.5 
and 7.7). In contrast, patients 5 and 6 lost K4me at PEG10 but did not acquire 
methylation (Figures 7.5 and 7.7). Therefore, although we could not always correlate a 
loss of H3K4me with a gain in DNA methylation, infertile men appear more susceptible 
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to changes in DNA methylation independent of the changes in chromatin in the mature 
sperm.  
 
Changes in Protamine Localization Are Observed in the  
Gametes of Infertile Patients 
  Protamines were localized in three infertile men with an abnormal P1/P2 ratio. 
The data presented are the averages from two biological replicas. The correlations 
between the replicas were greater than 0.8. Similar to fertile men, protamines were 
present throughout in the genome as shown in Figure 7.8a. Gene ontology analysis did 
not enrich for a particular cellular process. However, the correlation and hierarchal 
clustering results show that patients clustered away from donors (Figure 7.8b), suggesting 
potential differences in protamine levels as well as localization genome-wide in the 





This paper provides several lines of evidence that the genome packaging and 
epigenomic modifications are altered in the gametes of some infertile men. A few reports 
have shown that the methylation at several imprinted loci were altered in the gametes of 
infertile men.13-15,17,21,32,33 We add that the alteration in the epigenome extends beyond 
DNA methylation at imprinted loci and entails changes in histone modifications and 
localization genome-wide at a large number of loci.  
Altered histone localization patterns identified in the sperm of infertile men 
generally reflect a more random pattern of nucleosome retention rather than the localized 
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retention seen in all fertile donors. This incomplete removal of nucleosomes might be 
attributed to problems with the chromatin remodeling machinery or improper histone 
acetyl transferase (HAT) activity during the histone-to-protamine exchange, however, the 
effect of improper histone retention in early embryos is currently not well understood. 
 While nucleosomes were randomly retained genome-wide in infertile men, the 
localization of modified nucleosomes was similar to fertile controls suggesting that the 
establishment of epigenetic marks in the spermatogonial stem cell remain largely intact in 
infertile men. However, subtle but potentially important differences were identified. For 
example developmental promoters enriched with H3K4 and H3K27me in known fertile 
men were lost or significantly reduced in most infertile men.  The most striking 
observation is the loss of H3K4me3 from three paternally imprinted loci, a mark 
normally highly correlated with hypomethylation, in keeping with structural and 
functional studies of DNMT3L and DNMT3A in mice.31  However, the loss or reduction 
of K4me3 in the mature sperm correlated with a gain in DNA methylation in only one of 
the seven patients.  This shows that the loss of H3K4me3 is likely insufficient to cause 
DNA methylation, suggesting that additional mechanisms are likely involved in 
preventing DNA methylation at these imprinted loci.   
The clinical ramifications of an altered H3K4me/H3K27me bound promoters in 
the gametes of infertile men is not yet known. However, clinical case studies have 
established that imprinting diseases in particular are not binary (presence or absence), but 
instead can result from moderate changes in DNA methylation status, e.g., in Beckwith-
weidmann’s syndrome a 20% reduction in the number of methylated CpGs in a 
paternally-methylated DMR results in disease onset. Therefore, the fidelity of the 
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epigenome may need to be quite high to ensure embryo viability and health. Future 
studies that determine the relevance of chromatin marks in the germ-line are essential.  
Although the number of patients assessed in this study is small (necessarily so due 
to the extreme costs associated with genome-wide analysis) the results are intriguing. 
Previously we, and others, have shown that all fertile men tested programmatically retain 
nucleosomes genomewide. In contrast to fertile controls, six of seven infertile men had 
abnormal histone retention patterns, suggesting that histone to protamine exchange is 
defective in many infertile men. Furthermore, a subset of the patients displayed 
abnormalities in histone modifications (H3K4me and H3K27me) and DNA methylation 
at imprinted and developmental loci, which was absent in the fertile control pooled 
sample. This study demonstrates differences in the chromatin composition and epigenetic 
marking in the sperm of infertile men, especially at imprinted and developmental loci. 
Although no single locus displays a complete change in chromatin packaging or DNA 
modification, these moderate changes at many loci may have a cumulative detrimental 
affect on fecundity. This is aligned with current notions, since infertility is a 
multifactorial disease, and like other complex diseases, numerous etiologies likely 
contribute to male infertility or poor embryo outcome, with epigenetics being just one 
potential contributor. 
In summary, this is the first report examining the sperm epigenome (histone 
localization and histone modifications) genome-wide in men with abnormal 
spermatogenesis or repeated poor embryo outcome. The risks associated with germ-line 
epigenetic abnormalities for the embryo is unclear, but we know subtle differences in 
chromatin packaging were observed in the gametes of infertile men, and the penetrance 
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of epigenetic abnormalities according to the literature is low, therefore it is not entirely 
surprising that the frequency of epigenetic anomalies from ART is rare. The low disease 
penetrance can be attributed to several selected defense mechanism acquired through 
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Donor H3K4me3 vs. Patient 1 H3K4me3 0.786 
Donor H3K4me3 vs. Patient 2 H3K4me3 0.826 
Donor H3K4me3 vs. Patient 3 H3K4me3 0.788 
Donor H3K4me3 vs. Patient 4H3K4me3 0.868 
Donor H3K4me3 vs. Patient 5 H3K4me3 0.698 
Donor H3K4me3 vs. Patient 6 H3K4me3 0.749 
Donor H3K4me3 vs. Patient 7 H3K4me3 0.749 
Donor H3K27me3 vs Patient 1 H3K27me3 0.807 
Donor H3K27me3 vs. Patient 2 H3K27me3 0.771 
 
Donor H3K27me3 vs. Patient 3 H3K27me3 0.818 
Donor H3K27me3 vs. Patient 4 H3K27me3 0.787 
Donor H3K27me3 vs. Patient 5 H3K27me3 0.666 
Donor H3K27me3 vs. Patient 6 H3K27me3 0.775 
















Figure 7.1. High throughput sequencing of mononucleosomes reveals relatively 
random histone retention at the HOX loci in most infertile patients. Mapped 
sequencing reads were scored for enrichment (score) and for significance. Regions 
significantly enriched for histone relative to the input control (sheared total sperm DNA) 
were identified using a 300-bp window metric. For display, we depict score and false 
discovery rate (FDR) window scores (-10Log(FDR)). Note a FDR of 20 is equal to <0.01 






































































Figure 7.2. H3K4me3 localization patterns are generally normal in the gametes of 
infertile men. This figure illustrates H3K4me3 retention aligned to the physical map of 
the HOXD locus. The y-axis depicts Storey q-value false discovery rate (-10Log(FDR)). 











































































































































































Figure 7.3. H3K27me3 localization patterns are generally normal in the gametes of 
infertile men. This figure illustrates H3K27me3 retention aligned to the physical map of 
the HOXD locus. The y-axis depicts Storey q-value false discovery rate (-10Log(FDR)). 

















































































































































































Figure 7.4. Gene Ontology Analysis reveals similar K4 and K27me localization 
patterns in fertile and infertile men. GoMiner was used to identify enriched categories, 
and all categories displayed have an FDR < 0.001.  The top five general categories are 


















































































Figure 7.5. A few maternally or paternally imprinted loci are improperly modified 
in the gametes of infertile men. (A) Depicts two paternally imprinted genes PEG10 and 
SGCE that lack or have reduced levels of H3K4me3 in patients (B) Represents a 
maternally imprinted gene (ZNF264) that lacks K4me in fertile donors but acquires 
K4me in infertile men. (C) and (D) represent two properly marked materally imprinted 













































































































































































Figure 7.6. DNA hypomethylation is largely maintained at developmental promoters 
of infertile men.  Bisulfite sequencing of developmental promoters that lack or have 
reduced levels of K4me.  CpGs are represented as open dots (if unmethylated) or filled 























































































































































































































Figure 7.7. DNA methylation patterns are altered at a subset of paternally 
imprinted loci in the gametes of infertile men. CpGs are represented as open dots (if 
















































































































































































Figure 7.8. Genome-wide protamine localization and Pearson correlations suggest 
differences in protamine localization. a. Protamine localization in fertile and infertile 
men. The y-axis is the signal intensity (log2 for ChIP-chip arrays) and the x-axis is the 
annotated physical map (HG18). B. Hierarchal clustering of raw datasets shows that 
























































   
Genetic Mutations in the Protamine Cluster and its Role in Infertility 
The hypothesis underlying this work is that the genetic and epigenetic states of 
the mature sperm have important roles in the establishment of proper germ cell identity 
and function, and in early developmental capacity. We reason that perturbations to the 
genome or epigenome of the male germ cell may underlie a subset of idiopathic cases of 
male infertility.  
Initially, we investigated genetic causes of male infertility. Abnormal expression 
of protamine genes is associated with male infertility and reduced reproductive 
efficiency. Work from our lab and others has shown that abnormal protamine expression 
could not be explained by protamine gene body mutations.1-6 As an alternative we tested 
whether the abnormal protamine ratio in sperm may be due to mutations in the 5’ and 3’ 
untranslated regions of the protamine genes, which are known to contain regulatory 
elements important for modulating gene transcription or gene translation. We identified a 
number of genetic variants in the protamine gene UTRs, however, these variants were 
present in similar frequencies in both patients and controls (Chapter 3). In a subsequent 
study performed by an independent group, a significant 5’UTR SNP that specifically 
associated with abnormal protamine was identified in patients with less than 9% normal 
sperm head morphology.7 The differences reported between the two studies may be due 
to differences in patient selection criteria. Our patients were selected according to the 
P1/P2 ratio alone with no preset threshold for semen parameter such as morphology or 
motility. However, we have previously shown that patients with abnormal protamine 
ratio typically have poor semen parameters. An alternative explanation for the genetic 
differences reported in the two studies may be due to the differences in patient ethnicities. 
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Previous works has revealed that certain polymorphisms are more prevalent in some 
ethnic groups than in others.8  
Although many of the SNPs reported to date in the protamine gene or UTRs alone 
do not confer susceptibility to protamine abnormality, one can speculate that if the 
protamine polymorphisms segregate with other polymorphisms located in nearby genes, 
then a particular haplotype may contribute to an altered P1/P2 ratio in patients. This 
aligns with the current understanding that many common diseases in humans are not 
caused by a single genetic variant within a single gene but are influenced by complex 
interactions among multiple genes as well as environmental and lifestyle factors. 9 The 
candidate gene approach applied for decades to identify genetic variants contributing to 
disease states has been slow, inefficient, and arduous. Whereas, the introduction of 
genome-wide association studies, in which millions of SNPs are assayed in large patient 
populations, have provided a new tool for investigating the genetic complexity of 
multifactorial diseases.10-14 A low but significant number of SNPs have been associated 
with a number of diseases including infertility, however, the limitation has been the small 
effect conferred by common SNP variants to a disease state with a typical odd ratio of 1.1 
-1.2.9 A low odd ratio may seem clinically irrelevant for estimating the risk a particular 
haplotype poses, but can help identify biological pathways that may be used as potential 
drug targets to treat or impede disease progression. 
 
Epigenetics and its Role in Infertility 
Currently, the only treatment option for severe male factor infertility is 
intracytoplasmic sperm injection (ICSI), due in large part to the lack of understanding of 
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the underlying mechanism contributing to infertility. Although ICSI has revolutionized 
the treatment of male infertility and provided a quick fix for the couple undergoing 
infertility treatment, this treatment strategy may place parents at risk of transmitting 
genetic and epigenetic abnormalities to the progeny. The long-term implications and 
safety of assisted reproductive technologies (ART), specifically intracytoplasmic sperm 
injection (ICSI), have not been defined since the first ICSI child was conceived in the 
early ‘90s.15   
With the growing understanding of the role and significance of epigenetics in 
cellular processes, developmental pathways, and disease states (i.e., complex and 
monogenic diseases such as cancer and imprinting diseases), we and other raised the 
question of whether epigenetic abnormalities in gametes may be associated with 
infertility or poor reproductive outcome. To achieve a better understanding of the role of 
epigenetics in infertility, we first investigated the epigenetic state of fertile men. This 
work revealed many new and interesting concepts, which revised our understanding of 
the potential paternal contribution to zygotic development. Our data suggest that the 
sperm epigenome retains a substantial amount of epigenetic information, although the 
vast majority of the genome is packaged with protamines. However, we find that the 
small amounts of nucleosomes retained were not randomly distributed, but enriched at 
many developmental promoters, miRNA genes and imprinted loci.  These initial findings 
suggest that histone retention might be programmatic.  
To infer a developmental role to the retained nucleosomes, canonical 
nucleosomes alone will be insufficient to differentiate retained vs newly incorporated 
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maternal histones shortly after fertilization, but rather these retained nucleosomes should 
be secondarily marked by methylation or acetylation, etc. Genome-wide maps for a 
number of modifications reveal that the sperm genome is in fact poised for two programs: 
the first is a gametogenesis program which is highly enriched with H3K4me3 (a mark of 
gene activation) and the second is a developmental program that correlates with 
H3K27me3 (a repressive mark) or the presence of two contrasting marks H3K4me and 
H3K27me- reminiscent of bivalent domains in embryonic stem cells. Furthermore, the 
majority of developmental transcription and differentiation factors were found to be 
hypomethylated,16-18 but acquired methylation in a differentiated tissue (Chapter 5).  
Retaining a stem-like state in a mature fully differentiated germ cell suggests 
either these marks have an instructive role in the developing embryo or are residual 
marks from the spermatogonial stem cell and a property of the germline. In short, direct 
evidence for either hypothesis is lacking. Prior to our work, it was long thought that the 
potential contribution from the paternal genome to the zygote was limited due to changes 
in chromatin composition during spermatogenesis, which resulted in the vast replacement 
of histones with protamines,19,20 proteins not known to propagate information via 
modifications.  One hypothesis is that the male genome does not convey gene packaging 
information (beyond the methylated imprinted genes), as it can simply be 
‘reprogrammed’ and repackaged by the egg following fertilization to achieve totipotency.  
This notion has predominated given the active DNA demethylation observed in mice and 
humans shortly upon fertilization.21,22 Although demethylation of a portion of the genome 
clearly occurs, this has only been studied in ‘bulk’ and we currently lack an 
understanding of which genes in the genome are susceptible or resistant to DNA 
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demethylation, beyond the known resistant imprinted genes. A full understanding of the 
methylation state of the gametes before and after fertilization will be an important step 
forward. 
An alternative perspective is that the sperm chromatin is indeed poised and that 
the small amounts of histones retained in the paternal genome may be instructive. The 
conservation in chromatin packaging and DNA hypomethylation at many developmental 
loci in human, mouse, and zebrafish sperm genomes makes the genome-wide 
demethylation of the paternal genome all the more curious, if needed (in part) for 
totipotency, and raises many questions regarding the extent of embryonic 
reprogramming.17,23,24 
Although a definitive answer for genome-wide reprogramming at fertilization in 
mammals is unknown, in early zebrafish embryos it was found that H3K4me and 
H3K27me marks were erased and later re-established after fertilization.25 This could 
imply that the zebrafish zygotic genome may undergo complete erasure with epigenetic 
reestablishment occurring from a clean slate. Alternatively, germ cells may retain cellular 
memory but the levels of H3K4me and H3K27me may be extremely low and beyond 
antibody detection limits. In contrast to the finding in zebrafish, Brykczynska et al. 
(2010), mentioned in his discussion that paternal histones in both mouse and human 
embryos were retained in the embryo (unpublished data from Antione Peter’s Lab).24 
Whether this discrepancy between human/mouse vs. zebrafish is true is uncertain.  
However, an indirect approach to assess the potential significance of the sperm 
epigenome to development and fertility and overcome the known limitation of human 
genetic experiments will be to establish a direct correlation between alterations in 
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chromatin composition, or epigenetic state, to cases of male infertility or poor 
reproductive outcome. Animal studies 26 and human meta-analysis 27-30 have shown that 
ART increases the risk of imprinting disorders, but whether this is due to epigenetic 
alterations in the gametes or derived from in-vitro culture and manipulation is unclear. It 
was recently shown that embryo culture conditions induced persistent epigenetic changes 
at the agouti locus in mice. This is the first study to establish a strong correlation between 
preimplantation embryo growth conditions and persistent epigenetic changes.31 
Furthermore, we and others have concurrently showed that the epigenetic changes at 
maternally and paternally imprinted loci reside in the gametes of infertile men (Chapter 
6), but whether these epimutations in sperm can be inherited is unknown.32-38 
Remarkably, when we were examining normally demethylated differentially methylated 
regions (DMRs), the alleles of infertile patients are often either unaffected, have a 
moderate number of CpGs affected, or entirely methylated. Clearly, complete 
methylation of a normally unmethylated locus may lead to an imprinting disorder in the 
embryo if proper imprint reestablishment mechanisms are not implemented.39,40 Also the 
small number of CGs affected within some genes and alleles raise concerns regarding 
whether the few abnormally methylated Cs have reached a critical threshold that results 
in the recruitment of methyl binding proteins and DNA methyltransferases and lead to 
complete methylation in the embryo (at a certain unknown probability) and confer 
disease. Therefore, these data suggest that epigenetic changes, specifically DNA 
methylation in gamates, if not corrected may account for the increased incidence of 
imprinting disorders in offspring conceived by ART.  
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To determine whether epigenetic changes in gametes of infertile men were 
restricted to imprinted loci or extended genome-wide we characterized the sperm 
epigenome of two patient populations: infertile men with poor semen parameters and 
abnormal protamine ratios and the second population were recurrent poor reproductive 
outcome patients. Unlike fertile men, infertile men have nonprogrammatic histone 
retention genomewide, and the abnormal histone localization pattern is a result of an 
incomplete replacement of histone by protamine in the genome as whole. This results in 
an increased background of abnormally retained histone that obscures the pattern of 
appropriately retained histones seen in normal sperm. This incomplete removal of 
nucleosomes might be attributed to improper histone acetyl transferase activity in the 
round spermatid or due to the inefficiency in chromatin remodeling machinery.  
These findings raise concerns regarding the clinical ramifications of an altered 
histone retention profile in the sperm of infertile men. Although the perdurance of sperm 
nucleosomes in the embryo has not been established, we speculate that if histones are 
replaced following fertilization, then nonprogrammatic histone retention may not 
necessarily affect the embryo other than potentially increasing levels of sperm DNA 
damage, which may be corrected by the oocyte’s DNA repair machinery.41 In contrast, if 
nucleosomes are retained in the male pronucleus but active genome-wide reprogramming 
in the male pronucleus requires naked DNA, then this non-programmatic histone 
retention may affect the efficiency and extent of reprogramming of the paternal 
pronucleus. Several studies, including recent nuclear transfer studies of either 
gynogenetic or androgenetic embryos, have suggested that the active demethylation of 
the paternal genome takes place during the remodeling of sperm chromatin following 
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fertilization but prior to pronuclear formation.42,43 During this period of protein exchange 
the paternal DNA is presumably loosely packaged or possibly naked,44 therefore, 
providing a unique opportunity for active DNA demethylation.  
While nucleosomes were randomly retained genome-wide in infertile men, the 
localization of modified nucleosomes was similar to fertile controls suggesting that the 
establishment of epigenetic marks in the spermatogonial stem cell remains largely intact 
in infertile men, however, H3K4me and H3K27me levels were significantly reduced or 
absent at a number of developmental promoters and imprinted loci. The loss or reduction 
in H3K4me at the developmental and imprinted loci did not always correlate with a gain 
in DNA methylation in sperm. However, the loss of H3K4me may predispose these 
regions to acquiring DNA methylation in the early embryo since DNMT3A/B/3L 
specifically interact with the amino terminus of H3 and this interaction was strongly 
inhibited by H3K4me.45 
 
Conclusion and Future Direction 
Together this body of work provides a better understanding of the sperm genetic 
and epigenetic states and their potential role in spermatogenesis and fertility. Most 
importantly, we have revealed new features of germline chromatin, which has 
significantly expanded our understanding of the potential role of the sperm epigenome. 
Furthermore, we show for the first time genomewide changes in chromatin packaging 
and poising are common in the gametes of infertile men.  
Given that in males the spermatogenic process is continuous throughout life, it is 
essential to elucidate how genetic and epigenetic processes are influenced by aging and 
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environmental cues. Recently, a sizeable body of evidence suggested that epigenetic 
alterations acquired with age might also be inherited by the offspring.46-48 In humans, 
advanced paternal age (APA) is associated with an increased risk of neuro developmental 
and neuro psychiatric disorders such as schizophrenia, autism, bipolar disorder, dyslexia, 
reduced intelligence, and neural tube defects.46-48  Therefore, evaluating semen samples 
collected at different time-points or environmental exposures will be important to identify 
whether methylation changes occur genomewide or at a subset of genes promoters (ex; 
promoters with or without repeat elements). 
While it has long been known that the maternal contribution to the embryo is 
extensive, little is known about the genome status and the role of genome packaging 
(chromatin), modification (methylation) and expression (RNA) in the creation of a 
totipotent egg or embryo. Like sperm, a multitude of contributing mechanisms can be 
envisioned for the oocyte including the loading of maternal RNAs (coding and 
noncoding) that promote totipotency, the loading and function of key transcription factor 
proteins (including pluripotency/self renewal factors), and chromatin structures that 
enable (or prevent) the expression of particular embryonic developmental regulators. 
A full understanding of both maternal and paternal chromatin status and the extent 
of embryonic reprogramming in early embryos will clarify the role and significance of 
germ cell chromatin to development, fertility, and transgenerational inheritance. These 
questions have recently become feasible as a result of the recent advances in 
sophisticated genomic methodologies such as high through-put genome-wide sequencing 
and tools for methylation analysis at single base pair resolution.  
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Sequence alterations in the YBX2 gene are associated
with male factor infertility
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Objective: To investigate YBX2 gene alterations in men with severe defects in spermatogenesis, including
azoospermia or severe oligozoospermia, and protamine deregulation. MSY2 has been identified as a central
component in the regulation of spermatogenesis in mice, but the potential role of its human orthologue, YBX2
or ‘‘Contrin,’’ in human infertility is not known.
Design: A prospective cohort study.
Setting: University infertility clinic and associated research laboratory.
Patient(s): A total of 288 men were evaluated. Diagnoses were made of complete azoospermia, severe oligozoo-
spermia, and protamine deregulation, or men were of known paternity.
Intervention(s): Deoxyribonucleic acid (from peripheral blood) and semen samples were collected and analyzed
for gene mutations and semen parameters respectively.
Main Outcome Measure(s): YBX2 gene alterations.
Result(s): YBX2 sequence analysis revealed 15 polymorphic sites, of which seven polymorphisms were present
at a statistically higher frequency in one or both of the patient populations than in controls. Of these seven, two
resulted in an amino acid substitution in the highly conserved cold shock domain and one resulted in a highly
significant synonymous change in exon 8 of infertile patients. The frequency of single nucleotide polymor-
phisms was significantly elevated in patients with infertility, particularly in men with abnormal protamine
expression.
Conclusion(s): These data indicate a significant association between gene alterations in the YBX2 gene and
abnormal spermatogenesis in humans, including a potential role in altering protamine expression, and implicate
YBX2 gene alterations as a potential cause of male factor infertility. (Fertil Steril! 2009;91:1090–5. "2009 by
American Society for Reproductive Medicine.)
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One of the distinctive characteristics of chromatin remodel-
ing during spermatogenesis is the sequential transition of
the histone-bound genome in primary spermatocytes to
a protamine-bound genome in the elongating spermatid
(1–4). This transition requires temporal uncoupling of
DNA transcription and messenger RNA (mRNA) translation
in the developing spermatid (5–7) and results in a highly
condensed and likely transcriptionally silent chromatin struc-
ture (2). Therefore, it is believed that the regulation of prot-
amine incorporation is related strongly to the temporal
uncoupling of transcription and translation in the developing
sperm (8).
The mechanism by which spermatogenic translational re-
pression operates is not entirely understood. However, it is
clear that messenger ribonucleoproteins (mRNPs), com-
plexes of RNA-binding proteins (RBP) andmRNAs, are pres-
ent in the round and elongating spermatid stages (9). The
phosphorylated RBPs bind mRNAs with little sequence spec-
ificity (10) and associate with mRNPs to inhibit translation
(11). Modifications to the mRNP complexes release translat-
able mRNAs to reinitiate protein synthesis.
A number of RNA-binding proteins in mice, and their
human homologues, have been identified in germ cells
(12–14). One family of RBPs is the Y-box protein family,
which is known to include the mouse variants: MSY1,
MSY2, and MSY4 (15–18). The mouse Y-box protein
MSY2 is one of the most abundant DNA/RNA-binding pro-
teins, constituting 0.7% of the total protein in the spermatid
(19). In the mouse testis, MSY2 expression is highest in
the round spermatid, where translational repression domi-
nates, suggesting a role for MSY2 as an mRNA-stabilizing
protein (20).
MSY2 may also function as a transcription factor in mam-
malian male germ cells because it binds to the Y-box sequence
in the mouse protamine 2 promoter (21) and stimulates tran-
scription from the mouse protamine 2 promoter in in vitro as-
says (22). It has also been postulated that MSY2 acts as
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a nuclear shuttle protein, binding specific transcripts and re-
moving them from the spermatocyte nucleus (19, 23, 24).
These data suggest that MSY2 functions as a transcription fac-
tor promoting the transcription of testis-specific genes and also
functions as a structural component of mRNPs in the cyto-
plasm of maturing germ cells (14, 25).
Gene-targeting studies have demonstrated that MSY2
knockout mice appear phenotypically normal but males are
sterile (23). Spermatogenesis is disrupted in the postmeiotic
null germcellswithmany amorphous andmultinucleated sper-
matids in the testis, but no spermatozoa are present in the ep-
ididymis (24). The efficiency of nuclear histones’ replacement
with protamines in sperm from these transgenic mice has not
been reported, but it is likely that it has been affected. This con-
clusion is supported by the analysis of testicular sperm mor-
phology, which indicates a failure of proper elongation of
sperm, a process tightly coupled to protamine incorporation.
Recent studies demonstrate that a human homologue of
MSY2 is expressed in human testis and is known as YBX2
or ‘‘Contrin’’ (26). To determine whether mutations in the
YBX2 gene are associated with specific subtypes of male in-
fertility, we evaluated the genomic sequence of YBX2 in pa-
tients with azoospermia, oligozoospermia, and protamine
deficiency in comparison with men of known paternity.
MATERIALS AND METHODS
After obtaining University of Utah Institutional Review
Board approval for all aspects of the study, 288 patients
were recruited for YBX2 gene sequencing. These patients
were classified into three groups: group 1 contained 96 men
of known paternity from the Utah Genetic Reference Project
(UGRP), group 2 contained 47 men with azoospermia and 49
men with severe oligozoospermia (<5! 106 sperm/mL), and
group 3 included 96 infertile men with an abnormal prot-
amine 1 to protamine 2 ratio (P1/P2). The above samples
have been screened previously for alterations in the prot-
amine and transition protein gene regions (27). Patients
with abnormal protamine expression were selected on the ba-
sis of previous work identifying YBX2 as an important com-
ponent of spermatogenic gene expression (16, 19). To
increase the chance of identifying a mutation in the YBX2
gene responsible for male infertility and to decrease possible
confounding factors, patients were excluded if they had any
suspected or known causes of male factor infertility. This cri-
terion excluded patients with a known Y-chromosome micro-
deletion, cystic fibrosis, varicocele, Klinefelter’s syndrome,
or prior exposure to chemotherapeutics or radiation. Deoxy-
ribonucleic acid was extracted from peripheral lymphocytes
with use of the Puregene DNA extraction kit (Gentra
Systems, Minneapolis, MN).
Evaluation of Sperm P1/P2 Ratio
Study participants with an abnormal protamine ratio were
identified with use of nuclear protein extraction, gel electro-
phoresis, and densitometry analysis. Sperm nuclear proteins
were extracted from cryopreserved semen aliquots as previ-
ously described (28). Gel electrophoresis reagents were ob-
tained from Bio-Rad Laboratories (Hercules, CA). All
other reagents were obtained from Sigma Chemical Com-
pany (St. Louis, MO).
Screening for Mutations
Primer sets were designed and optimized to amplify the ex-
onic regions of YBX2with their bordering intronic sequences
by standard polymerase chain reaction (PCR) techniques.
Primary PCR products were cleaned with use of ExoSAP-
IT (USB, Cleveland, OH) and sequenced in the forward
and reverse direction.
Samples were sequenced with use of ABI 3700 capillary
sequencer. Sequence traces were assembled with use of the
Phrap software (available from http://www.phrap.org) and
analyzed for significant changes with use of Phred and
Consed. Phred assigns a quantitative value to quality of
each sequenced base. This base quality provides a probabilis-
tic estimate of the correctness of the base call.
Potential mutations were identified with use of Consed,
which has the ability to search for high-quality base discrep-
ancies in the assembled sequences. Visual analysis was also
used to confirm identified polymorphisms and potential mu-
tations. The frequencies of novel single nucleotide polymor-
phisms (SNPs) were compared by c2 analysis with Fisher
correction when necessary and use of SPSS (SPSS Inc.,
Chicago, IL) and Intercooled Stata (StataCorp, College
Station, TX).
RESULTS
Direct sequencing of the YBX2 gene in the control and study
populations revealed 13 SNPs, one dinucleotide deletion, and
a single trinucleotide deletion (Table 1). These polymorphic
sites were found in exonic and neighboring intronic regions.
The frequencies of the heterozygous and homozygous muta-
tions are reported in Table 1. Gene alterations were consid-
ered significant at a P value%.05.
Among these gene alterations, four are exonic polymor-
phisms that resulted in either an amino acid change or amino
acid deletion. Three of these SNPs localized to the highly
conserved region of exon 1 and one to exon 5. Two of the
three SNPs occurring in exon 1 were found at a significantly
increased frequency in either one or both of the study popu-
lation groups (oligozoospermic/azoospermic or abnormal P1/
P2) when compared with controls (UGRP patients), whereas
the Ser53-Pro amino acid change in exon 1 was present at
similar frequencies in all populations tested. The Val9-Gly
change in exon 1, which occurs at a significantly higher inci-
dence in men with protamine abnormalities than in UGRP
controls, has been reported previously as a miscellaneous dif-
ference between a reported mRNA sequence and the human
genome (build 36) (29). However, the previously unreported
Pro80-Gln alteration in exon 1 is not found in any of the se-
quenced UGRP controls but is prevalent in both patient
groups (oligozoospermic/azoospermic or abnormal P1/P2)
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at an allelic frequency of 0.062 (P¼.019) for the men with
azoospermia or oligozoospermia and 0.037 (P¼.08) in the
abnormal protamine group. The Phe229 deletion (the dele-
tion does not cause any frameshift events or early termination
sites) in exon 5 was present only in the patients with abnormal
protamine but absent in the remaining two populations (oli-
gozoospermic/azoospermic and UGRP). However, the prev-
alence of this deletion was very low and did not achieve
significance.
In addition, three synonymous SNPs were identified in
exons 5 and 8. The SNP in exon 8 is drastically increased
in infertile patients (those with oligozoospermia or azoosper-
mia or abnormal P1/P2) and absent from the control popula-
tion (UGRP). Single nucleotide polymorphisms identified in
the 50 UTR and in the noncoding region of exon 9 are limited
to infertile patients but are present at insignificant frequencies
(Table 1). The remaining six SNPs were localized to intron/
exon borders; four are significantly increased in the study
populations (Table 1).
When calculating the overall allelic frequency of gene al-
terations in the three different patient populations, we note
that the frequency is significantly higher in the infertile pa-
tients (oligozoospermic/azoospermic or abnormal P1/P2)
when compared with controls. However, when we calculated
the allelic frequency of polymorphisms that resulted in amino
acid changes, the frequency was not different for patients
with azoospermia or oligozoospermia when compared with
controls but was significantly higher in patients with abnor-
mal protamine expression. The corresponding frequencies
and P value results are summarized in Table 2.
DISCUSSION
This is the first report to establish a potential link between ge-
nomic alterations of a key spermatogenesis regulator (YBX2)
and male factor infertility. The subgroups of infertility patients
tested are men with azoospermia or severe oligozoospermia
andmenwith protamine deregulation. Variations in the number
of reads sequenced for each gene alteration are dependent on
Guanine and Cytosine (GC) content, the number of repetitive
nucleotides, and DNA fidelity. Among the identified novel
gene polymorphisms reported here are several alterations that
correlate with sperm production and/or sperm function, in
that there is an overall increase in the frequency of men carry-
ing any one of the identified polymorphisms in the azoosper-
mic/oligospermic or abnormal protamine groups (16.50% and
25.20%, respectively) when compared with the UGRP (fertile
control) population (11.60%) (Table 2). However, these data in-
dicate that gene alterations of the YBX2 gene and bordering in-
tronic areas are far more common in these two subgroups of
infertile men than is seen in the general population. Thus our
findings suggest that the regulatory role of YBX2 in regard to
male factor fertility and specifically to patients with abnormal
protamine expression is paramount, just as has been shown in
the mouse model with the MSY2 homologue (19, 23, 24, 30).
The gene alterations identified in exon 1 become more in-
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cold shock domain among mammalian species and contains
a putative casein kinase 2 phosphorylation site (26). The
Val9-Gly substitution is in close proximity to this putative re-
gion, whereas the remaining polymorphisms in this exon are
in highly conserved regions from mouse to human (26).
It is intriguing that four of the nine polymorphisms identi-
fied in the nearby intronic and noncoding regions occur at sig-
nificantly higher frequencies in the infertile groups than in the
UGRP controls. These are all novel gene alterations and are
not overlapping with genes in the plus or minus direction of
the YBX2 gene. Further analysis of sequence alterations in
intronic and noncoding regions is required to determine
whether these modifications potentially may alter mRNA
splicing or create de novo splice sites that may alter sper-
matogenesis.
The significance of the findings reported here is threefold.
First, this is the first report of an infertility gene that has been
characterized with several significant and potentially mean-
ingful alterations that are likely associated with spermatogen-
esis. Second, these data clearly indicate that infertility
patients have a significantly increased frequency of gene al-
terations compared with the control patients (UGRP) in the
YBX2 gene. Third, many of the identified alterations are
novel. Currently this proposition is limited to the populations
of men with decreased or few sperm in the ejaculate and men
with an abnormal pattern of protamine expression; however,
a strong relationship between YBX2 gene fidelity and male
factor infertility looks promising. Currently there is no
proved causal association between YBX2 alteration and prot-
amine deregulation, but it may be one of the potential causes.
However, it has been hypothesized that the manifestation of
protamine deregulation in men is an indication of a more
global spermatogenic defect (8). Future studies will examine
the relationship of YBX2 regulatory mechanisms, sperm con-
centration, and protamine deregulation.
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